{"messages":[{"status":"ok","interval":"2020-03-01:2020-03-30","cursor":"5","count":100,"total":"108"}], "collection":[{"preprint_doi":"10.1101\/19006163","published_doi":"10.1002\/pds.4984","published_journal":"Pharmacoepidemiology and Drug Safety","preprint_platform":"medRxiv","preprint_title":"Rise and Regional Disparities in Buprenorphine Utilization in the United States","preprint_authors":"Pashmineh, A. A. R.; Cruz-Mullane, A.; Podd, J. C.; Lam, W. S.; Kaleem, S. S.; Lockard, L. B.; Mandel, M. R.; Chung, D. Y.; Davis, C. S.; Nichols, S. D.; McCall, K. L.; Piper, B. J.","preprint_category":"addiction medicine","preprint_date":"2019-09-09","published_date":"2020-03-16","preprint_abstract":"AimsBuprenorphine is an opioid partial-agonist used to treat Opioid Use Disorders (OUD). While several state and federal policy changes have attempted to increase buprenorphine availability, access remains well below optimal levels. This study characterized how buprenorphine utilization in the United States has changed over time and whether there are regional disparities in distribution.\n\nMeasurementsBuprenorphine weights distributed from 2007 to 2017 were obtained from the Drug Enforcement Administration. Data was expressed as the percent change and as the mg per person in each state. Separately, the formulations for prescriptions covered by Medicaid (2008 to 2018) were examined.\n\nFindingsBuprenorphine distributed to pharmacies increased about seven-fold (476.8 to 3,179.9 kg) while the quantities distributed to hospitals grew five-fold (18.6 to 97.6 kg) nationally from 2007 to 2017. Buprenorphine distribution per person was almost 20-fold higher in Vermont (40.4 mg\/person) relative to South Dakota (2.1 mg\/person). There was a strong association between the number of waivered physicians per 100K population and distribution per state (r(49) = +0.76, p < .0005). The buprenorphine\/naloxone sublingual film (Suboxone) was the predominant formulation (92.6% of 0.31 million Medicaid prescriptions) in 2008 but this accounted for less than three-fifths (57.3% of 6.56 million prescriptions) in 2018.\n\nConclusionsAlthough buprenorphine availability has substantially increased over the last decade, distribution was very non-homogenous across the US.","preprint_author_corresponding":"Brian James Piper","preprint_author_corresponding_institution":"Geisinger Commonwealth School of Medicine"},{"preprint_doi":"10.1101\/2020.02.03.20020248","published_doi":"10.1016\/j.ijid.2020.03.020","published_journal":"International Journal of Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Estimation of the asymptomatic ratio of novel coronavirus (2019-nCoV) infections among passengers on evacuation flights","preprint_authors":"Nishiura, H.; Kobayashi, T.; Miyama, T.; Suzuki, A.; Jung, S.; Hayashi, K.; Kinoshita, R.; Yang, Y.; Yuan, B.; Akhmetzhanov, A. R.; Linton, N. M.","preprint_category":"epidemiology","preprint_date":"2020-02-11","published_date":"2020-03-14","preprint_abstract":"A total of 565 Japanese citizens were evacuated from Wuhan, China to Japan. All passengers were screened for symptoms and also undertook reverse transcription polymerase chain reaction testing, identifying 5 asymptomatic and 7 symptomatic passengers testing positive for 2019-nCoV. We show that the screening result is suggestive of the asymptomatic ratio at 41.6%.","preprint_author_corresponding":"Hiroshi Nishiura","preprint_author_corresponding_institution":"Hokkaido University"},{"preprint_doi":"10.1101\/19003319","published_doi":"10.1186\/s12886-020-01352-w","published_journal":"BMC Ophthalmology","preprint_platform":"medRxiv","preprint_title":"Toric Intraocular Lens Implantation in Cataract Patients with Corneal Opacity.","preprint_authors":"Ra, H.; Kim, H. S.; Kim, M. S.; Kim, E. C.","preprint_category":"ophthalmology","preprint_date":"2019-07-30","published_date":"2020-03-13","preprint_abstract":"AimsTo evaluate the effect of toric intraocular lens implantation in cataract patient with corneal opacity and high astigmatism.\n\nMethods31 eyes of 31 patients who underwent cataract surgery with toric intraocular lens implantation were included. All patients had corneal opacity with regular astigmatism. Preoperative total corneal astigmatism was determined considering posterior astigmatism using a rotating Scheimpflug camera (Pentacam(R): Oculus, Wetzlar, Germany). At 2 months after toric intraocular lens implantation, we evaluated residual astigmatism, uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA).\n\nResultsPostoperative UCVA and BCVA (0.30 {+\/-} 0.17, 0.22 {+\/-} 0.16LogMAR) statistically improved compared to preoperative UCVA and BCVA (1.2 {+\/-} 0.34, 1.1 {+\/-} 0.30LogMAR, respectively) (P<0.01). Postoperative residual refractive astigmatism (1.2 {+\/-} 0.35D) was statistically reduced compared to preoperative refractive astigmatism (2.4 {+\/-} 0.65D) (P<0.05). Preoperative and postoperative total corneal astigmatism values were not statistically different. All cases achieved visual acuity were as good as or better than that preoperatively. The percentage of corneal opacity covering pupillary area had significant negative correlation with postoperative UCVA and BCVA (logMAR) (R=-0.88 P<0.00001 and R=-0.87 P<0.00001, respectively)\n\nConclusionToric intraocular lens implantation can improve UCVA, BCVA, and refractive astigmatism in cataract patient with corneal opacity. The percentage of central corneal opacity covering pupillary area is the major prognostic factor for postoperative visual improvement. Therefore, toric intraocular lens implantation should be considered for cataract patients who have corneal opacity with high astigmatism.","preprint_author_corresponding":"Eun Chul Kim","preprint_author_corresponding_institution":"Bucheon St. Mary\\'s Hospital, Catholic University of Korea"},{"preprint_doi":"10.1101\/19001313","published_doi":"10.1371\/journal.pone.0229790","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"The global scientific research response to the public health emergency of Zika virus infection","preprint_authors":"Oliveira, J. F.; Pescarini, J. M.; Rodrigues, M. S.; Almeida, B. A.; Henriques, C. M. P.; Gouveia, F. C.; Rabello, E. T.; Matta, G. C.; Barreto, M. L.; Sampaio, R. B.","preprint_category":"epidemiology","preprint_date":"2019-07-16","published_date":"2020-03-12","preprint_abstract":"BackgroundScience studies have been a field of research for different knowledge areas and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination. In this study, we aimed to verify how the Zika epidemic has moulded scientific production worldwide analysing international collaboration and the knowledge landscape through time, research topics and country involvement.\n\nMethodologyWe searched the Web of Science (WoS) for studies published up to 31st December 2018 on Zika using the search terms \"zika\", \"zkv\" or \"zikv\". We analysed the scientific production regarding which countries have published the most, on which topics, as well as country level collaboration. We performed a scientometric analysis of research on Zika focusing on knowledge mapping and the scientific research path over time and space.\n\nFindingsWe found two well defined research areas divided into three subtopics accounting for six clusters. With regard to country analysis, the USA followed by Brazil were the leading countries in publications on Zika. China entered as a new player focusing on specific research areas. When we took into consideration the epidemics and reported cases, Brazil and France were the leading research countries on related topics. As for international collaboration, the USA followed by England and France stand out as the main hubs. The research areas most published included public health related topics from 2015 until the very beginning of 2016, followed by an increase in topics related to the clinical aspects of the disease in 2016 and the beginnings of laboratorial research in 2017\/2018.\n\nConclusionsMapping the response to Zika, a public health emergency, demonstrated a clear pattern of the participation of countries in the scientific advances. The pattern of knowledge production found in this study represented the different perspectives and interests of countries based firstly on their level of exposure to the epidemic and secondly on their financial positions with regard to science.","preprint_author_corresponding":"Ricardo Barros Sampaio","preprint_author_corresponding_institution":"Centro de Integracao de Dados e Conhecimentos para Saude, Fiocruz, Salvador, Bahia, Brazil; Gerencia Regional de Brasilia, Fiocruz, Brasilia, Brazil"},{"preprint_doi":"10.1101\/19011130","published_doi":"10.1371\/journal.pone.0229883","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Prevalence of malnutrition and associated factors among adult patients on Antiretroviral Therapy follow up care in Jimma Medical Center, Southwest Ethiopia.","preprint_authors":"Daka, D. W.; Ergiba, M. S.","preprint_category":"hiv aids","preprint_date":"2019-11-05","published_date":"2020-03-12","preprint_abstract":"BackgroundMalnutrition especially under nutrition is the main problem that is seen over people living with HIV\/AIDS and can occur at any age. Multiple factors contributed to malnutrition of HIV\/AIDS patients and it need immediate identification and prompt action. The objective of this study was to assess the nutritional status of patients and identify factors associated with malnutrition among HIV\/AIDS patients on follow-up care in Jimma medical center, Southwest Ethiopia.\n\nMethodsA cross-sectional study design was conducted from March-April, 2016. Data was collected retrospectively from clinical records of HIV\/AIDS patients enrolled for follow up care in ART clinic from June 2010 to January 2016. Binary and multiple variable logistic regression was done to identify independent predictor of malnutrition.\n\nResultsData of 971 patients were included in the study. The prevalence of under nutrition (BMI<18.5) was (36.8%) (95% CI: 33.8%-39.8%) and out of which severe malnutrition accounts 9.7%. Overweight and obese was 8.6%. Malnutrition was more likely among widowed patients (AOR=1.7, 95% CI, 1.034-2.798), patients in the WHO clinical AIDS staging of three (AOR=2.3, 95% CI, 1.392-3.693) and four (AOR=3.2, 95% CI, 1.667-5.943), patients with CD4 cell count of <200 cells\/mm3 (AOR=2.0, 95% CI, 1.463-2.837) and patients with a functional status of bedridden (AOR=4.677, 95% CI, 1.761-12.419) and ambulatory (AOR=2.763, 95% CI, 1.833-4.165).\n\nConclusionBoth under nutrition and overweight are prevalent among HIV\/AIDS patients in Jimma Medical Center, Ethiopia. Malnutrition was significantly associated with clinical outcome of patients. Hence, nutritional assessment, care and support should be strengthened. Critical identification of malnourished patients and prompt interventions should be undertaken.","preprint_author_corresponding":"Dawit W Daka","preprint_author_corresponding_institution":"Jimma University"},{"preprint_doi":"10.1101\/19009589","published_doi":"10.1371\/journal.pone.0230274","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Dengue importation into Europe: a network connectivity-based approach","preprint_authors":"Salami, D.; Capinha, C.; Martins, M. d. R. O.; Sousa, C. A.","preprint_category":"public and global health","preprint_date":"2019-10-18","published_date":"2020-03-12","preprint_abstract":"The spread of dengue through global human mobility is a major public health concern. A key challenge is understanding the transmission pathways and mediating factors that characterized the patterns of dengue importation into non-endemic areas. Utilizing a network connectivity-based approach, we analyze the importation patterns of dengue fever into European countries.\n\nSeven connectivity indices were developed to characterize the role of the air passenger traffic, seasonality, incidence rate, geographical proximity, epidemic vulnerability, and wealth of a source country, in facilitating the transport and importation of dengue fever. We used generalized linear mixed models (GLMMs) to examine the relationship between dengue importation and the connectivity indices while accounting for the air transport network structure. We also incorporated network autocorrelation within a GLMM framework to investigate the propensity of a European country to receive an imported case, by virtue of its position within the air transport network.\n\nThe connectivity indices and dynamical processes of the air transport network were strong predictors of dengue importation in Europe. With more than 70% of the variation in dengue importation patterns explained. We found that transportation potential was higher for source countries with seasonal dengue activity, high passenger traffic, high incidence rates, lower economic status, and geographical proximity to a destination country in Europe. We also found that position of a European country within the air transport network was a strong predictor of the countrys propensity to receive an imported case.\n\nOur findings provide evidence that the importation patterns of dengue into Europe can be largely explained by appropriately characterizing the heterogeneities of the source, and topology of the air transport network. This contributes to the foundational framework for building integrated predictive models for bio-surveillance of dengue importation.","preprint_author_corresponding":"Donald Salami","preprint_author_corresponding_institution":"Institute of Hygiene and Tropical Medicine, Universidade Nova de Lisboa, Lisbon, Portugal"},{"preprint_doi":"10.1101\/19012823","published_doi":"10.1007\/s00520-020-05393-1","published_journal":"Supportive Care in Cancer","preprint_platform":"medRxiv","preprint_title":"Access to internet, smartphone usage, and acceptability of mobile health technology among cancer patients","preprint_authors":"Potdar, R.; Thomas, A.; DiMeglio, M.; Mohiuddin, K.; Djibo, D. A.; Laudanski, K.; Dourado, C.; Leighton, J.; Ford, J.","preprint_category":"oncology","preprint_date":"2019-11-22","published_date":"2020-03-12","preprint_abstract":"PurposeThe use of mobile health (mHealth) technologies to augment patient care, enables providers to communicate remotely with patients enhancing the quality of care and patient engagement. Few studies addressed barriers to its implementation, especially in medically underserved populations.\n\nMethodsA cross-sectional study of 151 cancer patients was conducted at an academic medical center in the United States. A trained interviewer performed structured interviews regarding the barriers and facilitators of patients current and desired utilization of technology for healthcare services.\n\nResultsOf the 151 participants, 35.8% were male and ages ranged from 21-104 years. Only 73.5% of participants currently have daily access to internet, and 68.2% currently own a smartphone capable of displaying mobile applications. Among all participants, utilization of a daily mHealth application was significantly higher in patients with a college-level degree (OR; 2.78, p<0.01) and lower in older patients (OR; 0.05, p<0.01). Differences in utilization when adjusted for current smartphone use and daily access to internet were nonsignificant. Among smartphone users, the desire to increase cancer knowledge was associated with a higher likelihood of utilizing a mHealth application (OR; 261.53, p<0.01).\n\nConclusionThe study suggests the access to mobile technology is the predominant determinant of utilization. Healthcare organizations should consider these factors when launching patient engagement platforms.","preprint_author_corresponding":"Matthew DiMeglio","preprint_author_corresponding_institution":"DO\/MBA Student, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA"},{"preprint_doi":"10.1101\/2020.01.31.20019901","published_doi":"10.1016\/S1473-3099(20)30144-4","published_journal":"The Lancet Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Early dynamics of transmission and control of 2019-nCoV: a mathematical modelling study","preprint_authors":"Kucharski, A. J.; Russell, T. W.; Diamond, C.; CMMID nCoV working group,  ; Funk, S.; Eggo, R. M.","preprint_category":"infectious diseases","preprint_date":"2020-02-02","published_date":"2020-03-12","preprint_abstract":"BackgroundAn outbreak of the novel coronavirus SARS-CoV-2 has led to 46,997 confirmed cases as of 13th February 2020. Understanding the early transmission dynamics of the infection and evaluating the effectiveness of control measures is crucial for assessing the potential for sustained transmission to occur in new areas.\n\nMethodsWe combined a stochastic transmission model with data on cases of novel coronavirus disease (COVID-19) in Wuhan and international cases that originated in Wuhan to estimate how transmission had varied over time during January and February 2020. Based on these estimates, we then calculated the probability that newly introduced cases might generate outbreaks in other areas.\n\nFindingsWe estimated that the median daily reproduction number, Rt, declined from 2.35 (95% CI: 1.15-4.77) one week before travel restrictions were introduced on 23rd January to 1.05 (95% CI: 0.413-2.39) one week after. Based on our estimates of Rt,we calculated that in locations with similar transmission potential as Wuhan in early January, once there are at least four independently introduced cases, there is a more than 50% chance the infection will establish within that population.\n\nInterpretationOur results show that COVID-19 transmission likely declined in Wuhan during late January 2020, coinciding with the introduction of control measures. As more cases arrive in international locations with similar transmission potential to Wuhan pre-control, it is likely many chains of transmission will fail to establish initially, but may still cause new outbreaks eventually.\n\nFundingWellcome Trust (206250\/Z\/17\/Z, 210758\/Z\/18\/Z), HDR UK (MR\/S003975\/1), Gates Foundation (INV-003174), NIHR (16\/137\/109)","preprint_author_corresponding":"Adam J Kucharski","preprint_author_corresponding_institution":"London School of Hygiene & Tropical Medicine"},{"preprint_doi":"10.1101\/19007005","published_doi":"10.1136\/tobaccocontrol-2019-055433","published_journal":"Tobacco Control","preprint_platform":"medRxiv","preprint_title":"Does e-cigarette use in non-smoking young adults act as a gateway to smoking? A systematic review and meta-analysis","preprint_authors":"Khouja, J. N.; Suddell, S. F.; Peters, S. E.; Taylor, A. E.; Munafo, M. R.","preprint_category":"epidemiology","preprint_date":"2019-10-08","published_date":"2020-03-11","preprint_abstract":"ObjectiveThe aim of this review was to investigate whether e-cigarette use compared to non-use in young non-smokers is associated with subsequent cigarette smoking.\n\nData sourcesPubMed, Embase, Web of Science, Wiley Cochrane Library databases, and the 2018 Society for Research on Nicotine and Tobacco and Society for Behavioural Medicine conference abstracts.\n\nStudy selectionAll studies of young people (up to age 30 years) with a measure of e-cigarette use prior to smoking and an outcome measure of smoking where an odds ratio could be calculated were included (excluding reviews and animal studies).\n\nData ExtractionIndependent extraction was completed by multiple authors using a pre-prepared extraction form.\n\nData synthesisOf 9,199 results, 17 studies were included in the meta-analysis. There was strong evidence for an association between e-cigarette use among non-smokers and later smoking (OR 4.59, 95% CI 3.60 to 5.85) when the results were meta-analysed in a random effects model. However, there was high heterogeneity (I2 = 88%).\n\nConclusionsWhilst the association between e-cigarette use among non-smokers and subsequent smoking appears strong, the available evidence is limited by the reliance on self-report measures of smoking history without biochemical verification. None of the studies included negative controls which would provide stronger evidence for whether the association may be causal. Much of the evidence also failed to consider the nicotine content of e-liquids used by non-smokers meaning it is difficult to make conclusions about whether nicotine is the mechanism driving this association.","preprint_author_corresponding":"Jasmine N Khouja","preprint_author_corresponding_institution":"University of Bristol"},{"preprint_doi":"10.1101\/19005421","published_doi":"10.1007\/s10552-020-01291-3","published_journal":"Cancer Causes & Control","preprint_platform":"medRxiv","preprint_title":"Systematic Review and Meta-Analysis of the Associations Between Body Mass Index, Prostate Cancer, Advanced Prostate Cancer and Prostate Specific Antigen","preprint_authors":"Harrison, S.; Tilling, K.; Turner, E. L.; Martin, R. M.; Lennon, R. J.; Lane, J. A.; Donovan, J.; Hamdy, F. C.; Neal, D. E.; Bosch, J. L. R.; Jones, H. E.","preprint_category":"oncology","preprint_date":"2019-09-09","published_date":"2020-03-11","preprint_abstract":"PurposeThe relationship between body-mass index (BMI) and prostate cancer remains unclear. However, there is an inverse association between BMI and prostate-specific antigen (PSA), used for prostate cancer screening. We conducted this review to estimate the associations between BMI and (1) prostate cancer, (2) advanced prostate cancer, and (3) PSA.\n\nMethodsWe searched PubMed and Embase for studies until 02 October 2017 and obtained individual participant data from four studies. In total, 78 studies were identified for the association between BMI and prostate cancer, 21 for BMI and advanced prostate cancer, and 35 for BMI and PSA. We performed random-effects meta-analysis of linear associations of log PSA and prostate cancer with BMI and, to examine potential non-linearity, of associations between categories of BMI and each outcome.\n\nResultsIn the meta-analyses with continuous BMI, a 5 kg\/m2 increase in BMI was associated with a percentage change in PSA of -5.88% (95% CI -6.87% to -4.87%). Using BMI categories, compared to normal weight men the PSA levels of overweight men were 3.43% lower (95% CI -5.57% to -1.23%), and obese men were 12.9% lower (95% CI -15.2% to -10.7%). Prostate cancer and advanced prostate cancer analyses showed little or no evidence associations.\n\nConclusionThere is little or no evidence of an association between BMI and risk of prostate cancer or advanced prostate cancer, and strong evidence of an inverse and non-linear association between BMI and PSA. The association between BMI and prostate cancer is likely biased if missed diagnoses are not considered.","preprint_author_corresponding":"Sean Harrison","preprint_author_corresponding_institution":"University of Bristol"},{"preprint_doi":"10.1101\/2020.02.27.20028639","published_doi":"10.1007\/s40484-020-0199-0","published_journal":"Quantitative Biology","preprint_platform":"medRxiv","preprint_title":"Modeling the Epidemic Dynamics and Control of COVID-19 Outbreak in China","preprint_authors":"Zhao, S.; Chen, H.","preprint_category":"epidemiology","preprint_date":"2020-02-29","published_date":"2020-03-11","preprint_abstract":"BackgroundThe coronavirus disease 2019 (COVID-19) is rapidly spreading in China and more than 30 countries over last two months. COVID-19 has multiple characteristics distinct from other infectious diseases, including high infectivity during incubation, time delay between real dynamics and daily observed number of confirmed cases, and the intervention effects of implemented quarantine and control measures.\n\nMethodWe develop a Susceptible, Un-quanrantined infected, Quarantined infected, Confirmed infected (SUQC) model to characterize the dynamics of COVID-19 and explicitly parameterize the intervention effects of control measures, which is more suitable for analysis than other existing epidemic models.\n\nResultsThe SUQC model is applied to the daily released data of the confirmed infections to analyze the outbreak of COVID-19 in Wuhan, Hubei (excluding Wuhan), China (excluding Hubei) and four first-tier cities of China. We found that, before January 30th, 2020, all these regions except Beijing had a reproductive number R > 1, and after January 30th, all regions had a reproductive number R < 1, indicating that the quarantine and control measures are effective in preventing the spread of COVID-19. The confirmation rate of Wuhan estimated by our model is 0.0643, substantially lower than that of Hubei excluding Wuhan (0.1914), and that of China excluding Hubei (0.2189), but jumps to 0.3229 after Feb 12th when clinical evidence was adopted in new diagnosis guidelines. The number of un-quarantined infected cases in Wuhan on February 12, 2020 is estimated to be 3,509 and declines to 334 on February 21th, 2020. After fitting the model with data as of February 21th, 2020, we predict that the end time of COVID-19 in Wuhan and Hubei is around late March, around mid March for China excluding Hubei, and before early March 2020 for the four tier-one cities. A total of 80,511 individuals are estimated to be infected in China, among which 49,510 are from Wuhan, 17,679 from Hubei (excluding Wuhan), and the rest 13,322 from other regions of China (excluding Hubei). Note that the estimates are from a deterministic ODE model and should be interpreted with some uncertainty.\n\nConclusionWe suggest that rigorous quarantine and control measures should be kept before early March in Beijing, Shanghai, Guangzhou and Shenzhen, and before late March in Hubei. The model can also be useful to predict the trend of epidemic and provide quantitative guide for other countries in a high risk of outbreak, such as South Korea, Japan, Italy and Iran.","preprint_author_corresponding":"Hua Chen","preprint_author_corresponding_institution":"Beijing Institute of Genomics, Chinese Academy of Sciences"},{"preprint_doi":"10.1101\/2020.01.21.20018101","published_doi":"10.1016\/j.neurobiolaging.2020.03.003","published_journal":"Neurobiology of Aging","preprint_platform":"medRxiv","preprint_title":"Comprehensive assessment of PINK1 variants in Parkinson's disease","preprint_authors":"Krohn, L.; Grenn, F. P.; Makarious, M. B.; Kim, J. J.; Bandres-Ciga, S.; Roosen, D. A.; Gan-Or, Z.; Nalls, M. A.; Singleton, A. B.; Blauwendraat, C.","preprint_category":"genetic and genomic medicine","preprint_date":"2020-01-27","published_date":"2020-03-10","preprint_abstract":"Multiple genes have been associated with monogenic Parkinsons disease and Parkinsonism syndromes. Mutations in PINK1 (PARK6) have been shown to result in autosomal recessive early onset Parkinsons disease. In the past decade, several studies have suggested that carrying a single heterozygous PINK1 mutation is associated with increased risk for Parkinsons disease. Here we comprehensively assess the role of PINK1 variants in Parkinsons disease susceptibility using several large datasets totalling 376,558 individuals including: 13,708 Parkinsons disease cases and 362,850 controls. After combining these data, we did not find evidence to support a role for heterozygous PINK1 mutations as a risk factor for Parkinsons disease.","preprint_author_corresponding":"Cornelis Blauwendraat","preprint_author_corresponding_institution":"NIH"},{"preprint_doi":"10.1101\/2020.02.29.20029322","published_doi":"10.1016\/j.bbi.2020.03.007","published_journal":"Brain, Behavior, and Immunity","preprint_platform":"medRxiv","preprint_title":"Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control","preprint_authors":"Li, Z.; Ge, J.; Yang, M.; Feng, J.; Qiao, M.; Jiang, R.; Bi, J.; Zhan, G.; Xu, X.; Wang, L.; Zhou, Q.; Zhou, C.; Pan, Y.; Liu, S.; Zhang, H.; Yang, J.; Zhu, B.; Hu, Y.; Hashimoto, K.; Jia, Y.; Wang, H.; Wang, R.; Liu, C.; Yang, C.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2020-03-03","published_date":"2020-03-10","preprint_abstract":"Since December 2019, more than 79,000 people have been diagnosed with infection of the Corona Virus Disease 2019 (COVID-19). A large number of medical staff were dispersed for Wuhan city and Hubei province to aid COVID-19 control. Psychological stress, especially vicarious traumatization (VT) caused by the COVID-19 pandemic, should not be ignored. To address this concern, the study employed a total of 214 general public (GP) and 526 nurses to evaluate VT scores via a mobile app-based questionnaire. Results showed that the VT scores slightly increased across periods of aiding COVID-19 control, although no statistical difference was noted (P = 0.083). However, the study found lower scores for VT in nurses [median = 69; interquartile range (IQR) = 56-85] than those of the GP (median = 75.5; IQR = 62-88.3) (P = 0.017). In addition, the VT scores for front-line nurses (FLNs; median = 64; IQR = 52-75), including scores for physiological and psychological responses, were significantly lower than those of non-front-line nurses (nFLNs; median = 75.5; IQR = 63-92) (P < 0.001). Interestingly, the VT scores of the GP were significantly higher than those of the FLNs (P < 0.001). However, no statistical difference was observed compared with those of nFLNs (P > 0.05). Importantly, nFLNs are more likely to suffer from VT, which might be related to two factors, namely, gender [odds ratio (OR) = 3.1717; 95% confidence interval (CI) = 4.247-18.808; P = 0.002] and fertility [OR = 2.072; 95%CI = 0.626-24.533; P = 0.039]. Therefore, increased attention should be paid to the psychological problems of the medical staff, especially nFLNs, and GP under the situation of the spread and control of COVID-19. Early strategies that aim to prevent and treat VT in medical staff and GP are extremely necessary.","preprint_author_corresponding":"Cunming Liu","preprint_author_corresponding_institution":"The First Affiliated Hospital of Nanjing Medical University"},{"preprint_doi":"10.1101\/19007740","published_doi":"10.1038\/s41598-020-61236-3","published_journal":"Scientific Reports","preprint_platform":"medRxiv","preprint_title":"MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma.","preprint_authors":"Lietz, C. E.; Garbutt, C.; Barry, W. T.; Deshpande, V.; Chen, Y.-L.; Lozano-Calderon, S. A.; Wang, Y.; Lawney, B.; Ebb, D.; Cote, G. M.; Duan, Z.; Hornicek, F. J.; Choy, E.; Nielsen, G. P.; Haibe-Kains, B.; Quackenbush, J.; Spentzos, D.","preprint_category":"genetic and genomic medicine","preprint_date":"2019-10-03","published_date":"2020-03-10","preprint_abstract":"BackgroundThere is a lack of well validated biomarkers in osteosarcoma, a rare, recalcitrant disease with variable outcome and poorly understood biologic behavior, for which treatment standards have stalled for decades. The only standard prognostic factor in osteosarcoma remains the amount of pathologic necrosis following pre-operative chemotherapy, which does not adequately capture the biologic complexity of the tumor and has not resulted in optimized patient therapeutic stratification. New, robust biomarkers are needed to understand prognosis and better reflect the underlying biologic and molecular complexity of this disease.\n\nMethodsWe performed microRNA sequencing in 74 frozen osteosarcoma biopsy samples, the largest single center translationally analyzed cohort to date, and separately analyzed a multi-omic dataset from a large (n = 95) NCI supported national cooperative group cohort. Molecular patterns were tested for association with outcome and used to identify novel therapeutics for further study by integrative pharmacogenomic analysis.\n\nResultsMicroRNA profiles were found predict Recurrence Free Survival (5-microRNA profile, Median RFS 59 vs 202 months, log rank p=0.06, HR 1.87, 95% CI 0.96-3.66). The profiles were independently prognostic of RFS when controlled for metastatic disease at diagnosis and pathologic necrosis following chemotherapy in multivariate Cox proportional hazards regression (5-microRNA profile, HR 3.31, 95% CI 1.31-8.36, p=0.01). Strong trends for survival discrimination were observed in the independent NCI dataset, and transcriptomic analysis revealed the downstream microRNA regulatory targets are also predictive of survival (median RFS 17 vs 105 months, log rank p=0.007). Additionally, DNA methylation patterns held prognostic significance. Through machine learning based integrative pharmacogenomic analysis, the microRNA biomarkers identify novel therapeutics for further study and stratified application in osteosarcoma.\n\nConclusionsOur results support the existence of molecularly defined phenotypes in osteosarcoma associated with distinct outcome independent of clinicopathologic features. We validated candidate microRNA profiles and their associated molecular networks for prognostic value in multiple independent datasets. These networks may define previously unrecognized osteosarcoma subtypes with distinct molecular context and clinical course potentially appropriate for future application of tailored treatment strategies in different patient subgroups.","preprint_author_corresponding":"Dimitrios Spentzos","preprint_author_corresponding_institution":"Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA."},{"preprint_doi":"10.1101\/19005603","published_doi":"10.1109\/JBHI.2020.2977925","published_journal":"IEEE Journal of Biomedical and Health Informatics","preprint_platform":"medRxiv","preprint_title":"Natural Language Processing for Mimicking Clinical Trial Recruitment in Critical Care: A Semi-automated Simulation Based on the LeoPARDS Trial","preprint_authors":"Tissot, H.; Shah, A.; Agbakoba, R.; Folarin, A.; Brealey, D.; Harris, S.; Dobson, R.; Asselbergs, F.","preprint_category":"health informatics","preprint_date":"2019-09-09","published_date":"2020-03-10","preprint_abstract":"Clinical trials often fail on recruiting an adequate number of appropriate patients. Identifying eligible trial participants is a resource-intensive task when relying on manual review of clinical notes, particularly in critical care settings where the time window is short. Automated review of electronic health records has been explored as a way of identifying trial participants, but much of the information is in unstructured free text rather than a computable form. We developed an electronic health record pipeline that combines structured electronic health record data with free text in order to simulate recruitment into the LeoPARDS trial. We applied an algorithm to identify eligible patients using a moving 1-hour time window, and compared the set of patients identified by our approach with those actually screened and recruited for the trial. We manually reviewed clinical records for a random sample of additional patients identified by the algorithm but not identified for screening in the original trial. Our approach identified 308 patients, of whom 208 were screened in the actual trial. We identified all 40 patients with CCHIC data available who were actually recruited to LeoPARDS in our centre. The algorithm identified 96 patients on the same day as manual screening and 62 patients one or two days earlier. Analysis of electronic health records incorporating natural language processing tools could effectively replicate recruitment in a critical care trial, and identify some eligible patients at an earlier stage. If implemented in real-time this could improve the efficiency of clinical trial recruitment.","preprint_author_corresponding":"Hegler Tissot","preprint_author_corresponding_institution":"University College London"},{"preprint_doi":"10.1101\/2020.01.07.20016816","published_doi":"10.1007\/s10522-020-09863-1","published_journal":"Biogerontology","preprint_platform":"medRxiv","preprint_title":"Informative Frailty Indices from Binarized Biomarkers","preprint_authors":"Stubbings, G. M.; Farrell, S.; Mitnitski, A.; Rockwood, K.; Rutenberg, A.","preprint_category":"health informatics","preprint_date":"2020-01-10","published_date":"2020-03-10","preprint_abstract":"Frailty indices (FI) based on continuous valued health data, such as obtained from blood and urine tests, have been shown to be predictive of adverse health outcomes. However, creating FI from such biomarker data requires a binarization treatment that is difficult to standardize across studies. In this work, we explore a \"quantile\" methodology for the generic treatment of biomarker data that allows us to construct an FI without preexisting medical knowledge (i.e. risk thresholds) of the included biomarkers. We show that our quantile approach performs as well as, or even slightly better than, established methods for the National Health and Nutrition Examination Survey (NHANES) and the Canadian Study of Health and Aging (CSHA) data sets. Furthermore, we show that our approach is robust to cohort effects within studies as compared to other data-based methods. The success of our binarization approaches provides insight into the robustness of the FI as a health measure, the upper limits of the FI observed in various data sets, and highlights general difficulties in obtaining absolute scales for comparing FI between studies.","preprint_author_corresponding":"Andrew Rutenberg","preprint_author_corresponding_institution":"Dalhousie University"},{"preprint_doi":"10.1101\/19007914","published_doi":"10.12688\/f1000research.22040.1","published_journal":"F1000Research","preprint_platform":"medRxiv","preprint_title":"Findings of a feasibility study of pre-operative pulmonary rehabilitation to reduce post-operative pulmonary complications in people with chronic obstructive pulmonary disease scheduled for major abdominal surgery.","preprint_authors":"Marlow, L.; Lee, A.; Hedley, E.; Grocott, M.; Steiner, M.; Young, D.; Rahman, N.; Snowden, C.; Pattinson, K. T. S.","preprint_category":"anesthesia","preprint_date":"2019-11-06","published_date":"2020-03-09","preprint_abstract":"BackgroundPatients with chronic obstructive pulmonary disease (COPD) are at increased risk of complications and death following surgery. Pulmonary complications are particularly prominent. Pulmonary rehabilitation is a course of physical exercise and education that helps people with COPD manage their condition. Although proven to improve health outcomes in patients with stable COPD, it has never been formally tested as a pre-surgical intervention in patients scheduled for non-cardiothoracic surgery. If a beneficial effect were to be demonstrated, pulmonary rehabilitation for pre-surgical patients with COPD might be rapidly implemented across the National Health Service, as pulmonary rehabilitation courses are already well established across much of the United Kingdom (UK).\n\nMethodsWe performed a feasibility study to test study procedures and barriers to identification and recruitment to a randomised controlled trial testing whether pulmonary rehabilitation, delivered before major abdominal surgery in a population of people with COPD, would reduce the incidence of post-operative pulmonary complications. This study was run in two UK centres (Oxford and Newcastle upon Tyne).\n\nResultsWe determined that a full randomised controlled trial would not be feasible, due to failure to identify and recruit participants. We identified an unmet need to identify more effectively patients with COPD earlier in the surgical pathway. Service evaluations suggested that barriers to identification and recruitment would likely be the same across other UK hospitals.\n\nConclusionsAlthough pulmonary rehabilitation is a potentially beneficial intervention to prevent post-operative pulmonary complications, a randomised controlled trial is unlikely to recruit sufficient participants to answer our study question conclusively at the present time, when spirometry is not automatically conducted in all patients planned for surgery. As pulmonary rehabilitation is a recommended treatment for all people with COPD, alternative study methods combined with earlier identification of candidate patients in the surgical pathway should be considered.\n\nTrial registrationISRCTN 29696295, http:\/\/www.isrctn.com\/ISRCTN29696295, registered 31st August 2017","preprint_author_corresponding":"Kyle T S Pattinson","preprint_author_corresponding_institution":"University of Oxford"},{"preprint_doi":"10.1101\/19012336","published_doi":"10.1113\/JP279377","published_journal":"The Journal of Physiology","preprint_platform":"medRxiv","preprint_title":"Limited Capacity for Ipsilateral Secondary Motor Areas to Support Hand Function Post-Stroke","preprint_authors":"Wilkins, K. B.; Yao, J.; Owen, M.; Karbasforoushan, H.; Carmona, C.; Dewald, J. P. A.","preprint_category":"rehabilitation medicine and physical therapy","preprint_date":"2019-11-19","published_date":"2020-03-07","preprint_abstract":"Recent findings have shown connections of ipsilateral cortico-reticulospinal tract (CRST), predominantly originating from secondary motor areas, to not only proximal but also distal portions of the arm. In unilateral stroke, CRST from the ipsilateral side is intact and thus has been proposed as a possible backup system for post-stroke rehabilitation even for the hand. We argue that although CRST from ipsilateral secondary motor areas can provide control for proximal joints, it is insufficient to control either hand or coordinated shoulder and hand movements due to its extensive branching compared to contralateral corticospinal tract. To address this issue, we combined MRI, high-density EEG, and robotics in 17 individuals with severe chronic hemiparetic stroke and 12 age-matched controls. We tested for changes in structural morphometry of the sensorimotor cortex and found that individuals with stroke demonstrated higher gray matter density in secondary motor areas ipsilateral to the paretic arm compared to controls. We then measured cortical activity while participants attempted to generate hand opening either supported on a table or while lifting against a shoulder abduction load. The addition of shoulder abduction during hand opening increased reliance on ipsilateral secondary motor areas in stroke, but not controls. Crucially, increased use of ipsilateral secondary motor areas was associated with decreased hand opening ability while lifting the arm due to involuntary coupling between the shoulder and wrist\/finger flexors. Together, this evidence implicates a compensatory role for ipsilateral (i.e., contralesional) secondary motor areas post-stroke, but with limited capacity to support hand function.","preprint_author_corresponding":"Julius P.A. Dewald","preprint_author_corresponding_institution":"Northwestern University"},{"preprint_doi":"10.1101\/2020.02.20.20025619","published_doi":"10.1007\/s11427-020-1661-4","published_journal":"Science China Life Sciences","preprint_platform":"medRxiv","preprint_title":"Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened among Close Contacts in Nanjing, China","preprint_authors":"Hu, Z.; Song, C.; Xu, C.; Jin, G.; Chen, Y.; Xu, X.; Ma, H.; Chen, W.; Lin, Y.; Zheng, Y.; Wang, J.; hu, z.; Yi, Y.; Shen, H.","preprint_category":"infectious diseases","preprint_date":"2020-02-23","published_date":"2020-03-07","preprint_abstract":"BackgroundPrevious studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers.\n\nMethodsEpidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed.\n\nFindingsNone of the 24 asymptomatic cases presented any obvious symptoms before nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P = 0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia.\n\nInterpretationThe asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged.","preprint_author_corresponding":"zhibin hu","preprint_author_corresponding_institution":"Nanjing Medical University"},{"preprint_doi":"10.1101\/19012880","published_doi":"10.1016\/j.hrthm.2020.02.036","published_journal":"Heart Rhythm","preprint_platform":"medRxiv","preprint_title":"Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia","preprint_authors":"Gianni, C.; Rivera, D.; Burkhardt, J. D.; Pollard, B.; Gardner, E.; Maguire, P.; Zei, P.; Natale, A.; Al-Ahmad, A.","preprint_category":"cardiovascular medicine","preprint_date":"2019-11-22","published_date":"2020-03-06","preprint_abstract":"BackgroundStereotactic radiosurgery is a form of radiotherapy that is performed in a single session and focuses high-dose ionizing radiation beams from a collimated radiation source to a small, localized area of the body. Recently, stereotactic radiosurgery has been applied to arrhythmias (stereotactic arrhythmia radioablation - STAR), with promising results reported in patients with refractory, scar-related ventricular tachycardia (VT), a cohort with known high morbidity and mortality.\n\nObjectiveHerein, we describe our experience with the use of CyberKnife, a frameless image-guided linear accelerator stereotactic radiosurgery system, in conjunction with CardioPlan, a cardiac specific radiotherapy planning software, to treat patients with scar-related VT, detailing its early and mid-to long-term results.\n\nMethodsThis is a pilot, prospective study of patients undergoing STAR for refractory VT. The anatomical target for radioablation was defined based on the clinical VT morphology, electroanatomical mapping, and study-specific pre-procedural imaging with cardiac computed tomography. The target volume delineated with the aid of CardioPlan was treated with a prescription radiation dose of 25 Gy delivered in a single fraction by CyberKnife in an outpatient setting. Ventricular arrhythmias and radiation-related adverse events were monitored at follow-up to determine STAR efficacy and safety.\n\nResultsFive patients (100 % male, 63 {+\/-} 12 years old, 80 % ischemic cardiomyopathy, left ventricular ejection fraction 34 {+\/-} 15 %) with refractory VT underwent STAR between January and June 2018. Radioablation was delivered in 82 {+\/-} 11 minutes without acute complications. During a mean follow-up of 12 {+\/-} 2 months, all patients experienced clinically significant mid-to late-term ventricular arrhythmia recurrence; two patients died of complications associated with their advanced heart failure. There were no clinical or imaging evidence of radiation necrosis or other radiation-induced complications in the organs at risk surrounding the scar targeted by radioablation.\n\nConclusionDespite good initial results, STAR did not result in effective ventricular arrhythmia control in the long term in a selected, high-risk population of patients with scar-related VT. The safety profile was confirmed to be favorable, with no radiation-related complications observed during follow-up. Further studies are needed to explain these disappointing results.","preprint_author_corresponding":"Carola Gianni","preprint_author_corresponding_institution":"Texas Cardiac Arrhythmia Institute, St. David\\'s Medical Center, Austin, TX, USA"},{"preprint_doi":"10.1101\/2019.12.17.19014415","published_doi":"10.1016\/j.pnpbp.2020.109911","published_journal":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","preprint_platform":"medRxiv","preprint_title":"Cortical thickness and formal thought disorder in schizophrenia: An ultra high-field network-based morphometry study","preprint_authors":"Palaniyappan, L.; Al-Radaideh, A.; Gowland, P.; Liddle, P.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2019-12-18","published_date":"2020-03-06","preprint_abstract":"BackgroundPersistent formal thought disorder (FTD) is a core feature of schizophrenia. Recent cognitive and neuroimaging studies indicate a distinct mechanistic pathway underlying the persistent positive FTD (pFTD or disorganized thinking), though its structural determinants are still elusive. Using network-based cortical thickness estimates from ultra-high field 7-Tesla Magnetic Resonance Imaging (7T MRI), we investigated the structural correlates of pFTD.\n\nMethodsWe obtained speech samples and 7T MRI anatomical scans from medicated clinically stable patients with schizophrenia (n=19) and healthy controls (n=20). Network-based morphometry was used to estimate the mean cortical thickness of 17 functional networks covering the entire cortical surface from each subject. We also quantified the vertexwise variability of thickness within each network to quantify the spatial coherence of the 17 networks, estimated patients vs. controls differences, and related the thickness of the affected networks to the severity of pFTD.\n\nResultsPatients had reduced thickness of the frontoparietal and default mode networks, and reduced spatial coherence affecting the salience and the frontoparietal control network. A higher burden of positive FTD related to reduced frontoparietal thickness and reduced spatial coherence of the salience network. The presence of positive FTD, but not its severity, related to the reduced thickness of the language network comprising of the superior temporal cortex.\n\nConclusionsThese results suggest that cortical thickness of both cognitive control and language networks underlie the positive FTD in schizophrenia. The structural integrity of cognitive control networks is a critical determinant of the expressed severity of persistent FTD in schizophrenia.","preprint_author_corresponding":"Lena Palaniyappan","preprint_author_corresponding_institution":"University of Western Ontario"},{"preprint_doi":"10.1101\/19011064","published_doi":"10.1186\/s12887-020-1985-6","published_journal":"BMC Pediatrics","preprint_platform":"medRxiv","preprint_title":"Factors associated with risk of developmental delay in preschool children in a setting with high rates of malnutrition: a cross-sectional analysis of data from the IHOPE study, Madagascar","preprint_authors":"Miller, A. C.; Garchitorena, A.; Rabemananjara, F.; Cordier, L.; Randriamanambintsoa, M.; Rabeza, V.; Rahaniraka Razanadrakoto, H.-T.; Rakoto Ramakasoa, R.; RamahefarisonTiana, O.; Ratsimbazafy, B. N.; Ouenzar, M. A.; Bonds, M. H.; Ratsifandrihamanana, L.","preprint_category":"public and global health","preprint_date":"2019-11-14","published_date":"2020-03-06","preprint_abstract":"BackgroundNearly two hundred eighty million children in low and middle income countries are at risk for not achieving their full developmental potential(1). Poor development can lead to reduced scholastic ability(2) or opportunity (promoting and entrenching inequity), and has been associated with lower adult earning potential(3), and poorer health(4), thus potentially contributing to intergenerational poverty traps.\n\nWhile the entire period of childhood is important for development, the first 1000 days (conception to age 2) are critically important for brain development; with the most rapid and prolific development of neural pathways, first in sensory development, then language skills and then higher cognitive functioning(5). Experiences during this period - positive or negative - can substantially impact the architecture of the developing brain. Adverse events such as exposure to familial or societal violence, toxins such as lead or arsenic, illness (anemia, diarrhea, HIV, chronic malnutrition, maternal depression), or lack of a developmentally stimulating and nurturing environment can all act as toxic stressors on young children that negatively impact cognitive development throughout the life-course(6). Infants and young children in settings of poverty are often faced with many of these stressors(7).","preprint_author_corresponding":"Ann C Miller","preprint_author_corresponding_institution":"Harvard Medical School"},{"preprint_doi":"10.1101\/2019.12.12.19014324","published_doi":"10.3389\/fbioe.2020.00179","published_journal":"Frontiers in Bioengineering and Biotechnology","preprint_platform":"medRxiv","preprint_title":"Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing","preprint_authors":"Srivastava, A.; Giangiobbe, S.; Kumar, A.; Dymerska, D.; Behnisch, W.; Witzens-Harig, M.; Lubinski, J.; Hemminki, K.; Foersti, A.; Bandapalli, O. R.","preprint_category":"genetic and genomic medicine","preprint_date":"2019-12-19","published_date":"2020-03-06","preprint_abstract":"Hodgkin lymphoma (HL) is a lymphoproliferative malignancy of B-cell origin that accounts for 10% of all lymphomas. Despite evidence suggesting strong familial clustering of HL, there is no clear understanding of the contribution of genes predisposing to HL. In this study, whole genome sequencing (WGS) was performed on 7 affected and 9 unaffected family members from three HL-prone families and variants were prioritized using our Familial Cancer Variant Prioritization Pipeline (FCVPPv2). WGS identified a total of 98564, 170550 and 113654 variants which were reduced by pedigree-based filtering to 18158, 465 and 26465 in families I, II and III, respectively. In addition to variants affecting amino acid sequences, variants in promoters, enhancers, transcription factors binding sites and microRNA seed sequences were identified from upstream, downstream, 5 and 3 untranslated regions. A panel of 565 cancer predisposing and other cancer-related genes and of 2383 high-risk HL genes were also screened in these families to aid further prioritization. Pathway analysis of segregating genes with CADD (Combined Annotation Dependent Depletion Tool) scores > 20 was performed using Ingenuity Pathway Analysis software which implicated several candidate genes in pathways involved in B-cell activation and proliferation and in the network of \"Cancer, Hematological disease and Immunological Disease\". We used the FCVPPv2 for further in silico analysis and prioritized 45 coding and 79 non-coding variants from the three families. Further literature-based analysis allowed us to constrict this list to one rare germline variant each in families I and II and two in family III. Functional studies were conducted on the candidate from family I in a previous study, resulting in the identification and functional validation of a novel heterozygous missense variant in the tumor suppressor gene DICER1 as potential HL predisposition factor. We aim to identify the individual genes responsible for predisposition in the remaining two families and will functionally validate these in further studies.","preprint_author_corresponding":"Obul Reddy Bandapalli","preprint_author_corresponding_institution":"Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), D69120 Heidelberg, Germany, Hopp Children\\'s Cancer Center (KiTZ), Heidelberg,"},{"preprint_doi":"10.1101\/19009647","published_doi":"10.1007\/s40262-020-00873-3","published_journal":"Clinical Pharmacokinetics","preprint_platform":"medRxiv","preprint_title":"Development of population and Bayesian models for applied use in patients receiving cefepime","preprint_authors":"Liu, J.; Neely, M.; Lipman, J.; Sime, F.; Roberts, J.; Kiel, P. J.; Avedissian, S. A.; Rhodes, N. J.; Scheetz, M.","preprint_category":"pharmacology and therapeutics","preprint_date":"2019-10-18","published_date":"2020-03-05","preprint_abstract":"Understanding exposures of cefepime, a {beta}-lactam antibiotic, is crucial for developing regimens to achieve optimal exposure and improved clinical outcomes. This study sought to develop and evaluate a unified population pharmacokinetic model in both pediatric and adult patients receiving cefepime treatment. Multiple physiologically relevant models were fit to pediatric and adult subject data. To evaluate the final model performance, a withheld group of twelve pediatric and two separate adult populations were assessed. Seventy subjects with a total of 604 cefepime concentrations were included in this study. All adults (n=34) on average weighed 82.7 kg and displayed a mean creatinine clearance (CrCL) of 106.7 mL\/min. All pediatric subjects (n=36) had mean weight and CrCL of 16.0 kg and 195.64 mL\/min, respectively. A covariate-adjusted two compartment model described the observed concentrations well (population model R2, 87.0%; Bayesian model R2, 96.5%). In the evaluation subsets, the model performed similarly well (population R2, 84.0%; Bayesian R2, 90.2%). The identified model serves well for population dosing and as a Bayesian prior for precision dosing.\n\nKey pointsO_LIA unified cefepime population pharmacokinetic model has been developed from adult and pediatric patients and evaluates well in independent populations.\nC_LIO_LIWhen paired with real time beta-lactam assays, precision dosing approach will optimize drug exposure and improve clinical outcomes.\nC_LI","preprint_author_corresponding":"Marc Scheetz","preprint_author_corresponding_institution":"Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA; Northwestern Memorial Hospital, Chicago, IL, USA; Midwestern University Chicago Colle"},{"preprint_doi":"10.1101\/2020.02.22.20024927","published_doi":"10.1371\/journal.pone.0230548","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China","preprint_authors":"Yuan, M.; Yin, W.; Tao, Z.; Tan, W.; Hu, Y.","preprint_category":"infectious diseases","preprint_date":"2020-02-23","published_date":"2020-03-19","preprint_abstract":"BackgroundRadiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had not been fully understood are especially important for diagnosing and predicting prognosis.\n\nPurposeTo summarize the clinical and radiologic characteristics of NCIP cases and analyze the association of radiologic findings with mortality cases.\n\nMaterial and methodsWe retrospective studied 27 consecutive patients who were confirmed NCIP, the clinical characteristics and CT image findings were collected, and the association of radiologic findings with mortality of patients was evaluated.\n\nResults27 patients included 12 men and 15 women, with median age of 60 years (IQR 47-69). 17 patients discharged in recovered condition and 10 patients died in hospital. The median age of mortality group was higher compared to survival group (68 (IQR 63-73) vs 55 (IQR 35-60), P = 0.003). The comorbidity rate in mortality group was significantly higher than in survival group (80% vs 29%, P = 0.018). The predominant CT characteristics consisted of ground glass opacity (67%), bilateral sides involved (86%), both peripheral and central distribution (74%), and lower zone involvement (96%). The median CT score of mortality group was higher compared to survival group (30 (IQR 7-13) vs 12 (IQR 11-43), P = 0.021), with more frequency of consolidation (40% vs 6%, P = 0.047) and air bronchogram (60% vs 12%, P = 0.025). An optimal cutoff value of a CT score of 24.5 had a sensitivity of 85.6% and a specificity of 84.5% for the prediction of mortality.\n\nConclusions2019-nCoV was more likely to infect elderly people with chronic comorbidities. CT findings of NCIP were featured by predominant ground glass opacities mixed with consolidations, mainly peripheral or combined peripheral and central distributions, bilateral and lower lung zones being mostly involved. A simple CT scoring method was capable to predict mortality.","preprint_author_corresponding":"Yi Hu","preprint_author_corresponding_institution":"Wuhan central hospital"},{"preprint_doi":"10.1101\/19006312","published_doi":"10.1136\/bmjgh-2019-001974","published_journal":"BMJ Global Health","preprint_platform":"medRxiv","preprint_title":"Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India","preprint_authors":"Thomas, B. E.; Suresh, C.; Lavanya, J.; Lindsley, M. M.; Galivanche, A. T.; Sellappan, S.; Ovung, S.; Aravind, A.; Lincy, S.; Raja, A. L.; Kokila, S.; Javeed, B.; Arumugam, S.; Mayer, K. H.; Swaminathan, S.; Subbaraman, R.","preprint_category":"infectious diseases","preprint_date":"2019-09-16","published_date":"2020-03-02","preprint_abstract":"IntroductionPretreatment loss to follow-up (PTLFU)--dropout of patients after diagnosis but before registration in treatment--is a major gap in TB care delivery in India and globally. Patient and healthcare worker (HCW) perspectives are critical for developing interventions to address this problem.\n\nMethodsWe prospectively tracked newly diagnosed smear-positive TB patients from 22 TB diagnostic centers in Chennai, one of Indias largest cities. Patients who did not start therapy within 14 days, or who died or were lost to follow-up before official registration in treatment, were classified as PTLFU cases. We conducted qualitative interviews with all trackable PTLFU patients, or family members of patients who had died. We conducted focus group discussions (FGDs) with three types of HCWs involved in TB care. Interview and FGD recordings were transcribed, coded, and analyzed with the support of Dedoose 8.0.35 software to identify key themes. We created categories into which these themes clustered, identified relationships among thematic categories, and assembled findings into a broader explanatory model for PTLFU.\n\nResultsWe conducted six FGDs comprising 53 HCWs and 33 individual patient or family member interviews. Themes clustered into five categories. Examining relationships among these categories revealed two pathways leading to PTLFU as part of a broader explanatory model. In the first pathway, administrative and organizational health system barriers--including the complexity of navigating the system, healthcare worker absenteeism, and infrastructure failures--resulted in patients feeling frustration or resignation, leading to disengagement from care. Health system barriers experienced by patients were in turn shaped by constraints that made it difficult for HCWs to do their jobs effectively. In the second pathway, negative or judgmental HCW attitudes and behaviors towards patients contributed to patient distrust of the health system, resulting in refusal of further care.\n\nConclusionHealth system barriers contribute substantially to PTLFU directly and by amplifying patient-related challenges to engaging in care. Interventions should focus on removing administrative hurdles patients face in the health system, improving the quality of the HCW-patient interaction, and alleviating constraints HCWs face in being able to provide optimal patient-centered care.","preprint_author_corresponding":"Ramnath Subbaraman","preprint_author_corresponding_institution":"Tufts University School of Medicine"},{"preprint_doi":"10.1101\/2020.02.18.20021881","published_doi":"10.1016\/j.jhin.2020.02.021","published_journal":"Journal of Hospital Infection","preprint_platform":"medRxiv","preprint_title":"Association between 2019-nCoV transmission and N95 respirator use","preprint_authors":"Wang, X.; Pan, Z.; Cheng, Z.","preprint_category":"infectious diseases","preprint_date":"2020-02-19","published_date":"2020-03-03","preprint_abstract":"2019-nCoV had caused pneumonia outbreak in Wuhan. Existing evidence have confirmed the human-to-human transmission of 2019-nCoV. We retrospectively collected infection data from 2 January to 22 January at six departments from Zhongnan Hospital of Wuhan University. In our study, we found N95 respirators, disinfection and hand washing can help to reduce the risk of 2019-nCoV infection in medical staffs. Our results call for re-emphasizing strict occupational protection code in battling this novel contagious disease. The risk of 2019-nCoV infection was higher in the open area than in the quarantined area. N95 may be more effective for 2019-nCoV infections.","preprint_author_corresponding":"Xinghuan Wang","preprint_author_corresponding_institution":"Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China"},{"preprint_doi":"10.1101\/2020.02.17.20023721","published_doi":"10.1053\/j.gastro.2020.02.055","published_journal":"Gastroenterology","preprint_platform":"medRxiv","preprint_title":"Evidence for gastrointestinal infection of SARS-CoV-2","preprint_authors":"Xiao, F.; Tang, M.; Zheng, X.; Li, C.; He, J.; Hong, Z.; Huang, S.; Zhang, Z.; Lin, X.; Fang, Z.; Lai, R.; Chen, S.; Liu, J.; Huang, J.; Xia, J.; Li, Z.; Jiang, G.; Liu, Y.; Li, X.; Shan, H.","preprint_category":"infectious diseases","preprint_date":"2020-02-20","published_date":"2020-03-03","preprint_abstract":"The new coronavirus (SARS-CoV-2) outbreak originating from Wuhan, China, poses a threat to global health. While its evident that the virus invades respiratory tract and transmits from human to human through airway, other viral tropisms and transmission routes remain unknown. We tested viral RNA in stool from 73 SARS-CoV-2-infected hospitalized patients using rRT-PCR. 53.42% of the patients tested positive in stool. 23.29% of the patients remained positive in feces even after the viral RNA decreased to undetectable level in respiratory tract. The viral RNA was also detected in gastrointestinal tissues. Furthermore, gastric, duodenal and rectal epithelia showed positive immunofluorescent staining of viral host receptor ACE2 and viral nucleocapsid protein in a case of SARS-CoV-2 infection. Our results provide evidence for gastrointestinal infection of SARS-CoV-2, highlighting its potential fecal-oral transmission route.","preprint_author_corresponding":"Hong Shan","preprint_author_corresponding_institution":"the Fifth Affiliated Hospital, Sun Yat-sen University"},{"preprint_doi":"10.1101\/19013656","published_doi":"10.1016\/j.nicl.2020.102235","published_journal":"NeuroImage: Clinical","preprint_platform":"medRxiv","preprint_title":"PSA and VIM DBS efficiency in essential tremor depends on distance to the dentatorubrothalamic tract","preprint_authors":"Dembek, T. A.; Petry-Schmelzer, J. N.; Reker, P.; Wirths, J.; Hamacher, S.; Steffen, J. K.; Dafsari, H. S.; Hoevels, M.; Fink, G. R.; Visser-Vandewalle, V.; Barbe, M. T.","preprint_category":"neurology","preprint_date":"2019-12-09","published_date":"2020-03-04","preprint_abstract":"ObjectiveTo investigate the relation between deep brain stimulation (DBS) of the posterior-subthalamic-area (PSA) and the ventral-intermediate-nucleus (VIM) and the distance to the dentatorubrothalamic tract (DRTT) in essential tremor (ET).\n\nMethodsTremor rating scale (TRS) hemi-scores were analyzed in 13 ET patients, stimulated in both the VIM and the PSA in a randomized, crossover trial. Distances of PSA and VIM contacts to population-based DRTTs were calculated. The relationships between distance to DRTT and stimulation amplitude, as well as DBS efficiency (TRS improvement per amplitude) were investigated.\n\nResultsPSA contacts were closer to the DRTT (p=0.019) and led to a greater improvement in TRS hemi-scores (p=0.005) than VIM contacts. Proximity to the DRTT was related to lower amplitudes (p<0.001) and higher DBS efficiency (p=0.017).\n\nConclusionsDifferences in tremor outcome and stimulation parameters between contacts in the PSA and the VIM can be explained by their different distance to the DRTT.","preprint_author_corresponding":"Till A Dembek","preprint_author_corresponding_institution":"University of Cologne, Faculty of Medicine"},{"preprint_doi":"10.1101\/2020.03.09.20033217","published_doi":"10.1056\/NEJMc2004973","published_journal":"The New England Journal of Medicine","preprint_platform":"medRxiv","preprint_title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1","preprint_authors":"van Doremalen, N.; Bushmaker, T.; Morris, D.; Holbrook, M.; Gamble, A.; Williamson, B.; Tamin, A.; Harcourt, J.; Thornburg, N.; Gerber, S.; Lloyd-Smith, J.; de Wit, E.; Munster, V.","preprint_category":"infectious diseases","preprint_date":"2020-03-10","published_date":"2020-03-17","preprint_abstract":"To the EditorA novel human coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, referred to as HCoV-19 here) that emerged in Wuhan, China in late 2019 is now causing a pandemic1. Here, we analyze the aerosol and surface stability of HCoV-19 and compare it with SARS-CoV-1, the most closely related human coronavirus.2 We evaluated the stability of HCoV-19 and SARS-CoV-1 in aerosols and on different surfaces and estimated their decay rates using a Bayesian regression model (see Supplementary Appendix). All experimental measurements are reported as mean across 3 replicates.","preprint_author_corresponding":"Vincent Munster","preprint_author_corresponding_institution":"NIAID"},{"preprint_doi":"10.1101\/2020.03.16.20037135","published_doi":"10.1016\/j.ijantimicag.2020.105949","published_journal":"ScienceDirect","preprint_platform":"medRxiv","preprint_title":"Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial","preprint_authors":"GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D.","preprint_category":"infectious diseases","preprint_date":"2020-03-20","published_date":"2020-03-20","preprint_abstract":"BackgroundChloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads.\n\nPatients and methodsPatients were included in a single arm protocol to receive 600mg of hydroxychloroquine daily and their viral load in nasal swabs was tested daily. Depending on their clinical presentation, azithromycin was added to the treatment. Untreated patients from another center and cases refusing the protocol were included as negative controls. Presence and absence of virus at Day6-post inclusion was considered the end point.\n\nResultsTwenty cases were treated in this study and showed a significant reduction of the viral carriage at D6-post inclusion compared to controls, and much lower average carrying duration than reported of untreated patients in the literature. Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.\n\nConclusionHydroxychloroquine is significantly associated with viral load reduction\/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.","preprint_author_corresponding":"Didier RAOULT Sr.","preprint_author_corresponding_institution":"IHU Mediterrane Infection, Aix Marseille University"},{"preprint_doi":"10.1101\/2020.02.19.20025452","published_doi":"10.3201\/eid2606.200357","published_journal":"Emerging Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"The serial interval of COVID-19 from publicly reported confirmed cases","preprint_authors":"Du, Z.; Wang, L.; Xu, X.; Wu, Y.; Cowling, B. J.; Meyers, L. A.","preprint_category":"epidemiology","preprint_date":"2020-02-23","published_date":"2020-03-19","preprint_abstract":"Short AbstractWe estimate the distribution of serial intervals for 468 confirmed cases of COVID-19 reported in 93 Chinese cities by February 8, 2020. The mean and standard deviation are 3.96 (95% CI 3.53-4.39) and 4.75 (95% CI 4.46-5.07) days, respectively, with 12.6% of reports indicating pre-symptomatic transmission.\n\nOne sentence summaryWe estimate the distribution of serial intervals for 468 confirmed cases of COVID-19 reported in 93 Chinese cities by February 8, 2020.","preprint_author_corresponding":"Lauren Ancel Meyers","preprint_author_corresponding_institution":"The University of Texas at Austin"},{"preprint_doi":"10.1101\/19001156","published_doi":"10.1038\/s41598-020-60671-6","published_journal":"Scientific Reports","preprint_platform":"medRxiv","preprint_title":"Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: Safety and Preliminary Efficacy by Microscopy and Sequencing","preprint_authors":"van de Wijgert, J.; Verwijs, M. C.; Agaba, S. K.; Bronowski, C.; Mwambarangwe, L.; Uwineza, M.; Lievens, E.; Nivoliez, A.; Ravel, J.; Darby, A.","preprint_category":"sexual and reproductive health","preprint_date":"2019-07-08","published_date":"2020-03-03","preprint_abstract":"Bacterial vaginosis (BV) is associated with HIV acquisition and adverse pregnancy outcomes. Recurrence after metronidazole treatment is high. HIV-negative, non-pregnant Rwandan BV patients were randomized to four groups (n=17\/group) after seven-day oral metronidazole treatment: behavioral counseling only (control), or counseling plus intermittent use of oral metronidazole, Ecologic Femi+ vaginal capsule (containing multiple Lactobacillus and one Bifidobacterium species), or Gynophilus LP vaginal tablet (L. rhamnosus 35) for two months. Vaginal microbiota assessments at all visits included Gram stain Nugent scoring and 16S rRNA gene qPCR and HiSeq sequencing. All interventions were safe. BV (Nugent 7-10) incidence was 10.18 per person-year at risk in the control group, and lower in the metronidazole (1.41\/person-year; p=0.004), Ecologic Femi+ (3.58\/person-year; p=0.043), and Gynophilus LP groups (5.36\/person-year; p=0.220). In mixed effects models adjusted for hormonal contraception\/pregnancy, sexual risk-taking, and age, metronidazole and Ecologic Femi+ users, each compared to controls, had higher Lactobacillus and lower BV-anaerobes concentrations and\/or relative abundances, and were less likely to have a dysbiotic vaginal microbiota type by sequencing. Inter-individual variability was high and effects disappeared soon after intervention cessation. Lactobacilli-based vaginal probiotics warrant further evaluation because, in contrast to antibiotics, they are not expected to negatively affect microbiota or cause antimicrobial resistance.","preprint_author_corresponding":"Janneke van de Wijgert","preprint_author_corresponding_institution":"Institute of Infection and Global Health, University of Liverpool, Liverpool, UK"},{"preprint_doi":"10.1101\/2020.02.20.20025866","published_doi":"10.2807\/1560-7917.ES.2020.25.10.2000180","published_journal":"Eurosurveillance","preprint_platform":"medRxiv","preprint_title":"Estimating the Asymptomatic Ratio of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020","preprint_authors":"Mizumoto, K.; Kagaya, K.; Zarebski, A.; Chowell, G.","preprint_category":"infectious diseases","preprint_date":"2020-02-23","published_date":"2020-03-12","preprint_abstract":"The potential infectiousness of asymptomatic COVID-19 cases together with a substantial fraction of asymptomatic infections among all infections, have been highlighted in clinical studies. We conducted statistical modeling analysis to derive the delay-adjusted asymptomatic proportion of the positive COVID-19 infections onboard the Princess Cruises ship along with the timeline of infections. We estimated the asymptomatic proportion at 17.9% (95% CrI: 15.5%-20.2%), with most of the infections occurring before the start of the 2-week quarantine.","preprint_author_corresponding":"Kenji Mizumoto","preprint_author_corresponding_institution":"Kyoto University"},{"preprint_doi":"10.1101\/19007450","published_doi":"10.1177\/1352458520907901","published_journal":"Multiple Sclerosis Journal","preprint_platform":"medRxiv","preprint_title":"Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors","preprint_authors":"Jacobs, B. M.; Giovannoni, G.; Cuzick, J.; Dobson, R.","preprint_category":"neurology","preprint_date":"2019-09-25","published_date":"2020-03-23","preprint_abstract":"BackgroundEBV infection is thought to play a central role in the development of Multiple Sclerosis (MS). If causal, it represents a target for interventions to reduce MS risk.\n\nObjectiveTo examine the evidence for interaction between EBV and other risk factors, and explore mechanisms via which EBV infection may influence MS risk.\n\nMethodsPubmed was searched using the terms \"multiple sclerosis\" AND \"Epstein Barr virus\", \"multiple sclerosis\" AND EBV, \"clinically isolated syndrome\" AND \"Epstein Barr virus\" and \"clinically isolated syndrome\" AND EBV. All abstracts were reviewed for possible inclusion.\n\nResults262 full-text papers were reviewed. There was evidence of interaction on the additive scale between anti-EBV antibody titre and HLA genotype (AP 0.48, p<1x10-4; RERI 3.84, p<5x10-3; S 1.68, p=0.06). Previous IM was associated with increased OR of MS in HLA-DRB1*1501 positive but not HLA-DRB1*1501 negative persons. Smoking was associated with a greater risk of MS in those with high anti-EBV antibodies (OR 2.76) but not low anti-EBV antibodies (OR 1.16). No interaction between EBV and risk factors was found on a multiplicative scale.\n\nConclusionsEBV appears to interact with at least some established MS risk factors. The mechanism via which EBV influences MS risk remains unknown.","preprint_author_corresponding":"Ruth Dobson","preprint_author_corresponding_institution":"Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London"},{"preprint_doi":"10.1101\/19007666","published_doi":"10.1371\/journal.pone.0229819","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Tumor Necrosis Factor (TNF) Blocking Agents Reduce Risk for Alzheimer's Disease in Patients with Rheumatoid Arthritis and Psoriasis","preprint_authors":"Zhou, M.; Kaelber, D.; Xu, R.; Gurney, M.","preprint_category":"neurology","preprint_date":"2019-09-27","published_date":"2020-03-23","preprint_abstract":"This large, retrospective case-control study of electronic health records from 56 million unique adult patients examined whether or not treatment with a Tumor Necrosis Factor (TNF) blocking agent is associated with lower risk for Alzheimers disease (AD) in patients with rheumatoid arthritis (RA), psoriasis, and other inflammatory diseases which are mediated in part by TNF and for which a TNF blocker is an approved treatment. The analysis compared the diagnosis of AD as an outcome measure in patients receiving at least one prescription for a TNF blocking agent (etanercept, adalimumab, and infliximab) or for methotrexate. Adjusted odds ratios (AORs) were estimated using the Cochran-Mantel-Haenszel (CMH) method and presented with 95% confidence intervals (CIs) and p-values. RA was associated with a higher risk for AD (Adjusted Odds Ratio (AOR) = 2.06, 95% Confidence Interval: (2.02-2.10), P-value <0.0001) as did psoriasis (AOR = 1.37 (1.31-1.42), P <0.0001), ankylosing spondylitis (AOR = 1.57 (1.39-1.77), P <0.0001), inflammatory bowel disease (AOR = 2.46 (2.33-2.59), P < 0.0001), ulcerative colitis (AOR = 1.82 (1.74-1.91), P <0.0001), and Crohns disease (AOR = 2.33 (2.22-2.43), P <0.0001). The risk for AD in patients with RA was lower among patients treated with etanercept (AOR = 0.34 (0.25-0.47), P <0.0001), adalimumab (AOR = 0.28 (0.19-0.39), P < 0.0001), or infliximab (AOR = 0.52 (0.39-0.69), P <0.0001). Methotrexate was also associated with a lower risk for AD (AOR = 0.64 (0.61-0.68), P <0.0001), while lower risk was found in patients with a prescription history for both a TNF blocker and methotrexate. Etanercept and adalimumab also were associated with lower risk for AD in patients with psoriasis: AOR = 0.47 (0.30-0.73 and 0.41 (0.20-0.76), respectively. There was no effect of gender or race, while younger patients showed greater benefit from a TNF blocker than did older patients. This study identifies a subset of patients in whom systemic inflammation contributes to risk for AD through a pathological mechanism involving TNF and who therefore may benefit from treatment with a TNF blocking agent.","preprint_author_corresponding":"Mengshi Zhou","preprint_author_corresponding_institution":"Case Western Reserve University"},{"preprint_doi":"10.1101\/19004598","published_doi":"10.1136\/bmjoq-2019-000856","published_journal":"BMJ Open Quality","preprint_platform":"medRxiv","preprint_title":"Accuracy of Medical Billing Data Against the Electronic Health Record in the Measurement of Colorectal Cancer Screening Rates","preprint_authors":"Rudrapatna, V. A.; Glicksberg, B. S.; Avila, P.; Harding-Theobald, E.; Wang, C.; Butte, A. J.","preprint_category":"health informatics","preprint_date":"2019-08-13","published_date":"2020-03-24","preprint_abstract":"ObjectiveAdministrative healthcare data are an attractive source of secondary analysis because of their potential to answer population-health questions. Although these datasets have known susceptibilities to biases, the degree to which they can distort measurements like cancer screening rates are not widely appreciated, nor are their causes and possible solutions.\n\nMethodsUsing a billing code database derived from our institutions electronic health records (EHR), we estimated the colorectal cancer screening rate of average-risk patients aged 50-74 seen in primary care or gastroenterology clinic in 2016-2017. 200 records (150 unscreened, 50 screened) were sampled to quantify the accuracy against manual review.\n\nResultsOut of 4,611 patients, an analysis of billing data suggested a 61% screening rate. Manual review revealed a positive predictive value of 96% (86-100%), negative predictive value of 21% (15-29%), and a corrected screening rate of 85% (81-90%). Most false negatives occurred due to exams performed outside the scope of the database - both within and outside of our institution - but 21% of false negatives fell within the databases scope. False positives occurred due to incomplete exams and inadequate bowel preparation. Reasons for screening failure include ordered but incomplete exams (48%), lack of or incorrect documentation by primary care (29%) including incorrect screening intervals (13%), and patients declining screening (13%).\n\nConclusionsAlthough analytics on administrative data are commonly  validated by comparison to independent datasets, comparing our naive estimate to the CDC estimate ([~]60%) would have been misleading. Therefore, regular data audits using the complete EHR are critical to improve screening rates and measure improvement.\n\nStudy HighlightsO_ST_ABSWHAT IS KNOWNC_ST_ABSO_LIMedical billing data might be useful for measuring colon cancer screening rates but are bias-prone and difficult to validate\nC_LIO_LIThe degree to which these biases may skew the results of simple population-level analytics is not widely appreciated, nor are their causes and possible solutions.\nC_LI\n\nWHAT IS NEW HEREO_LIBilling data from the health record does not accurately capture unscreened patients. Some reasons were predictable (screening outside the system or prior to software implementation) but others were not.\nC_LIO_LIThe common practice of external validation would have been falsely reassuring for these data. The naive estimate of screening rates matches the CDC estimate (61%); the true rate was 85%.\nC_LIO_LIPeriodic data audits using the full EHR is critical to continue to improve screening rates and monitor improvements accurately and at scale.\nC_LI","preprint_author_corresponding":"Atul J Butte","preprint_author_corresponding_institution":"UCSF"},{"preprint_doi":"10.1101\/2020.03.02.20026708","published_doi":"10.1126\/science.abb4218","published_journal":"Science","preprint_platform":"medRxiv","preprint_title":"The effect of human mobility and control measures on the COVID-19 epidemic in China","preprint_authors":"Kraemer, M. U. G.; Yang, C.-H.; Gutierrez, B.; Wu, C.-H.; Klein, B.; Pigott, D. M.; open COVID-19 data working group,  ; du Plessis, L.; Faria, N. R.; Li, R.; Hanage, W. P.; Brownstein, J. S.; Layan, M.; Vespignani, A.; Tian, H.; Dye, C.; Cauchemez, S.; Pybus, O.; Scarpino, S. V.","preprint_category":"epidemiology","preprint_date":"2020-03-06","published_date":"2020-03-25","preprint_abstract":"The ongoing COVID-19 outbreak has expanded rapidly throughout China. Major behavioral, clinical, and state interventions are underway currently to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide. It remains unclear how these unprecedented interventions, including travel restrictions, have affected COVID-19 spread in China. We use real-time mobility data from Wuhan and detailed case data including travel history to elucidate the role of case importation on transmission in cities across China and ascertain the impact of control measures. Early on, the spatial distribution of COVID-19 cases in China was well explained by human mobility data. Following the implementation of control measures, this correlation dropped and growth rates became negative in most locations, although shifts in the demographics of reported cases are still indicative of local chains of transmission outside Wuhan. This study shows that the drastic control measures implemented in China have substantially mitigated the spread of COVID-19.","preprint_author_corresponding":"Samuel V Scarpino","preprint_author_corresponding_institution":"Northeastern University"},{"preprint_doi":"10.1101\/19011213","published_doi":"10.1371\/journal.pone.0230734","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Impact of left ventricular assist devices and heart transplant on acute myocardial infarction and heart failure mortality and readmission measures","preprint_authors":"Brandt, E. J.; Ross, J. S.; Grady, J. N.; Ahmad, T.; Pawar, S.; Bernheim, S. M.; Desai, N.","preprint_category":"cardiovascular medicine","preprint_date":"2019-11-05","published_date":"2020-03-26","preprint_abstract":"BackgroundConcern has been raised about consequences of including patients with left ventricular assist device (LVAD) or heart transplantation (HT) in readmission and mortality measures.\n\nMethodsWe calculated unadjusted and hospital-specific 30-day risk-standardized mortality (RSMR) and readmission (RSRR) rates for all Medicare fee-for-service beneficiaries with a primary diagnosis of AMI or HF discharged between July 2010 and June 2013. Hospitals were compared before and after excluding LVAD and HT patients. LVAD indication was measured.\n\nResultsFor the AMI and HF cohorts, [&le;]0.2% of patients received an LVAD and [&le;]0.1% received HT in either cohort. Less than 2% of hospitals had either [&ge;]6 patients who received an LVAD or, independently, had [&ge;]1 HT. The AMI mortality and readmission cohorts used 1.8% and 2.8% of LVADs for semi-permanent\/permanent indications, versus 73.8% and 78.0% for HF patients, respectively. The rest were for temporary\/external indications.\n\nIn the AMI cohort, RSMR for hospitals without LVAD patients versus hospitals with [&ge;]6 LVADs was 14.8% and 14.3%, and RSRR was 17.8% and 18.3%, respectively; the HF cohort RSMR was 11.9% and 9.7% and RSRR was 22.6% and 23.4%, respectively. In the AMI cohort, RSMR for hospitals without versus with HT patients was 14.7% and 13.9% and RSRR was 17.8% and 17.7%, respectively; in the HF cohort, RSMR was 11.9% and 11.0%, and RSRR was 22.6% and 22.6%, respectively. Estimations changed [&le;]0.1% after excluding LVAD or HT patients.\n\nConclusionHospitals caring for [&ge;]6 patients with LVAD or [&ge;]1 HT had lower RSMRs but higher RSRRs on average. Rates were insignificantly changed when these patients were excluded. LVADs were primarily for acute-care in the AMI cohort and chronic support in the HF cohort. LVAD and HT patients are a distinct group with differential care requirements and outcomes, thus should be considered separately from the rest of the HF cohort.","preprint_author_corresponding":"Nihar Desai","preprint_author_corresponding_institution":"Yale School of Medicine"},{"preprint_doi":"10.1101\/19010728","published_doi":"10.1186\/s13148-020-00838-0","published_journal":"Clinical Epigenetics","preprint_platform":"medRxiv","preprint_title":"DNA methylation outlier burden, health and ageing in Generation Scotland and the Lothian Birth Cohorts of 1921 and 1936.","preprint_authors":"Seeboth, A.; McCartney, D. L.; Wang, Y.; Hillary, R. F.; Stevenson, A. J.; Walker, R. M.; Evans, K. L.; McIntosh, A. M.; Ha\u0308gg, S.; Deary, I. J.; Marioni, R. E.","preprint_category":"genetic and genomic medicine","preprint_date":"2019-11-02","published_date":"2020-03-26","preprint_abstract":"DNA methylation outlier burden has been suggested as a potential marker of biological age. An outlier is typically defined as DNA methylation levels at any one CpG site that are three times beyond the inter-quartile range from the 25th or 75th percentiles compared to the rest of the population. DNA methylation outlier burden (the number of such outlier sites per individual) increases exponentially with age. However, these findings have been observed in small samples. Here, we showed an association between age and log10-transformed DNA methylation outlier burden in a large cross-sectional cohort, the Generation Scotland Family Health Study (N=7,010, {beta}=0.0091, p<2x10-16), and in two longitudinal cohort studies, the Lothian Birth Cohorts of 1921 (N=430, {beta}=0.033, p=7.9x10-4) and 1936 (N=898, {beta}=7.9x10-3, p=0.074). Significant confounders of both cross-sectional and longitudinal associations between outlier burden and age included white blood cell proportions, BMI, smoking, and batch effects. In Generation Scotland, the increase in epigenetic outlier burden with age was not purely an artefact of an increase in DNA methylation level variability with age (epigenetic drift). Log10-transformed DNA methylation outlier burden in Generation Scotland was not related to self-reported, or family history of, age-related diseases and it was not heritable (SNP-based heritability of 4.4%, p=0.18). Finally, DNA methylation outlier burden was not significantly related to survival in either of the Lothian Birth Cohorts individually but it was in a meta-analysis (HRmeta=1.12; 95%CImeta=[1.02; 1.21]; pmeta=0.021). These findings suggest that, while it does not associate with ageing-related health outcomes, DNA methylation outlier burden does track chronological ageing and may also relate to survival. DNA methylation outlier burden may thus be useful as a marker of biological ageing.","preprint_author_corresponding":"Riccardo E. Marioni","preprint_author_corresponding_institution":"The University of Edinburgh"},{"preprint_doi":"10.1101\/2020.01.22.20018374","published_doi":"10.3390\/cancers12030764","published_journal":"Cancers","preprint_platform":"medRxiv","preprint_title":"Global DNA hypomethylation in epithelial ovarian cancer: passive demethylation and association with genomic instability","preprint_authors":"Zhang, W.; Klinkebiel, D.; Barger, C. J.; Pandey, S.; Guda, C.; Miller, A.; Akers, S.; Odunsi, K.; Karpf, A. R.","preprint_category":"oncology","preprint_date":"2020-01-27","published_date":"2020-03-24","preprint_abstract":"A hallmark of human cancer is global DNA hypomethylation (GDHO), but the mechanisms accounting for this defect and its pathological consequences are ill-defined. In human epithelial ovarian cancer (EOC), GDHO was associated with advanced disease and reduced overall and disease-free survival. GDHO(+) EOC was enriched for a proliferative gene expression signature, including FOXM1 activation. DNA hypomethylation preferentially occurred within genomic blocks (hypo blocks) overlapping late-replicating, lamina-associated domains, PRC2 binding, and H3K27me3. Increased proliferation coupled with hypo block formation at late replicating regions suggested passive hypomethylation, which was further supported by the observation that cytosine DNA methyltransferases (DNMTs) and UHRF1 showed significantly reduced expression in GDHO(+) EOC, after normalization to proliferation markers. Importantly, GDHO(+) EOC showed elevated chromosomal instability (CIN), and copy number alterations (CNA) were enriched at hypo blocks. Together, these findings implicate a passive demethylation mechanism for GDHO that promotes genomic instability and poor prognosis in EOC.","preprint_author_corresponding":"Adam R Karpf","preprint_author_corresponding_institution":"University of Nebraska Medical Center"},{"preprint_doi":"10.1101\/2020.03.01.20029074","published_doi":"10.1038\/s41392-020-0148-4","published_journal":"Signal Transduction and Targeted Therapy","preprint_platform":"medRxiv","preprint_title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","preprint_authors":"Tan, L.; Wang, Q.; Zhang, D.; Ding, J.; Huang, Q.; Tang, Y.-Q.; Wang, Q.; Miao, H.","preprint_category":"infectious diseases","preprint_date":"2020-03-03","published_date":"2020-03-27","preprint_abstract":"BackgroundCoronavirus disease-2019 (COVID-19) is a rapidly escalating epidemic caused by SARS-CoV-2. Identification of a simple and effective indicator to assess disease severity and prognosis is urgently needed.\n\nMethodsDynamic changes of blood lymphocyte percentage (LYM%) in 15 death cases, 15 severe cases as well as 40 moderate cases of COVID-19 patients were retrospectively analyzed. A Time-LYM% model (TLM) was established according to the descriptive studies and was validated in 92 hospitalized cases.\n\nResultsResults from death and severe cases showed that LYM% in blood tests were inversely associated with the severity and prognosis of COVID-19. LYM% in moderate type of patients with COVID-19 remained higher than 20% 10-12 days after symptom onset. In contrast, LYM% was lower than 20% in severe cases. However, LYM% in severe cases was higher than 5% 17-19 days after the onset of the disease, while it fell below 5% in death cases. Accordingly, we established a Time-LYM% model (TLM), which was validated as an independent criterion of disease classification in another 92 hospitalized patients with COVID-19.\n\nConclusionLymphopenia can be used as an indicator of disease severity and prognosis of COVID-19 patients. TLM is worth of application in the clinical practice.","preprint_author_corresponding":"Hongming Miao","preprint_author_corresponding_institution":"Third Military Medical University (Army Medical University)"},{"preprint_doi":"10.1101\/19012286","published_doi":"10.1136\/oemed-2019-106325","published_journal":"Occupational and Environmental Medicine","preprint_platform":"medRxiv","preprint_title":"Step-downs reduce workers compensation payments to encourage return to work. Are they effective?","preprint_authors":"Lane, T.; Sheehan, L. R.; Gray, S. E.; Beck, D.; Collie, A.","preprint_category":"occupational and environmental health","preprint_date":"2019-11-19","published_date":"2020-03-27","preprint_abstract":"ObjectiveTo determine whether step-downs, which cut the rate of compensation paid to injured workers after they have been on benefits for several months, are effective as a return to work incentive.\n\nMethodsWe aggregated administrative claims data from seven Australian workers compensation systems to calculate weekly scheme exit rates, a proxy for return to work. Jurisdictions were further subdivided into four injury subgroups: fractures, musculoskeletal, mental health, and other trauma. The effect of step-downs on scheme exit was tested using a regression discontinuity design. Results were pooled into meta-analyses to calculate combined effects and the proportion of variance attributable to heterogeneity.\n\nResultsThe combined effect of step-downs was a 0.86 percentage point (95% CI -1.45 to -0.27) reduction in the exit rate, with significant heterogeneity between jurisdictions (I2 = 68%, p = .003). Neither timing nor magnitude of step-downs was a significant moderator of effects. Within injury subgroups, only fractures had a significant combined effect (-0.84, 95% CI -1.61 to -0.07). Sensitivity analysis indicated potential effects within mental health and musculoskeletal conditions as well.\n\nConclusionsThe results suggest some workers compensation recipients anticipate step-downs and exit the system early to avoid the reduction in income. However, the effects were small and suggest step-downs have marginal practical significance. We conclude that step-downs are generally ineffective as a return to work policy initiative.\n\nKey messages1. What is already known about this subject?A number of workers compensation systems around the world reduce payments to injured workers after they have been in the system for several months. In Australia, where each state, territory, and Commonwealth system employs step-downs, the stated policy objective is to increase the rate of return to work through financial incentives. However, there is little empirical evidence to either support or reject this claim.\n\n2. What are the new findings?The rate at which claimants exited workers compensation systems increased ahead of step-downs taking effect, suggesting an anticipatory effect. However, the effect was relatively small, changing the exit rate by less than a percentage point overall, with substantial heterogeneity between systems.\n\n3. How might this impact on policy or clinical practice in the foreseeable future?While statistically significant, the findings suggest that step-downs provide workers compensation claimants little incentive to return to work. Policymakers may need to reconsider step-downs as a component of scheme design, or justify them according to their original purpose, which was to save costs.","preprint_author_corresponding":"Tyler Lane","preprint_author_corresponding_institution":"Monash University"},{"preprint_doi":"10.1101\/2020.03.13.20035568","published_doi":"10.2196\/18790","published_journal":"Journal of Medical Internet Research","preprint_platform":"medRxiv","preprint_title":"Knowledge and perceptions of coronavirus disease 2019 among the general public in the United States and the United Kingdom: A cross-sectional online survey","preprint_authors":"Geldsetzer, P.","preprint_category":"infectious diseases","preprint_date":"2020-03-17","published_date":"2020-03-27","preprint_abstract":"BackgroundGiven the extensive time needed to conduct a nationally representative household survey and the commonly low response rate in phone surveys, rapid online surveys may be a promising method to assess and track knowledge and perceptions among the general public during fast-moving infectious disease outbreaks.\n\nObjectiveTo apply rapid online surveying to determine knowledge and perceptions of coronavirus disease 2019 (Covid-19) among the general public in the United States (US) and the United Kingdom (UK).\n\nMethodsAn online questionnaire was administered to 3,000 adults residing in the US and 3,000 adults residing in the UK who had registered with Prolific Academic to participate in online research. Strata by age (18 - 27, 28 - 37, 38 - 47, 48 - 57, or [&ge;]58 years), sex (male or female), and ethnicity (White, Black or African American, Asian or Asian Indian, Mixed, or \"Other\"), and all permutations of these strata, were established. The number of participants who could enrol in each of these strata was calculated to reflect the distribution in the US and UK general population. Enrolment into the survey within the strata was on a first-come, first-served basis. Participants completed the questionnaire between February 23 and March 2 2020.\n\nResults2,986 and 2,988 adults residing in the US and the UK, respectively, completed the questionnaire. 64.4% (1,924\/2,986) of US and 51.5% (1,540\/2,988) of UK participants had a tertiary education degree. 67.5% (2,015\/2,986) of US participants had a total household income between $20,000 and $99,999, and 74.4% (2,223\/2,988) of UK participants had a total household income between {pound}15,000 and {pound}74,999. US and UK participants median estimate for the probability of a fatal disease course among those infected with SARS-CoV-2 was 5.0% (IQR: 2.0% - 15.0%) and 3.0% (IQR: 2.0% - 10.0%), respectively. Participants generally had good knowledge of the main mode of disease transmission and common symptoms of Covid-19. However, a substantial proportion of participants had misconceptions about how to prevent an infection and the recommended care-seeking behavior. For instance, 37.8% (95% CI: 36.1% - 39.6%) of US and 29.7% (95% CI: 28.1% - 31.4%) of UK participants thought that wearing a common surgical mask was  highly effective in protecting them from acquiring Covid-19. 25.6% (95% CI: 24.1% - 27.2%) of US and 29.6% (95% CI: 28.0% - 31.3%) of UK participants thought it prudent to refrain from eating at Chinese restaurants. Around half (53.8% [95% CI: 52.1% - 55.6%] of US and 39.1% [95% CI: 37.4% -40.9%] of UK participants) thought that children were at an especially high risk of death when infected with SARS-CoV-2.\n\nConclusionsThe distribution of participants by total household income and education followed approximately that of the general population. The findings from this online survey could guide information campaigns by public health authorities, clinicians, and the media. More broadly, rapid online surveys could be an important tool in tracking the publics knowledge and misperceptions during rapidly moving infectious disease outbreaks.","preprint_author_corresponding":"Pascal Geldsetzer","preprint_author_corresponding_institution":"Stanford University"},{"preprint_doi":"10.1101\/2020.03.02.20030189","published_doi":"10.1093\/cid\/ciaa344","published_journal":"Clinical Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","preprint_authors":"Zhao, J.; Yuan, Q.; Wang, H.; Liu, W.; Liao, X.; Su, Y.; Wang, X.; Yuan, J.; Li, T.; Li, J.; Qian, S.; Hong, C.; Wang, F.; Liu, Y.; Wang, Z.; He, Q.; Li, Z.; He, B.; Zhang, T.; Ge, S.; Liu, L.; Zhang, J.; Xia, N.; Zhang, Z.","preprint_category":"infectious diseases","preprint_date":"2020-03-03","published_date":"2020-03-27","preprint_abstract":"BackgroundThe novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated.\n\nMethodsA total of 173 patients with confirmed SARS-CoV-2 infection were enrolled. Their serial plasma samples (n = 535) collected during the hospitalization period were tested for total antibodies (Ab), IgM and IgG against SARS-CoV-2 using immunoassays. The dynamics of antibodies with the progress and severity of disease was analyzed.\n\nResultsAmong 173 patients, the seroconversion rate for Ab, IgM and IgG was 93.1% (161\/173), 82.7% (143\/173) and 64.7% (112\/173), respectively. Twelve patients who had not seroconverted were those only blood samples at the early stage of illness were collected. The seroconversion sequentially appeared for Ab, IgM and then IgG, with a median time of 11, 12 and 14 days, respectively. The presence of antibodies was < 40% among patients in the first 7 days of illness, and then rapidly increased to 100.0%, 94.3% and 79.8% for Ab, IgM and IgG respectively since day 15 after onset. In contrast, the positive rate of RNA decreased from 66.7% (58\/87) in samples collected before day 7 to 45.5% (25\/55) during days 15 to 39. Combining RNA and antibody detections significantly improved the sensitivity of pathogenic diagnosis for COVID-19 patients (p < 0.001), even in early phase of 1-week since onset (p = 0.007). Moreover, a higher titer of Ab was independently associated with a worse clinical classification (p = 0.006).\n\nConclusionsThe antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients.","preprint_author_corresponding":"Quan Yuan","preprint_author_corresponding_institution":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases"},{"preprint_doi":"10.1101\/2020.03.15.20032870","published_doi":"10.1002\/jmv.25794","published_journal":"Journal of Medical Virology","preprint_platform":"medRxiv","preprint_title":"GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY","preprint_authors":"Zehender, G.; Lai, A.; Bergna, A.; Meroni, L.; Riva, A.; Balotta, C.; Tarkowski, M.; Gabrieli, A.; Bernacchia, D.; Rusconi, S.; Rizzardini, G.; Antinori, S.; Galli, M.","preprint_category":"epidemiology","preprint_date":"2020-03-20","published_date":"2020-03-29","preprint_abstract":"This report describes the isolation, the molecular characterization and the phylogenetic analysis of the first three complete genomes of SARS-CoV-2 isolated from three patients involved in the first outbreak of COVID-19 in Lombardy, Italy. Early molecular epidemiological tracing suggests that SARS-CoV-2 was present in Italy weeks before the first reported cases of infection.","preprint_author_corresponding":"Gianguglielmo Zehender","preprint_author_corresponding_institution":"University of Milan"},{"preprint_doi":"10.1101\/2020.02.29.20029462","published_doi":"10.1111\/irv.12739","published_journal":"Influenza and Other Respiratory Viruses","preprint_platform":"medRxiv","preprint_title":"68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit","preprint_authors":"Easom, N.; Moss, P.; Barlow, G.; Samson, A.; Taynton, T.; Adams, K.; Ivan, M.; Burns, P.; Gajee, K.; Eastick, K.; Lillie, P.","preprint_category":"infectious diseases","preprint_date":"2020-03-06","published_date":"2020-03-29","preprint_abstract":"Clinical assessment of possible infection with SARS-CoV-2, the novel coronavirus responsible for the outbreak of COVID-19 respiratory illness, has been a major activity of infectious diseases services in the UK and elsewhere since the first report of cases in December 2019. We report our case series of 68 patients, reviewed by Infectious Diseases Consultants at a Regional Infectious Diseases Unit in the UK. We prospectively evaluated our service between the 29th Jan 2020 and 24th Feb 2020.\n\nDemographic, clinical, epidemiological and laboratory data were collected. We have compared clinical features and subsequent diagnosis between well patients not requiring admission for clinical reasons or antimicrobials with those assessed as needing either admission or antimicrobial treatment.\n\nFinal microbiological diagnoses included SARS-CoV-2 (COVID-19), Mycoplasma pneumonia, influenza A, RSV, non SARS\/MERS coronaviruses, rhinovirus\/enterovirus. 9\/68 were treated with antimicrobials, 15\/68 were admitted to a negative pressure room of whom 5\/68 were admitted solely due to an inability to isolate at home. Patients requiring either admission on clinical grounds or antimicrobials (14\/68) were similar to those not requiring admission or antimicrobials, with modestly more fever and shortness of breath in the clinically admitted \/ antimicrobial group. The most commonly prescribed antimicrobials were doxycycline, moxifloxacin and oseltamivir.\n\nThe majority of patients had mild illness which did not require a clinical intervention to manage. This finding supports a community testing approach supported by clinicians to review the proportion of more unwell patients.","preprint_author_corresponding":"Patrick Lillie","preprint_author_corresponding_institution":"Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, East Yorkshire, United Kingdom"},{"preprint_doi":"10.1101\/19007708","published_doi":"10.1136\/bmjopen-2019-034595","published_journal":"BMJ Open","preprint_platform":"medRxiv","preprint_title":"Systematic review and network meta-analysis with individual participant data on Cord Management at Preterm Birth (iCOMP): study protocol","preprint_authors":"Seidler, A. L. L.; Duley, L.; Katheria, A.; De Paco Matallana, C.; Dempsey, E.; Rabe, H.; Kattwinkel, J.; Mercer, J.; Josephsen, J.; Fairchild, K.; Andersson, O.; Hosono, S.; Sundaram, V.; Datta, V.; El-Naggar, W.; Tarnow-Mordi, W.; Debray, T. P. A.; Hooper, S.; Kluckow, M.; Polglase, G.; Davis, P.; Montgomery, A.; Hunter, K. E.; Barba, A.; Simes, J.; Askie, L.","preprint_category":"obstetrics and gynecology","preprint_date":"2019-10-05","published_date":"2020-03-30","preprint_abstract":"IntroductionTiming of cord clamping and other cord management strategies may improve outcomes at preterm birth. However, it is unclear whether benefits apply to all preterm subgroups such as those who usually receive immediate neonatal care. Previous and current trials compare various policies, including immediate cord clamping, time- or physiology-based deferred cord clamping, and cord milking. Individual participant data (IPD) enables exploration of different strategies within subgroups. Network meta-analysis (NMA) enables comparison and ranking of all available interventions using a combination of direct and indirect comparisons.\n\nObjectives1) To evaluate the effectiveness of cord management strategies for preterm infants on neonatal mortality and morbidity overall and for different participant characteristics using IPD meta-analysis; and 2) to evaluate and rank the effect of different cord management strategies for preterm births on mortality and other key outcomes using NMA.\n\nMethods and analysisWe will conduct a systematic search of Medline, Embase, clinical trial registries, and other sources for all planned, ongoing and completed randomised controlled trials comparing alternative cord management strategies at preterm birth (before 37 weeks gestation). IPD will be sought for all trials. First, deferred clamping and cord milking will be compared with immediate clamping in pairwise IPD meta-analyses. The primary outcome will be death prior to hospital discharge. Effect differences will be explored for pre-specified subgroups of participants. Second, all identified cord management strategies will be compared and ranked in an IPD NMA for the primary outcome and the key secondary outcomes intraventricular haemorrhage (any grade) and infant blood transfusions (any). Treatment effect differences by participant characteristics will be identified. Inconsistency and heterogeneity will be explored.\n\nEthics and disseminationApproved by University of Sydney Human Research Ethics Committee (2018\/886). Results will be relevant to clinicians, guideline-developers and policy-makers, and will be disseminated via publications, presentations, and media releases.\n\nRegistrationAustralian New Zealand Clinical Trials Registry: ACTRN12619001305112.\n\nSTRENGTH AND LIMITATIONS OF THIS STUDYO_LIThis will be the most comprehensive review to date of interventions for umbilical cord management in preterm infants and the findings will be highly relevant to clinicians and guideline developers\nC_LIO_LIThe use of individual participant data will allow assessment of the best treatment option for key subgroups of participants\nC_LIO_LINetwork meta-analysis will enable the comparison and ranking of all available treatment options using direct and indirect evidence\nC_LIO_LIFor some of the trials it will not be possible to obtain individual participant data, so published aggregate results will be used instead\nC_LIO_LIRisk of bias in the primary trials will be assessed using Cochrane criteria, and certainty of evidence for the meta-analyses will be appraised using the GRADE approach for the pairwise comparisons, and the CINeMA approach for the network meta-analysis\nC_LI","preprint_author_corresponding":"Anna Lene L Seidler","preprint_author_corresponding_institution":"University of Sydney, NHMRC Clinical Trials Centre"},{"preprint_doi":"10.1101\/2020.03.17.20037408","published_doi":"10.1016\/j.puhe.2020.03.007","published_journal":"Public Health","preprint_platform":"medRxiv","preprint_title":"How to improve adherence with quarantine: Rapid review of the evidence","preprint_authors":"Webster, R.; Brooks, S.; Smith, L.; Woodland, L.; Wessely, S.; Rubin, J.","preprint_category":"public and global health","preprint_date":"2020-03-20","published_date":"2020-03-30","preprint_abstract":"ObjectivesThe January 2020 outbreak of coronavirus has once again thrown the vexed issue of quarantine into the spotlight, with many countries asking their citizens to  self-isolate if they have potentially come into contact with the infection. However, adhering to quarantine is difficult. Decisions on how to apply quarantine should be based on the best available evidence to increase the likelihood of people adhering to protocols. We conducted a rapid review to identify factors associated with adherence to quarantine during infectious disease outbreaks.\n\nStudy designRapid evidence review.\n\nMethodsWe searched Medline, PsycINFO and Web of Science for published literature on the reasons for and factors associated with adherence to quarantine during an infectious disease outbreak.\n\nResultsWe found 3163 papers and included 14 in the review. Adherence to quarantine ranged from as little as 0 up to 92.8%. The main factors which influenced or were associated with adherence decisions were the knowledge people had about the disease and quarantine procedure, social norms, perceived benefits of quarantine and perceived risk of the disease, as well as practical issues such as running out of supplies or the financial consequences of being out of work.\n\nConclusionsPeople vary in their adherence to quarantine during infectious disease outbreaks. To improve this, public health officials should provide a timely, clear rationale for quarantine and information about protocols; emphasise social norms to encourage this altruistic behaviour; increase the perceived benefit that engaging in quarantine will have on public health; and ensure that sufficient supplies of food, medication and other essentials are provided.","preprint_author_corresponding":"Rebecca Webster","preprint_author_corresponding_institution":"King's College London"},{"preprint_doi":"10.1101\/2020.03.24.20042598","published_doi":"10.1093\/cid\/ciaa354","published_journal":"Clinical Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea","preprint_authors":"Dudley, J. P.; Lee, N. T.","preprint_category":"epidemiology","preprint_date":"2020-03-27","published_date":"2020-03-27","preprint_abstract":"We analyzed age-specific and sex-specific morbidity and mortality data from SARS-COV-2 pandemic in China and Republic of Korea (ROK). Data from China exhibit a standard Gaussian distribution with peak morbidity in the 50-59 years cohort, while the ROK data have a bimodal distribution with highest morbidity in the 20-29 years cohort.","preprint_author_corresponding":"Joseph P Dudley","preprint_author_corresponding_institution":"Leidos Inc."},{"preprint_doi":"10.1101\/19004069","published_doi":"10.1097\/j.pain.0000000000001860","published_journal":"PAIN","preprint_platform":"medRxiv","preprint_title":"Enhanced mindfulness based stress reduction (MBSR+) in episodic migraine: a randomized clinical trial with MRI outcomes","preprint_authors":"Seminowicz, D. A.; Burrowes, S.; Kearson, A.; Zhang, J.; Krimmel, S.; Samawi, L.; Furman, A.; Keaser, M.; Gould, N.; Magyari, T.; White, L.; Goloubeva, O.; Goyal, M.; Peterlin, L.; Haythornthwaite, J.","preprint_category":"pain medicine","preprint_date":"2019-08-06","published_date":"2020-03-20","preprint_abstract":"We aimed to evaluate the efficacy of an enhanced mindfulness based stress reduction (MBSR+) versus stress management for headache (SMH). We performed a randomized, assessor-blind, clinical trial of 98 adults with episodic migraine recruited at a single academic center comparing MBSR+ (n=50) to SMH (n=48). MBSR+ and SMH were delivered weekly by group for 8 weeks, then bi-weekly for another 8 weeks. The primary clinical outcome was reduction in headache days from baseline to 20 weeks. MRI outcomes included activity of left dorsolateral prefrontal cortex (DLPFC) and cognitive task network during cognitive challenge, resting state connectivity of right dorsal anterior insula (daINS) to DLPFC and cognitive task network, and gray matter volume of DLPFC, daINS, and anterior midcingulate. Secondary outcomes were headache-related disability, pain severity, response to treatment, migraine days, and MRI whole-brain analyses. Reduction in headache days from baseline to 20 weeks was greater for MBSR+ (7.8 [95%CI, 6.9-8.8] to 4.6 [95%CI, 3.7-5.6]) than for SMH (7.7 [95%CI 6.7-8.7] to 6.0 [95%CI, 4.9-7.0]) (P=0.04). 52% of the MBSR+ group showed a response to treatment (50% reduction in headache days) compared with 23% in the SMH group (P=0.004). Reduction in headache-related disability was greater for MBSR+ (59.6 [95%CI, 57.9-61.3] to 54.6 [95%CI, 52.9-56.4]) than SMH (59.6 [95%CI, 57.7-61.5] to 57.5 [95%CI, 55.5-59.4]) (P=0.02). There were no differences in clinical outcomes at 52 weeks or MRI outcomes at 20 weeks, although changes related to cognitive networks with MBSR+ were observed. MBSR+ is an effective treatment option for episodic migraine.","preprint_author_corresponding":"David A Seminowicz","preprint_author_corresponding_institution":"University of Maryland Baltimore"},{"preprint_doi":"10.1101\/2020.03.13.20035410","published_doi":"10.1016\/j.jinf.2020.03.018","published_journal":"Journal of Infection","preprint_platform":"medRxiv","preprint_title":"Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources","preprint_authors":"Zhang, Z.; Yao, W.; Wang, Y.; Long, C.; FU, X.","preprint_category":"epidemiology","preprint_date":"2020-03-17","published_date":"2020-03-21","preprint_abstract":"We report that COVID-19 mortality and recovery rates in Hubei Province, China exponentially decays (R2>0.93) and grows (R2>0.95), respectively. A great number of newly supplied medical resources, including more than 42000 aided health workers, over 26000 makeshift beds and 23000 acute care beds, enabled overwhelming patients to be treated effectively in hospitals. This may inform other countries to deal with the coming COVID-19 pandemic when patients are overwhelming the local health care system.","preprint_author_corresponding":"XINMIAO FU","preprint_author_corresponding_institution":"Fujian Normal University"},{"preprint_doi":"10.1101\/2019.12.11.19013649","published_doi":"10.1155\/2020\/3254820","published_journal":"Journal of Oncology","preprint_platform":"medRxiv","preprint_title":"Using Media to Promote Public Awareness of Early Detection of Kaposi's Sarcoma in Africa","preprint_authors":"Laker-Oketta, M.; Butler, L. M.; Kadama-Makanga, P.; Inglis, R.; Wenger, M.; Katongole-Mbidde, E.; Maurer, T.; Kambugu, A.; Martin, J. N.","preprint_category":"oncology","preprint_date":"2019-12-14","published_date":"2020-03-21","preprint_abstract":"BackgroundDespite its hallmark cutaneous presentation, most Kaposis sarcoma (KS) in Africa is diagnosed too late for effective treatment. Early diagnosis will only be achievable if patients with KS present earlier for care. We hypothesized that public awareness about KS can be enhanced through exposure to common media.\n\nMethodsWe developed educational messages regarding early detection of KS for the general African public portraying a three-part theme: \"Look\" (regularly examine ones skin\/mouth); \"Show\" (bring to the attention of a healthcare provider any skin\/mouth changes); and \"Test\" (ask for a biopsy for definitive diagnosis). We packaged the messages in three common media forms (comic strips, radio, and video) and tested their effect on increasing KS awareness among adults attending markets in Uganda. Participants were randomized to a single exposure to one of the media and evaluated for change in KS-related knowledge and attitudes.\n\nResultsAmong 420 participants, media exposure resulted in increased ability to identify KS (from 0.95% pre-test to 46% post-test); awareness that anyone is at risk for KS (29% to 50%); belief that they may be at risk (63% to 76%); and knowledge that definitive diagnosis requires biopsy (23% to 51%) (all p<0.001). Most participants (96%) found the media culturally appropriate.\n\nConclusionExposure to media featuring a theme of \"Look\", \"Show\", \"Test\" resulted in changes in knowledge and attitudes concerning KS among the general public in Uganda. High incidence and poor survival of KS in Africa are an impetus to further evaluate these media, which are freely available online.","preprint_author_corresponding":"Miriam Laker-Oketta","preprint_author_corresponding_institution":"Infectious Diseases Institute, Makerere University, Kampala, Uganda"},{"preprint_doi":"10.1101\/2020.03.05.20031773","published_doi":"10.2807\/1560-7917.ES.2020.25.12.2000256","published_journal":"Eurosurveillance","preprint_platform":"medRxiv","preprint_title":"Estimating the infection and case fatality ratio for COVID-19 using age-adjusted data from the outbreak on the Diamond Princess cruise ship","preprint_authors":"Russell, T. W.; Hellewell, J.; Jarvis, C. I.; van-Zandvoort, K.; Abbott, S.; Ratnayake, R.; CMMID nCov working group,  ; Flasche, S.; Eggo, R. M.; Kucharski, A. J.","preprint_category":"epidemiology","preprint_date":"2020-03-08","published_date":"2020-03-26","preprint_abstract":"Adjusting for delay from confirmation-to-death, we estimated case and infection fatality ratios (CFR, IFR) for COVID-19 on the Diamond Princess ship as 2.3% (0.75%-5.3%) and 1.2% (0.38-2.7%). Comparing deaths onboard with expected deaths based on naive CFR estimates using China data, we estimate IFR and CFR in China to be 0.5% (95% CI: 0.2-1.2%) and 1.1% (95% CI: 0.3-2.4%) respectively.\n\nAimTo estimate the infection and case fatality ratio of COVID-19, using data from passengers of the Diamond Princess cruise ship while correcting for delays between confirmation-and-death, and age-structure of the population.","preprint_author_corresponding":"Timothy W Russell","preprint_author_corresponding_institution":"London School of Hygiene and Tropical Medicine"},{"preprint_doi":"10.1101\/2020.02.27.20028829","published_doi":"10.1016\/j.ijid.2020.03.031","published_journal":"The International Journal of Infectious Diseases ","preprint_platform":"medRxiv","preprint_title":"Transmission potential of COVID-19 in South Korea","preprint_authors":"Shim, E.; Tariq, A.; Choi, W.; Lee, Y.; Chowell, G.","preprint_category":"epidemiology","preprint_date":"2020-02-29","published_date":"2020-03-17","preprint_abstract":"Since the first identified individual of 2019 novel coronavirus (COVID-19) infection on Jan 20, 2020 in South Korea, the number of confirmed cases rapidly increased. As of Feb 26, 2020, 1,261 cases of COVID-19 including 12 deaths were confirmed in South Korea. Using the incidence data of COVID-19, we estimate the reproduction number at 1.5 (95% CI: 1.4-1.6), which indicates sustained transmission and support the implementation of social distancing measures to rapidly control the outbreak.","preprint_author_corresponding":"Eunha Shim","preprint_author_corresponding_institution":"Soongsil University"},{"preprint_doi":"10.1101\/2020.03.10.20033605","published_doi":"10.1093\/cid\/ciaa352","published_journal":"Clinical Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study","preprint_authors":"Li, N.; Han, L.; Peng, M.; Lv, Y.; Ouyang, Y.; Liu, K.; Yue, L.; Li, Q.; Sun, G.; Chen, L.; Yang, L.","preprint_category":"infectious diseases","preprint_date":"2020-03-13","published_date":"2020-03-27","preprint_abstract":"BackgroundThe ongoing epidemics of coronavirus disease 2019 (COVID-19) have caused serious concerns about its potential adverse effects on pregnancy. There are limited data on maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia.\n\nMethodsWe conducted a case-control study to compare clinical characteristics, maternal and neonatal outcomes of pregnant women with and without COVID-19 pneumonia.\n\nResultsDuring January 24 to February 29, 2020, there were sixteen pregnant women with confirmed COVID-19 pneumonia and eighteen suspected cases who were admitted to labor in the third trimester. Two had vaginal delivery and the rest took cesarean section. Few patients presented respiratory symptoms (fever and cough) on admission, but most had typical chest CT images of COVID-19 pneumonia. Compared to the controls, COVID-19 pneumonia patients had lower counts of white blood cells (WBC), neutrophils, C-reactive protein (CRP), and alanine aminotransferase (ALT) on admission. Increased levels of WBC, neutrophils, eosinophils, and CRP were found in postpartum blood tests of pneumonia patients. There were three (18.8%) and two (10.5%) of the mothers with confirmed or suspected COVID-19 pneumonia had preterm delivery due to maternal complications, which were significantly higher than the control group. None experienced respiratory failure during hospital stay. COVID-19 infection was not found in the newborns and none developed severe neonatal complications.\n\nConclusionSevere maternal and neonatal complications were not observed in pregnant women with COVID-19 pneumonia who had vaginal delivery or caesarean section. Mild respiratory symptoms of pregnant women with COVID-19 pneumonia highlight the need of effective screening on admission.","preprint_author_corresponding":"Lin Yang","preprint_author_corresponding_institution":"The Hong Kong Polytechnic University"},{"preprint_doi":"10.1101\/2019.12.19.19015453","published_doi":"10.1111\/epi.16485","published_journal":"Epilepsia","preprint_platform":"medRxiv","preprint_title":"Forecasting Cycles of Seizure Likelihood","preprint_authors":"Karoly, P. J.; Maturana, M. I.; Cook, M. J.; Nurse, E. S.; Payne, D.; Brinkmann, B.; Grayden, D. B.; Dumanis, S. B.; Richardson, M. P.; Worrell, G.; Schulze-Bonhage, A.; Kuhlmann, L.; Freestone, D. R.","preprint_category":"neurology","preprint_date":"2019-12-21","published_date":"2020-03-27","preprint_abstract":"ObjectiveSeizure unpredictability is rated as one of the most challenging aspects of living with epilepsy. Seizure likelihood can be influenced by a range of environmental and physiological factors that are difficult to measure and quantify. However, some generalizable patterns have been demonstrated in seizure onset. A majority of people with epilepsy exhibit circadian rhythms in their seizure times and many also show slower, multiday patterns. Seizure cycles can be measured using a range of recording modalities, including self-reported electronic seizure diaries. This study aimed to develop personalized forecasts from a mobile seizure diary app.\n\nMethodsForecasts based on circadian and multiday seizure cycles were tested pseudo-prospectively using data from 33 app users (mean of 103 seizures per subject). Individuals strongest cycles were estimated from their reported seizure times and used to derive the likelihood of future seizures. The forecasting approach was validated using self-reported events and electrographic seizures from the Neurovista dataset, an existing database of long-term electroencephalography that has been widely used to develop forecasting algorithms.\n\nResultsThe validation dataset showed that forecasts of seizure likelihood based on self-reported cycles were predictive of electrographic seizures. Forecasts using only mobile app diaries allowed users to spend an average of 62.8% of their time in a low-risk state, with 16.6% of their time in a high-risk warning state. On average, 64.5% of seizures occurred during high-risk states and less than 10% of seizures occurred in low-risk states.\n\nSignificanceSeizure diary apps can provide personalized forecasts of seizure likelihood that are accurate and clinically relevant for electrographic seizures. These results have immediate potential for translation to a prospective seizure forecasting trial using a mobile diary app. It is our hope that seizure forecasting apps will one day give people with epilepsy greater confidence in managing their daily activities.","preprint_author_corresponding":"Philippa J Karoly","preprint_author_corresponding_institution":"The University of Melbourne"},{"preprint_doi":"10.1101\/2020.01.20.20016766","published_doi":"10.1093\/noajnl\/vdaa042","published_journal":"Neuro-Oncology Advances","preprint_platform":"medRxiv","preprint_title":"Tumor Mutational Burden Predicts Survival In Patients With Low Grade Gliomas Expressing Mutated IDH1","preprint_authors":"Alghamri, M.; Thalla, R.; Avvari, R.; Dabaja, A.; Taher, A.; Zhao, L.; Castro, M. G.; Lowenstein, P.","preprint_category":"oncology","preprint_date":"2020-01-23","published_date":"2020-03-27","preprint_abstract":"Gliomas are the most common primary brain tumors. High Grade Gliomas have a median survival of 18 months, while Low Grade Gliomas (LGG) have a median survival of [~]7.3 years. Seventy-six percent of patients with LGG express mutated isocitrate dehydrogenase (mIDH1) enzyme (IDH1R132H). Survival of these patients ranges from 1-15 years, and tumor mutational burden ranges from 8 to 447 total somatic mutations per tumor. We tested the hypothesis that the tumor mutational burden would predict survival of patients with tumors bearing mIDH1R132H. We analyzed the effect of tumor mutational burden on patients survival using clinical and genomic data of 1199 glioma patients from The Cancer Genome Atlas and validated our results using the Chinese Glioma Genome Atlas. High tumor mutational burden negatively correlates with survival of patients with LGG harboring IDH1R132H (p<0.0001). This effect was significant for both Oligodendroglioma and Astrocytoma LGG-mIDH1 patients. In the TCGA data, median survival of the high mutational burden group was 76 months, while in the low mutational burden group it was 136 months; p<0.0001. There was no differential representation of frequently mutated genes (e.g., TP53, ATRX, CIC, FUBP) in either group. Gene set enrichment analysis revealed an enrichment in Gene Ontologies related to Cell cycle, DNA damage response in high vs low tumor mutational burden. Finally, we identified a 19 gene signature that predicts survival for patients from both databases. In summary, we demonstrate that tumor mutational burden is a powerful, robust, and clinically relevant prognostic factor of median survival in mIDH1 patients.","preprint_author_corresponding":"Pedro Lowenstein","preprint_author_corresponding_institution":"University of Michigan"},{"preprint_doi":"10.1101\/19012260","published_doi":"10.1093\/brain\/awaa097","published_journal":"Brain","preprint_platform":"medRxiv","preprint_title":"Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes","preprint_authors":"Murley, A. G.; Coyle-Gilchrist, I.; Rouse, M.; Jones, P. S.; Li, W.; Wiggins, J.; Lansdall, C.; Vazquez Rodriguez, P.; Wilcox, A.; Tsvetanov, K. A.; Patterson, K.; Lambon Ralph, M. A.; Rowe, J. B.","preprint_category":"neurology","preprint_date":"2019-11-22","published_date":"2020-03-12","preprint_abstract":"The syndromes caused by frontotemporal lobar degeneration (FTLD) have highly heterogenous and overlapping clinical features. There has been great progress in the refinement of clinical diagnostic criteria in the last decade, but we propose that a better understanding of aetiology, pathophysiology and symptomatic treatments can arise from a transdiagnostic approach to clinical phenotype and brain morphometry. In a cross-sectional epidemiological study, we examined 310 patients with a syndrome likely to be caused by frontotemporal lobar degeneration, including behavioural variant frontotemporal dementia (bvFTD), the non-fluent (nfvPPA), semantic (svPPA) variants of primary progressive aphasia, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). We also included patients with logopenic primary progressive aphasia (lvPPA) and those who met criteria for PPA but not one of the three subtypes. To date, forty-nine patients have a neuropathological diagnosis. A principal component analysis identified symptom dimensions that broadly recapitulated the core features of the main clinical syndromes. However, the subject-specific scores on these dimensions showed considerable overlap across the diagnostic groups. Sixty-two percent of participants had phenotypic features that met the diagnostic criteria for more than one syndrome. Behavioural disturbance was prevalent in all groups. Forty-four percent of patients with CBS had PSP-like features and thirty percent of patients with PSP had CBS-like features. Many patients with PSP and CBS had language impairments consistent with nfvPPA while patients with bvFTD often had semantic impairments. Using multivariate source-based morphometry on a subset of patients (n=133), we identified patterns of co-varying brain atrophy that were represented across the diagnostic groups. Canonical correlation analysis of clinical and imaging components found three key brain-behaviour relationships that revealed a continuous spectrum across the cohort rather than discrete diagnostic entities. In the forty-six patients with longitudinal follow up (mean 3.6 years) syndromic overlap increased with time. Together, these results show that syndromes associated with FTLD do not form discrete mutually exclusive categories from their clinical features or structural brain changes, but instead exist in a multidimensional spectrum. Patients often manifest diagnostic features of multiple disorders and deficits in behaviour, movement and language domains are not confined to specific diagnostic groups. It is important to recognise individual differences in clinical phenotype, both for clinical management and to understand pathogenic mechanisms. We suggest that the adoption of a transdiagnostic approach to the spectrum of FTLD syndromes provides a useful framework with which to understand disease progression, heterogeneity and treatment.","preprint_author_corresponding":"Alexander G Murley","preprint_author_corresponding_institution":"University of Cambridge"},{"preprint_doi":"10.1101\/2020.01.09.20017012","published_doi":"10.1212\/NXI.0000000000000691","published_journal":"Neurology - Neuroimmunology Neuroinflammation","preprint_platform":"medRxiv","preprint_title":"Insights into smouldering MS brain pathology with multimodal diffusion tensor and PET imaging","preprint_authors":"Bezukladova, S.; Tuisku, J.; Matilainen, M.; Vuorimaa, A.; Nylund, M.; Smith, S.; Sucksdorff, M.; Mohammadian, M.; Saunavaara, V.; Laaksonen, S.; Rokka, J.; Rinne, J.; Rissanen, E.; Airas, L.","preprint_category":"neurology","preprint_date":"2020-01-10","published_date":"2020-03-02","preprint_abstract":"ObjectiveTo evaluate in vivo the co-occurrence of microglial activation and microstructural white matter damage in multiple sclerosis (MS) brain, and to examine their association with clinical disability.\n\nMethods18-kDa translocator protein (TSPO) brain PET imaging was performed for evaluation of microglial activation by using the radioligand [11C](R)-PK11195. TSPO-binding was evaluated as the distribution volume ratio (DVR) from dynamic PET images. Diffusion tensor imaging (DTI) and conventional MRI were performed at the same time. Mean fractional anisotropy (FA) and mean (MD), axial (AD) and radial (RD) diffusivities were calculated within the whole normal appearing white matter (NAWM) and segmented NAWM regions appearing normal in conventional MRI. 55 MS patients and 15 healthy controls were examined.\n\nResultsMicrostructural damage was observed in the NAWM of MS brain. DTI parameters of MS patients were significantly altered in the NAWM, when compared to an age- and sex-matched healthy control group: mean FA was decreased, and MD, AD and RD were increased. These structural abnormalities correlated with increased TSPO binding in the whole NAWM and in the temporal NAWM (p<0.05 for all correlations; p<0.01 for RD in the temporal NAWM). Both compromised WM integrity and increased microglial activation in the NAWM correlated significantly with higher clinical disability measured with expanded disability status scale (EDSS).\n\nConclusionsWidespread structural disruption in the NAWM is linked to neuroinflammation, and both phenomena associate with clinical disability. Multimodal PET and DTI imaging allows in vivo evaluation of widespread MS pathology not visible using conventional MRI.\n\nSupplemental data: Table e-1. Clinical and conventional MRI parameters of healthy controls and multiple sclerosis patients\n\nTable e-2. The effect of number of gradients (64 vs. 33) on DTI-derived measures\n\nTable e-3. Associations of DTI and TSPO-PET measures in the segmented NAWM with disability and disease severity among MS patients (n=55).","preprint_author_corresponding":"Laura Airas","preprint_author_corresponding_institution":"Turku PET Centre"},{"preprint_doi":"10.1101\/19006866","published_doi":"10.1016\/j.gaitpost.2020.02.007","published_journal":"Gait & posture","preprint_platform":"medRxiv","preprint_title":"Discriminating Progressive Supranuclear Palsy from Parkinson's Disease using wearable technology","preprint_authors":"De Vos, M.; Prince, J.; Buchanan, T.; FitzGerald, J.; Antoniades, C. A.","preprint_category":"neurology","preprint_date":"2019-11-06","published_date":"2020-03-20","preprint_abstract":"BackgroundProgressive supranuclear palsy (PSP), a neurodegenerative conditions may be difficult to discriminate clinically from idiopathic Parkinsons disease (PD). It is critical that we are able to do this accurately and as early as possible in order that future disease modifying therapies for PSP may be deployed at a stage when they are likely to have maximal benefit. Analysis of gait and related tasks is one possible means of discrimination.\n\nResearch QuestionHere we investigate a wearable sensor array coupled with machine learning approaches as a means of disease classification.\n\nMethods21 participants with PSP, 20 with PD, and 39 healthy control (HC) subjects performed a two minute walk, static sway test, and timed up-and-go task, while wearing an array of six inertial measurement units. The data were analysed to determine what features discriminated PSP from PD and PSP from HC. Two machine learning algorithms were applied, Logistic Regression (LR) and Random Forest (RF).\n\nResults17 features were identified in the combined dataset that contained independent information. The RF classifier outperformed the LR classifier, and allowed discrimination of PSP from PD with 86% sensitivity and 90% specificity, and PSP from HC with 90% sensitivity and 97% specificity. Using data from the single lumbar sensor only resulted in only a modest reduction in classification accuracy, which could be restored using 3 sensors (lumbar, right arm and foot). However for maximum specificity the full six sensor array was needed.\n\nSignificanceA wearable sensor array coupled with machine learning methods can accurately discriminate PSP from PD. Choice of array complexity depends on context; for diagnostic purposes a high specificity is needed suggesting the more complete array is advantageous, while for subsequent disease tracking a simpler system may suffice.","preprint_author_corresponding":"Chrystalina A Antoniades","preprint_author_corresponding_institution":"University of Oxford"},{"preprint_doi":"10.1101\/19011197","published_doi":"10.1093\/cid\/ciaa333","published_journal":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","preprint_platform":"medRxiv","preprint_title":"Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications","preprint_authors":"Thomas, B. E.; Kumar, J. V.; M., C.; Shah, D.; Khandewale, A.; Haberer, J. E.; Mayer, K. H.; Subbaraman, R.","preprint_category":"infectious diseases","preprint_date":"2019-11-05","published_date":"2020-03-28","preprint_abstract":"99DOTS is a cellphone-based strategy for monitoring tuberculosis medication adherence. In a cohort of 650 Indian tuberculosis patients, we compared 99DOTS adherence record against results of urine isoniazid tests collected during unannounced home visits. 99DOTS had suboptimal accuracy for measuring adherence, partly due to poor patient engagement with 99DOTS.","preprint_author_corresponding":"Ramnath Subbaraman","preprint_author_corresponding_institution":"Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, USA"},{"preprint_doi":"10.1101\/19008854","published_doi":"10.1093\/infdis\/jiz561","published_journal":"The Journal of infectious diseases","preprint_platform":"medRxiv","preprint_title":"Mosquito exposure and malaria morbidity; a micro-level analysis of household mosquito populations and malaria in a population-based longitudinal cohort in western Kenya","preprint_authors":"Prudhomme O'Meara, W.; Simmons, R.; Bullins, P.; Freedman, B.; Abel, L.; Mangeni, J.; Taylor, S. M.; Obala, A. A.","preprint_category":"epidemiology","preprint_date":"2019-10-18","published_date":"2020-03-16","preprint_abstract":"BackgroundMalaria morbidity is highly overdispersed in the population. Fine-scale differences in mosquito exposure may partially explain this heterogeneity. However, exposure variability has not been related to individual malaria outcomes.\n\nMethodsWe established a cohort of 38 households to explore the effect of household-level mosquito exposure and individual insecticide treated net(ITN) use on relative risk(RR) of diagnostically-confirmed malaria. We conducted monthly active surveillance (n=254; 2,624 person-months) and weekly mosquito collection in all households (2,092 household-days of collection). We used molecular techniques to confirm human blood feeding and exposure to infectious mosquitoes.\n\nResultsOf 1,494 female anopheles (89.8% Anopheles gambiae s.l.). 88.3% were fed, 51.9% had a human bloodmeal, and 9.2% were sporozoite-infected. 168 laboratory-confirmed malaria episodes were reported (incidence rate 0.064 episodes per person-month at risk, 95% confidence interval [CI]:0.055,0.074). Malaria risk was directly associated with exposure to sporozoite-infected mosquitoes (RR=1.24, 95%CI:1.11,1.38). No direct effect was measured between ITN use and malaria morbidity, however, ITN use did moderate the effect of mosquito exposure on morbidity.\n\nConclusionsMalaria risk increases linearly with vector density and feeding success for persons with low ITN use. In contrast, malaria risk among high ITN users is consistently low and insensitive to variation in mosquito exposure.\n\nSummaryIn this study, we measure the relationship between fine-scale spatio-temporal heterogeneity in exposure to infected and successfully-fed malaria vectors, the incidence of malaria, and their interaction with ITN use in a population-based cohort.","preprint_author_corresponding":"Wendy Prudhomme O'Meara","preprint_author_corresponding_institution":"Duke University"},{"preprint_doi":"10.1101\/19004432","published_doi":"10.1080\/09638288.2020.1742391","published_journal":"Disability and Rehabilitation","preprint_platform":"medRxiv","preprint_title":"Identifying barriers and facilitators to physical activity for people with scleroderma: A nominal group technique study","preprint_authors":"Harb, S.; Cumin, J.; Rice, D. B.; Pelaez, S.; Hudson, M.; Bartlett, S. J.; Roren, A.; Furst, D. E.; Frech, T. M.; Nguyen, C.; Nielson, W. R.; Thombs, B. D.; Shrier, I.; Patient Advisory Team, S.-P.","preprint_category":"rheumatology","preprint_date":"2019-08-11","published_date":"2020-03-19","preprint_abstract":"PurposeTo identify physical activity barriers and facilitators experienced by people with systemic sclerosis (SSc; scleroderma).\n\nMaterials and MethodsWe conducted nominal group technique sessions with SSc patients who shared barriers to physical activities, barrier-specific facilitators, and general facilitators. Participants rated importance of barriers and likelihood of using facilitators from 0-10, and indicated whether they had tried facilitators. Barriers and facilitators across sessions were subsequently merged to eliminate overlap; edited based on feedback from investigators, patient advisors, and clinicians; and categorized.\n\nResultsWe conducted nine sessions (n=41 total participants) and initially generated 181 barriers, 457 barrier-specific facilitators, and 20 general facilitators. The number of consolidated barriers (barrier-specific facilitators in parentheses) for each category were: 14 (61) for health and medical; 4 (23) for social and personal; 1 (3) for time, work, and lifestyle; and 1 (4) for environmental. There were 12 consolidated general facilitators. The consolidated items with [&ge;] 1\/3 of participants ratings [&ge;] 8 were: 15 barriers, 69 barrier-specific facilitators, and 9 general facilitators.\n\nConclusionsPeople with SSc reported many barriers related to health and medical aspects of SSc and several barriers in other categories. They reported facilitators to remain physically active despite the barriers.\n\nImplications for RehabilitationO_LIPeople with scleroderma experience difficulty being physically active due to the diverse and often severe manifestations of the disease, including involvement of the skin, musculoskeletal system, and internal organs.\nC_LIO_LIIn addition to regular care of scleroderma-related symptoms, patients overcome many exercise challenges by selecting physical activities that are comfortable for them, adjusting the intensity and duration of activities, adapting activities, and using adapted equipment or other materials to reduce discomfort.\nC_LIO_LIRehabilitation professionals should help people with scleroderma to tailor activity options to their capacity and needs when providing care and advice to promote physical activity.\nC_LI","preprint_author_corresponding":"Ian Shrier","preprint_author_corresponding_institution":"Lady Davis Institute for Medical Research, Jewish General Hospital"},{"preprint_doi":"10.1101\/19001883","published_doi":"10.1371\/journal.pmed.1003032","published_journal":"PLOS Medicine","preprint_platform":"medRxiv","preprint_title":"Maternal and child gluten intake and risk of type 1 diabetes: The Norwegian Mother and Child Cohort Study","preprint_authors":"Lund-Blix, N. A.; Tapia, G.; Marild, K.; Brantsaeter, A. L.; Njolstad, P. R.; Joner, G.; Skrivarhaug, T.; Stordal, K.; Stene, L. C.","preprint_category":"nutrition","preprint_date":"2019-07-19","published_date":"2020-03-02","preprint_abstract":"OBJECTIVETo examine the association between maternal and child gluten intake and risk of type 1 diabetes in children.\n\nDESIGNPregnancy cohort\n\nSETTINGPopulation-based, nation-wide study in Norway\n\nPARTICIPANTS86,306 children in The Norwegian Mother and Child Cohort Study born from 1999 through 2009, followed to April 15, 2018.\n\nMAIN OUTCOME MEASURESClinical type 1 diabetes, ascertained in a nation-wide childhood diabetes registry. Hazard ratios were estimated using Cox regression for the exposures maternal gluten intake up to week 22 of pregnancy and childs gluten intake when the child was 18 months old.\n\nRESULTSDuring a mean follow-up of 12.3 years (range 0.7-16.0), 346 children (0.4%) developed type 1 diabetes (incidence rate 32.6 per 100,000 person-years). The average gluten intake was 13.6 grams\/day for mothers during pregnancy, and 8.8 grams\/day for the child at 18 months of age. Maternal gluten intake in mid-pregnancy was not associated with the development of type 1 diabetes in the child (adjusted hazard ratio 1.02 (95% confidence interval 0.73 to 1.43) per 10 grams\/day increase in gluten intake). However, the childs gluten intake at 18 months of age was associated with an increased risk of later developing type 1 diabetes (adjusted hazard ratio 1.46 (95% confidence interval 1.06 to 2.01) per 10 grams\/day increase in gluten intake).\n\nCONCLUSIONSThis study suggests that the childs gluten intake at 18 months of age, and not the maternal intake during pregnancy, could increase the risk of type 1 diabetes in the child.\n\nWHAT IS ALREADY KNOWN ON THIS TOPICA national prospective cohort study from Denmark found that a high maternal gluten intake during pregnancy could increase the risk of type 1 diabetes in the offspring (adjusted hazard ratio 1.31 (95% confidence interval 1.001 to 1.72) per 10 grams\/day increase in gluten intake). No studies have investigated the relation between the amount of gluten intake by both the mother during pregnancy and the child in early life and risk of developing type 1 diabetes in childhood.\n\nWHAT THIS STUDY ADDSIn this prospective population-based pregnancy cohort with 86,306 children of whom 346 developed type 1 diabetes we found that the childs gluten intake at 18 months of age was associated with the risk of type 1 diabetes (adjusted hazard ratio 1.46 (95% confidence interval 1.06 to 2.01) per 10 grams\/day increase in gluten intake). This study suggests that the childs gluten intake at 18 months of age, and not the maternal intake during pregnancy, could increase the childs risk of type 1 diabetes.","preprint_author_corresponding":"Nicolai A Lund-Blix","preprint_author_corresponding_institution":"Norwegian Institute of Public Health, and Oslo University Hospital"},{"preprint_doi":"10.1101\/19004895","published_doi":"10.1371\/journal.pmed.1003062","published_journal":"PLOS Medicine","preprint_platform":"medRxiv","preprint_title":"Apolipoprotein B underlies the causal relationship of circulating blood lipids with coronary heart disease","preprint_authors":"Richardson, T. G.; Sanderson, E.; Palmer, T. M.; Ala-Korpela, M.; Ference, B. A.; Davey Smith, G.; Holmes, M. V.","preprint_category":"cardiovascular medicine","preprint_date":"2019-08-29","published_date":"2020-03-23","preprint_abstract":"BackgroundCirculating blood lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. We sought to explore the causal relationships of blood lipid traits with risk of CHD using multivariable Mendelian randomization.\n\nMethodsWe conducted GWAS of circulating blood lipid traits in UK Biobank (up to n=440,546) for LDL cholesterol, triglycerides and apolipoprotein B to identify lipid-associated SNPs. Using data from CARDIoGRAMplusC4D for CHD (consisting of 60,801 cases and 123,504 controls), we performed univariable and multivariable Mendelian randomization (MR) analyses. Similar analyses were conducted for HDL cholesterol and apolipoprotein A-I.\n\nFindingsGWAS identified multiple independent SNPs associated at P<5x10-8 for LDL cholesterol (220), apolipoprotein B (n=255), triglycerides (440), HDL cholesterol (534) and apolipoprotein AI (440). Between 56-93% of SNPs identified for each lipid trait had not been previously reported in large-scale GWAS. Almost half (46%) of these SNPs were associated at P<5x10-8 with more than one lipid related trait. Assessed individually using MR, each of LDL cholesterol (OR 1.66 per 1 standard deviation higher trait; 95%CI: 1.49; 1.86; P=2.4x10-19), triglycerides (OR 1.34; 95%CI: 1.25, 1.44; P=9.1x10-16) and apolipoprotein B (OR 1.73; 95%CI: 1.56, 1.91; P=1.5x10-25) had effect estimates consistent with a higher risk of CHD. In multivariable MR, only apolipoprotein B (OR 1.92; 95%CI: 1.31, 2.81; P=7.5x10-4) retained a robust effect with the estimate for LDL cholesterol (OR 0.85; 95%CI: 0.57; 1.27; P=0.44) reversing and that of triglycerides (OR 1.12; 95%CI: 1.02, 1.23; P=0.01) becoming markedly weaker.\n\nIndividual MR analyses showed a 1-SD higher HDL-C (OR 0.80; 95%CI: 0.75, 0.86; P=1.7x10-10) and apolipoprotein A-I (OR 0.83; 95%CI: 0.77, 0.89; P=1.0x10-6) to lower the risk of CHD but these effect estimates weakened to include the null on accounting for apolipoprotein B.\n\nConclusionsApolipoprotein B is of fundamental causal relevance in the aetiology of CHD, and underlies the relationship of LDL cholesterol and triglycerides with CHD.","preprint_author_corresponding":"Tom G Richardson","preprint_author_corresponding_institution":"University of Bristol"},{"preprint_doi":"10.1101\/19002485","published_doi":"10.1098\/rsif.2019.0879","published_journal":"Journal of The Royal Society Interface","preprint_platform":"medRxiv","preprint_title":"Considerations in the deployment of novel universal vaccines against epidemic and pandemic influenza","preprint_authors":"Arinaminpathy, N.; Riley, S.; Barclay, W.; Saad-Roy, C. M.; Grenfell, B. T.","preprint_category":"infectious diseases","preprint_date":"2019-07-29","published_date":"2020-03-04","preprint_abstract":"There is increasing interest in the development of new,  universal influenza vaccines (UIV) that - unlike current vaccines - are effective against a broad range of seasonal influenza strains, as well as against novel pandemic viruses. Even where these vaccines do not block infection, they can moderate clinical severity, reducing morbidity and mortality while potentially also reducing opportunities for transmission. Previous modelling studies have illustrated the potential epidemiological benefits of UIVs, including their potential to mitigate pandemic burden. However, these new vaccines could shape population immunity in complex ways. Here, using mathematical models of influenza transmission, we illustrate two types of unintended consequences that could arise from their future deployment. First, by reducing the amount of infection-induced immunity in a population without fully replacing it, a seasonal UIV programme may permit larger pandemics than in the absence of vaccination. Second, the more successful a future UIV programme is in reducing transmission of seasonal influenza, the more vulnerable the population could become to the emergence of a vaccine-escape variant. These risks could be mitigated by optimal deployment of any future UIV vaccine: namely, the use of a combined vaccine formulation (incorporating conventional as well as multiple universal antigenic targets), and by achieving sufficient population coverage to compensate for reductions in infection-induced immunity. As early candidates of UIVs approach advanced clinical trials, there is a need to monitor their characteristics in such a way that is focused on their potential impact. This work offers a first step in this direction.","preprint_author_corresponding":"Nimalan Arinaminpathy","preprint_author_corresponding_institution":"Imperial College London"},{"preprint_doi":"10.1101\/19005629","published_doi":"10.3390\/jcm9030711","published_journal":"Journal of Clinical Medicine","preprint_platform":"medRxiv","preprint_title":"The purine pathway in liver tissue biopsies from donors for transplantation is associated to immediate graft function and survival","preprint_authors":"Xu, J.; Hassan-Ally, M.; Casas-Ferreira, A. M.; Suvitaival, T.; Ma, Y.; Vilca-Melendez, H.; Rela, M.; Heaton, N.; Jassem, W.; Legido-Quigley, C.","preprint_category":"transplantation","preprint_date":"2019-09-09","published_date":"2020-03-05","preprint_abstract":"Background & AimsThe current shortage of livers for transplantation has increased the use of organs sourced from donation after circulatory death (DCD). These organs are prone to higher incidence of graft failure, but the underlying mechanisms are largely unknown. Here we aimed to find biomarkers of liver function before transplantation to better inform clinical evaluation.\n\nMethodsMatched pre- and post-transplant liver biopsies from DCD (n=24) and donation after brain death (DBD, n=70) were collected. Liver biopsies were analysed using mass spectroscopy molecular phenotyping. First, a discrimination analysis DCD vs DBD was used to parse metabolites associated to DCD. Then a data-driven approach was used to predict Immediate Graft Function (IGF). The metabolites were tested in models to predict survival.\n\nResultsFive metabolites in the purine pathway were selected and investigated. The ratios of: adenine monophosphate (AMP), adenine, adenosine and hypoxanthine to urate, differed between DBD and DCD biopsies at pre-transplantation stage (q<0.05). The ratios of AMP and adenine to urate also differed in biopsies from recipients undergoing IGF (q<0.05). Using random forest a panel composed by alanine aminotransferase (ALT) and AMP, adenine, hypoxanthine ratio to urate predicted IGF with AUC 0.84 (95% CI [0.71, 0.97]). In comparison AUC 0.71 (95%CI [0.52, 0.90]) was achieved by clinical measures. Survival analysis revealed that the metabolite classifier could stratify 6-year survival outcomes (p = 0.0073) while clinical data and donor class could not.\n\nConclusionsAt liver pre-transplantation stage, a panel composed of purine metabolites and ALT in tissue could improve prediction of IGF and survival.\n\nLay summaryNew liver function biomarkers could help clinicians assess livers before transplantation. Purines are small molecules that are found in healthy livers, and in this work we found that their levels changed critically in livers from cardiac death donors. Measuring them before transplantation improved the prediction of the livers immediate graft function.\n\nGraphic abstract\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=65 SRC=\"FIGDIR\/small\/19005629v1_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (16K):\norg.highwire.dtl.DTLVardef@1e3c207org.highwire.dtl.DTLVardef@1d760b0org.highwire.dtl.DTLVardef@10cf605org.highwire.dtl.DTLVardef@1ebebd5_HPS_FORMAT_FIGEXP  M_FIG C_FIG HighlightsO_LIThe ratios of purine metabolites to urate differ between DCD and DBD in liver tissue at pre-transplantation.\nC_LIO_LIThe ratios of purine metabolites to urate and ALT pre-transplantation can improve prediction of IGF after transplantation.\nC_LIO_LIPurine metabolites ratios to urate stratified 6-year survival outcome better than clinical data and donor class.\nC_LI","preprint_author_corresponding":"Cristina Legido-Quigley","preprint_author_corresponding_institution":"King's College London"},{"preprint_doi":"10.1101\/19006759","published_doi":"10.1371\/journal.pone.0224118","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Correlates of better linear growth among children in sub-Saharan Africa: Cross sectional survey analysis of positive deviants in poor households","preprint_authors":"Amugsi, D. A.; Dimbuene, Z. T.; Kimani-Murage, E. W.","preprint_category":"nutrition","preprint_date":"2019-09-16","published_date":"2020-03-11","preprint_abstract":"BackgroundChildhood malnutrition is a significant public health problem confronting countries across the globe. Nonetheless, recent evidence suggests a downward trend in undernutrition among children globally. Despite the progress made at the global level, sub-Saharan Africa did not experience significant improvement in the past decades. The objective of this study was to investigate the basic determinants associated with linear growth among children under 5 years living in poor households.\n\nMethodsThe study used nationally representative cross-sectional survey data from Ghana, Kenya, Democratic Republic of Congo (DRC), Nigeria and Mozambique. The participants are children aged 0-59 months (N=24,264) living in poor households. The DHS obtained information on children through face-to-face interviews with mothers. The height of the children was also measured and used to compute the height-for-age Z-scores (HAZ). In this study, HAZ is categorised into HAZ>-2 standard deviations (SD) (not stunted\/better growth) and HAZ<-2 SD (stunted\/poor growth).\n\nResultsA unit change in maternal years of education was associated with increased odds of better growth among children living in poor households in DRC [adjusted odds ratio (aOR)= 1.03, 95% CI=1.01,1.07)], Ghana (aOR=1.06, 95% CI=1.01,1.11), Kenya (aOR=1.03, 95% CI= 1.01, 1.05) and Nigeria (aOR=1.08, 95%=1.06,1.10). Maternal antenatal attendance of at least four visits was associated positively with better child growth in DRC (aOR=1.32, 95% CI=1.05, 1.67) and Ghana (aOR=1.67, 95% CI=1.19, 2.33). In Ghana, Mozambique and DRC, breastfeeding was associated significantly with the likelihood of better linear growth when only socio-demographic correlates were included in the models but disappeared after the inclusion of child-level covariates. In Nigeria, normal maternal weight was associated with increased odds (aOR=1.24, 95% CI=1.08, 1.43) of positive growth among children living in poor households, so was overweight (aOR=1.51, 95% CI= 1.24, 1.83). In all the countries except Ghana, child biological factors such as sex and age were associated with reduced odds of better growth.\n\nConclusionsThe socio-demographic factors included in this analysis have the potential to promote linear growth of children under 5 years living in poor households. Interventions aimed at fostering linear growth among children living in poverty should target at enhancing these factors.","preprint_author_corresponding":"Dickson A Amugsi","preprint_author_corresponding_institution":"African Population and Health Research Center"},{"preprint_doi":"10.1101\/19009431","published_doi":"10.1093\/hmg\/ddaa052","published_journal":"Human Molecular Genetics","preprint_platform":"medRxiv","preprint_title":"Association of polygenic risk scores for coronary artery disease with subsequent events amongst established cases","preprint_authors":"Howe, L. J.; Dudbridge, F.; Schmidt, A. F.; Finan, C.; Denaxas, S.; Asselbergs, F. W.; Hingorani, A. D.; Patel, R. S.","preprint_category":"genetic and genomic medicine","preprint_date":"2019-10-16","published_date":"2020-03-27","preprint_abstract":"BackgroundThere is growing evidence that polygenic risk scores (PRS) can be used to identify individuals at high lifetime risk of coronary artery disease (CAD). Whether they can also be used to stratify risk of subsequent events among those surviving a first CAD event remains uncertain.\n\nMethodsUsing two subsamples of UK Biobank, defined at baseline as prevalent CAD (N=10,287) and without CAD (N=393,108), we evaluated associations between a CAD PRS and incident cardiovascular and fatal outcomes, during a median follow up of 7.8 years.\n\nResultsA 1 S.D. higher PRS was associated with increased risk of incident MI in participants without CAD (OR 1.33; 95% C.I. 1.29, 1.38), but the effect estimate was markedly attenuated in those with prevalent CAD (OR 1.15; 95% C.I. 1.06, 1.25); heterogeneity P =0.0012. Additionally, among prevalent CAD cases, we found evidence of an inverse association between the CAD PRS and risk of all-cause death (OR 0.91; 95% C.I. 0.85, 0.98) compared to those without CAD (OR 1.01; 95% C.I. 0.99, 1.03); heterogeneity P =0.0041. A similar inverse association was found for ischaemic stroke (Prevalent CAD (OR 0.78; 95% C.I. 0.67, 0.90); without CAD (OR 1.09; 95% C.I. 1.04, 1.15), heterogeneity P <0.001).\n\nConclusionsBias induced by case stratification and survival into UK Biobank may attenuate, or reverse, associations of polygenic risk scores derived from case-control studies or populations initially free of disease. Polygenic risk scores for subsequent events should be derived from new genome wide association studies conducted in patients with established disease.\n\nKey messagesO_LICAD PRS are positively associated with incident myocardial infarction risk amongst established CAD cases.\nC_LIO_LIHowever, the effect size is attenuated compared to estimates from CAD-free populations.\nC_LIO_LICAD PRS are inversely associated with mortality and stroke risk amongst established CAD cases.\nC_LIO_LIThese associations may reflect index event bias induced by stratifying on case status.\nC_LIO_LIDedicated GWAS of coronary disease progression are required to improve prediction of subsequent event risk.\nC_LI","preprint_author_corresponding":"Riyaz S Patel","preprint_author_corresponding_institution":"University College London"},{"preprint_doi":"10.1101\/19005520","published_doi":"10.1371\/journal.pone.0229917","published_journal":"PLOS ONE","preprint_platform":"medRxiv","preprint_title":"Community gender systems and daughter's risk of female genital mutilation\/cutting: New theory and application to Egypt","preprint_authors":"Yount, K. M.; Cheong, Y. F.; James-Hawkins, L.; Grose, R. G.; Hayford, S.","preprint_category":"public and global health","preprint_date":"2019-10-18","published_date":"2020-03-06","preprint_abstract":"We proposed and tested a feminist social-ecological theory about daughters experience of female genital mutilation\/cutting (FGMC) in Egypt, where over 90% of women ages 15-49 are cut. FGMC has potential adverse effects on demographic and health outcomes and has been defined as a human-rights violation. Contextual factors are important determinants of FGMC, but an integrated theory is lacking, and quantitative multilevel research is limited. We theorized that more favorable community-level gender systems, including gender norms opposing FGMC and expanded opportunities for women outside of the family, would be associated with a daughters lower risk of FGMC and would strengthen the negative association of a mothers opposition to FGMC with her daughters risk of cutting. Using a national sample of 14,171 mother-daughter dyads from the 2014 Egypt Demographic and Health Survey, we estimated multilevel discrete-time hazard models to test these relationships. Community gender norms opposing FGMC had significant direct, negative associations with the hazard that a daughter was cut, but womens opportunities outside the family did not. Maternal opposition to FGMC was negatively associated with cutting a daughter, and these associations were stronger where community opposition to FGMC and opportunities for women were greater. Results provided good support for a gender-systems theory of the multilevel influences on FGMC. Integrated, multilevel interventions that address gender norms about FGMC and opportunities for women in the community, as well as beliefs about the practice among the mothers of at-risk daughters may be needed for sustainable declines in the practice.","preprint_author_corresponding":"Kathryn M Yount","preprint_author_corresponding_institution":"Emory University"},{"preprint_doi":"10.1101\/19009134","published_doi":"10.1038\/s41386-020-0655-6","published_journal":"Neuropsychopharmacology","preprint_platform":"medRxiv","preprint_title":"Dissecting the association of C-reactive protein levels with PTSD, traumatic events, and social support","preprint_authors":"Muniz Carvalho, C.; Wendt, F.; Maihofer, A.; Stein, D.; Stein, M.; Sumner, J.; Hemmings, S.; Nievergelt, C.; Koenen, K.; Gelernter, J.; Belangero, S.; Polimanti, R.","preprint_category":"psychiatry and clinical psychology","preprint_date":"2019-10-22","published_date":"2020-03-16","preprint_abstract":"Inflammatory markers like C-reactive protein (CRP) have been associated with posttraumatic stress disorder (PTSD) and traumatic experience, but the underlying mechanisms are unclear. We investigated the association among CRP, PTSD, and traits related to traumatic events and social support using genome-wide data from the Psychiatric Genomics Consortium (30,000 cases and 170,000 controls), the UK Biobank (UKB; up to 117,900 individuals), and the CHARGE study (Cohorts for Heart and Aging Research in Genomic Epidemiology, 148,164 individual). Linkage disequilibrium score regression, polygenic risk scoring, and two-sample Mendelian randomization analyses were used to investigate genetic overlap and causal relationships. Genetic correlations of CRP were observed with PTSD (rg=0.16, p=0.026) and behavioral and emotional response to trauma, exposure to traumatic events, and the presence of social support (-0.28<rg<0.20; p<0.008). We observed a bidirectional association between CRP and PTSD (CRP[-&gt;]PTSD: {beta}=0.065, p=0.015; PTSD[-&gt;]CRP: {beta}=0.008, p=0.009). CRP also showed a negative association on the \"felt loved as a child\" trait (UKB, {beta}=-0.017, p=0.008). Due to the known association of socioeconomic status (SES) on PTSD and social support, a multivariable MR was performed to investigate SES as potential mediator. We found that household income (univariate MR: {beta}=-0.22, p=1.57x10-7; multivariate MR: {beta}=-0.17, p=0.005) and deprivation index (univariate MR: {beta}=0.38, p=1.63x10-9; multivariate MR: {beta}=0.27, p=0.016) were driving the causal estimates of \"felt loved as a child\" and CRP on PTSD. The present findings highlight a bidirectional association between PTSD and CRP levels, also suggesting a potential role of SES in the interplay between childhood support and inflammatory processes with respect to PTSD risk.","preprint_author_corresponding":"Renato Polimanti","preprint_author_corresponding_institution":"Yale University"},{"preprint_doi":"10.1101\/19010140","published_doi":"10.1093\/jpids\/piaa023","published_journal":"Journal of the Pediatric Infectious Diseases Society","preprint_platform":"medRxiv","preprint_title":"Whole genome sequencing detects minimal clustering among Escherichia coli Sequence Type 131 H30 isolates collected from U.S. children's hospitals","preprint_authors":"Miles-Jay, A.; Weissmann, S. J.; Adler, A. A.; Baseman, J. G.; Zerr, D. M.","preprint_category":"epidemiology","preprint_date":"2019-10-29","published_date":"2020-03-17","preprint_abstract":"Escherichia coli sequence type 131 H30 has garnered global attention as a dominant antimicrobial-resistant lineage of extraintestinal pathogenic E. coli, but its transmission dynamics remain undefined. We applied whole genome sequencing to identify putative transmission clusters among clinical isolates of H30 from children across the U.S. Of 126 isolates, 17 were involved in 8 putative transmission clusters; 4 clusters involved isolates with some evidence of healthcare-associated epidemiologic linkages. Geographic clustering analyses showed weak geographic clustering. These findings are consistent with a framework where within-hospital transmission is not a main contributor to the propagation of H30 in a pediatric setting.","preprint_author_corresponding":"Arianna Miles-Jay","preprint_author_corresponding_institution":"University of Michigan"},{"preprint_doi":"10.1101\/19009530","published_doi":"10.1016\/j.bja.2019.11.015","published_journal":"British Journal of Anaesthesia","preprint_platform":"medRxiv","preprint_title":"Elevated heart rate after non-cardiac surgery: post-hoc analysis of a prospective observational cohort study","preprint_authors":"Patel, A. B. U.; May, S. M.; Reyes, A.; Martir, G.; Abbott, T. E. F.; Brealey, D.; Stephens, R. C. M.; Ackland, G. L.","preprint_category":"anesthesia","preprint_date":"2019-11-02","published_date":"2020-03-12","preprint_abstract":"BackgroundElevated heart rate (HR) is associated with accelerated mortality and independently predicts poorer outcomes in patients discharged from hospital after myocardial infarction and\/or heart failure. We examined whether resting HR measured within 24 hours of hospital discharge following elective non-cardiac surgery was elevated compared to preoperative values. We also investigated the relationship between changes in HR with and\/or autonomic function associated with morbidity after surgery.\n\nMethodsWe conducted a post-hoc analysis of HR data obtained in a prospective observational cohort study of patients [&ge;]18years in whom serial Holter-based measurements of cardiac autonomic activity were made before, and for 48h after, surgery. The primary outcome was absolute discharge HR (beats minute-1), recorded at rest before hospital discharge. We examined the association between quartiles of discharge HR and autonomic measures (time\/frequency domain heart rate variability) associated with morbidity (defined by Postoperative morbidity survey).\n\nResultsIn 157 patients (66 (42%) male; age 67(9) years), HR at hospital discharge (range: 53-122) increased by 5 beats minute-1 (95%CI:3-7;p<0.001) compared to preoperative values. Patients in the upper quartile of discharge HR ([&ge;]85bpm) were more likely to sustain pulmonary (odds ratio (OR):2.18 (95%CI:1.07-4.44);p=0.03) and infectious (OR:2.31 (95%CI:1.13-4.75);p=0.02) morbidity within seven days of surgery, compared to lower quartiles. Pulmonary\/infectious morbidity was associated with loss of cardiac vagal activity.\n\nConclusionsHeart rate on discharge from hospital following major elective non-cardiac surgery is frequently elevated and is promoted by morbidity associated with reductions in cardiac vagal activity.","preprint_author_corresponding":"Gareth L. Ackland","preprint_author_corresponding_institution":"Queen Mary University of London"},{"preprint_doi":"10.1101\/19012419","published_doi":"10.1038\/s41586-020-2145-8","published_journal":"Nature","preprint_platform":"medRxiv","preprint_title":"Interpretable AI for beat-to-beat cardiac function assessment","preprint_authors":"Ouyang, D.; He, B.; Ghorbani, A.; Langlotz, C.; Heidenreich, P. A.; Harrington, R. A.; Liang, D. H.; Ashley, E. A.; Zou, J. Y.","preprint_category":"cardiovascular medicine","preprint_date":"2019-11-25","published_date":"2020-03-25","preprint_abstract":"Accurate assessment of cardiac function is crucial for diagnosing cardiovascular disease1, screening for cardiotoxicity2,3, and deciding clinical management in patients with critical illness4. However human assessment of cardiac function focuses on a limited sampling of cardiac cycles and has significant interobserver variability despite years of training2,5,6. To overcome this challenge, we present the first beat-to-beat deep learning algorithm that surpasses human expert performance in the critical tasks of segmenting the left ventricle, estimating ejection fraction, and assessing cardiomyopathy. Trained on echocardiogram videos, our model accurately segments the left ventricle with a Dice Similarity Coefficient of 0.92, predicts ejection fraction with mean absolute error of 4.1%, and reliably classifies heart failure with reduced ejection fraction (AUC of 0.97). Prospective evaluation with repeated human measurements confirms that our model has less variance than experts. By leveraging information across multiple cardiac cycles, our model can identify subtle changes in ejection fraction, is more reproducible than human evaluation, and lays the foundation for precise diagnosis of cardiovascular disease. As a new resource to promote further innovation, we also make publicly available one of the largest medical video dataset of over 10,000 annotated echocardiograms.\n\nKey PointsO_LIVideo based deep learning evaluation of cardiac ultrasound accurately identifies cardiomyopathy and predict ejection fraction, the most common metric of cardiac function.\nC_LIO_LIUsing human tracings obtained during standard clinical workflow, deep learning semantic segmentation accurately labels the left ventricle frame-by-frame, including in frames without prior human annotation.\nC_LIO_LIComputational cardiac function analysis allows for beat-by-beat assessment of ejection fraction, which more accurately assesses cardiac function in patients with atrial fibrillation, arrhythmias, and heart rate variability.\nC_LI","preprint_author_corresponding":"David Ouyang","preprint_author_corresponding_institution":"Stanford University"},{"preprint_doi":"10.1101\/2020.02.02.20020016","published_doi":"10.7326\/m20-0504","published_journal":"Annals of Internal Medicine","preprint_platform":"medRxiv","preprint_title":"The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application","preprint_authors":"Lauer, S. A.; Grantz, K. H.; Bi, Q.; Jones, F. K.; Zheng, Q.; Meredith, H.; Azman, A. S.; Reich, N. G.; Lessler, J.","preprint_category":"infectious diseases","preprint_date":"2020-02-04","published_date":"2020-03-09","preprint_abstract":"A novel human coronavirus (2019-nCoV) was identified in China in December, 2019. There is limited support for many of its key epidemiologic features, including the incubation period, which has important implications for surveillance and control activities. Here, we use data from public reports of 101 confirmed cases in 38 provinces, regions, and countries outside of Wuhan (Hubei province, China) with identifiable exposure windows and known dates of symptom onset to estimate the incubation period of 2019-nCoV. We estimate the median incubation period of 2019-nCoV to be 5.2 days (95% CI: 4.4, 6.0), and 97.5% of those who develop symptoms will do so within 10.5 days (95% CI: 7.3, 15.3) of infection. These estimates imply that, under conservative assumptions, 64 out of every 10,000 cases will develop symptoms after 14 days of active monitoring or quarantine. Whether this risk is acceptable depends on the underlying risk of infection and consequences of missed cases. The estimates presented here can be used to inform policy in multiple contexts based on these judgments.","preprint_author_corresponding":"Justin Lessler","preprint_author_corresponding_institution":"Johns Hopkins Bloomberg School of Public Health"},{"preprint_doi":"10.1101\/2020.02.08.20021246","published_doi":"10.1210\/clinem\/dgaa133","published_journal":"The Journal of Clinical Endocrinology & Metabolism","preprint_platform":"medRxiv","preprint_title":"Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery in adrenal insufficiency","preprint_authors":"Prete, A.; Taylor, A. E.; Bancos, I.; Smith, D. J.; Foster, M.; Kohler, S.; Fazel-Sanderson, V.; Komninos, J.; O'Neil, D. M.; Vassiliadi, D. A.; Mowatt, C. J.; Mihai, R.; Fallowfield, J. L.; Annane, D.; Lord, J. M.; Keevil, B. G.; Wass, J. A. H.; Karavitaki, N.; Arlt, W.","preprint_category":"endocrinology","preprint_date":"2020-02-11","published_date":"2020-03-14","preprint_abstract":"ContextPatients with adrenal insufficiency require increased hydrocortisone cover during major stress to avoid life-threatening adrenal crisis. However, current treatment recommendations are not evidence-based.\n\nObjectiveTo identify the most appropriate mode of hydrocortisone delivery in patients with adrenal insufficiency exposed to major stress.\n\nDesign and ParticipantsCross-sectional study: 122 unstressed healthy subjects and 288 subjects exposed to different stressors (major trauma [N=83], sepsis [N=100], and combat stress [N=105]). Longitudinal study: 22 patients with preserved adrenal function undergoing elective surgery. Pharmacokinetic study: 10 patients with primary adrenal insufficiency undergoing administration of 200mg hydrocortisone over 24 hours in four different delivery modes (continuous intravenous infusion; six-hourly oral, intramuscular or intravenous bolus administration).\n\nMain Outcome MeasureWe measured total serum cortisol and cortisone, free serum cortisol and urinary glucocorticoid metabolite excretion by mass spectrometry. Linear pharmacokinetic modelling was used to determine the most appropriate mode and dose of hydrocortisone administration in patients with adrenal insufficiency exposed to major stress.\n\nResultsSerum cortisol was increased in all stress conditions, with the highest values observed in surgery and sepsis. Continuous intravenous hydrocortisone was the only administration mode persistently achieving median cortisol concentrations in the range observed during major stress. Linear pharmacokinetic modelling identified continuous intravenous infusion of 200mg hydrocortisone over 24 hours, preceded by an initial bolus of 50-100mg hydrocortisone, as best suited for maintaining cortisol concentrations in the required range.\n\nConclusionsContinuous intravenous hydrocortisone infusion should be favored over intermittent bolus administration in the prevention and treatment of adrenal crisis during major stress.","preprint_author_corresponding":"Wiebke Arlt","preprint_author_corresponding_institution":"University of Birmingham"},{"preprint_doi":"10.1101\/2020.02.09.20021261","published_doi":"10.1126\/science.aba9757","published_journal":"Science","preprint_platform":"medRxiv","preprint_title":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak","preprint_authors":"Chinazzi, M.; Davis, J. T.; Ajelli, M.; Gioannini, C.; Litvinova, M.; Merler, S.; Pastore y Piontti, A.; Rossi, L.; Sun, K.; Viboud, C.; Xiong, X.; Yu, H.; Halloran, M. E.; Longini, I. M.; Vespignani, A.","preprint_category":"epidemiology","preprint_date":"2020-02-11","published_date":"2020-03-06","preprint_abstract":"Motivated by the rapid spread of a novel coronavirus (2019-nCoV) in Mainland China, we use a global metapopulation disease transmission model to project the impact of both domestic and international travel limitations on the national and international spread of the epidemic. The model is calibrated on the evidence of internationally imported cases before the implementation of the travel quarantine of Wuhan. By assuming a generation time of 7.5 days, the reproduction number is estimated to be 2.4 [90% CI 2.2-2.6]. The median estimate for number of cases before the travel ban implementation on January 23, 2020 is 58,956 [90% CI 40,759 - 87,471] in Wuhan and 3,491 [90% CI 1,924 - 7,360] in other locations in Mainland China. The model shows that as of January 23, most Chinese cities had already received a considerable number of infected cases, and the travel quarantine delays the overall epidemic progression by only 3 to 5 days. The travel quarantine has a more marked effect at the international scale, where we estimate the number of case importations to be reduced by 80% until the end of February. Modeling results also indicate that sustained 90% travel restrictions to and from Mainland China only modestly affect the epidemic trajectory unless combined with a 50% or higher reduction of transmission in the community.","preprint_author_corresponding":"Alessandro Vespignani","preprint_author_corresponding_institution":"Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA;  ISI Foundation, Turin, Italy"},{"preprint_doi":"10.1101\/2020.02.10.20021824","published_doi":"10.1097\/cm9.0000000000000782","published_journal":"Chinese Medical Journal","preprint_platform":"medRxiv","preprint_title":"Distribution of the 2019-nCoV Epidemic and Correlation with Population Emigration from Wuhan, China","preprint_authors":"Chen, Z.; Zhang, Q.; Lu, Y.; Zhang, X.; Zhang, W.; Guo, C.; Liao, C.; Li, Q.; Han, X.; Lu, J.","preprint_category":"infectious diseases","preprint_date":"2020-02-12","published_date":"2020-03-02","preprint_abstract":"BACKGROUNDSThe ongoing new coronavirus (2019-nCoV) pneumonia outbreak is spreading in China and has not reached its peak. Five millions of people had emigrated from Wuhan before the city lockdown, which potentially represent a source of virus spreaders. Case distribution and its correlation with population emigration from Wuhan in early epidemic are of great importance for early warning and prevention of future outbreak.\n\nMETHODSThe officially reported cases of 2019-nCoV pneumonia were collected as of January 30, 2020. Time and location information of these cases were extracted analyzed with ArcGIS and WinBUGS. Population migration data of Wuhan City and Hubei province were extracted from Baidu Qianxi and analyzed for their correlation with case number.\n\nFINDINGSThe 2019-nCoV pneumonia cases were predominantly distributed in Hubei and other provinces of South China. Hot spot provinces included Sichuan and Yunnan provinces that are adjacent to Hubei. While Wuhan city has the highest number of cases, the time risk is relatively stable. Numbers of cases in some cities are relatively low, but the time risks are continuously rising. The case numbers of different provinces and cities of Hubei province were highly correlated with the emigrated populations from Wuhan. Lockdown of 19 cities of Hubei province, and implementation of nationwide control measures efficiently prevented the exponential growth of case number.\n\nINTERPRETATIONPopulation emigrated from Wuhan was the main infection source for other cities and provinces. Some cities with low case number but were in rapid increase. Due to the upcoming Spring Festival return transport wave, understanding of the trends of risks in different regions is of great significance for preparedness for both individuals and institutions.\n\nFUNDINGSNational Key Research and Development Program of China, National Major Project for Control and Prevention of Infectious Disease in China, State Key Program of National Natural Science of China.","preprint_author_corresponding":"Jiahai Lu","preprint_author_corresponding_institution":"Sun Yat-sen University"},{"preprint_doi":"10.1101\/2020.02.03.20019497","published_doi":"10.1016\/j.ijid.2020.02.060","published_journal":"International Journal of Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Serial interval of novel coronavirus (2019-nCoV) infections","preprint_authors":"Nishiura, H.; Linton, N. M.; Akhmetzhanov, A. R.","preprint_category":"infectious diseases","preprint_date":"2020-02-13","published_date":"2020-03-04","preprint_abstract":"ObjectiveTo estimate the serial interval of novel coronavirus (COVID-19) from information on 28 infector-infectee pairs.\n\nMethodsWe collected dates of illness onset for primary cases (infectors) and secondary cases (infectees) from published research articles and case investigation reports. We subjectively ranked the credibility of the data and performed analyses on both the full dataset (n=28) and a subset of pairs with highest certainty in reporting (n=18). In addition, we adjusting for right truncation of the data as the epidemic is still in its growth phase.\n\nResultsAccounting for right truncation and analyzing all pairs, we estimated the median serial interval at 4.0 days (95% credible interval [CrI]: 3.1, 4.9). Limiting our data to only the most certain pairs, the median serial interval was estimated at 4.6 days (95% CrI: 3.5, 5.9).\n\nConclusionsThe serial interval of COVID-19 is shorter than its median incubation period. This suggests that a substantial proportion of secondary transmission may occur prior to illness onset. The COVID-19 serial interval is also shorter than the serial interval of severe acute respiratory syndrome (SARS), indicating that calculations made using the SARS serial interval may introduce bias.\n\nHighlights- The serial interval of novel coronavirus (COVID-19) infections was estimated from a total of 28 infector-infectee pairs.\n- The median serial interval is shorter than the median incubation period, suggesting a substantial proportion of pre-symptomatic transmission.\n- A short serial interval makes it difficult to trace contacts due to the rapid turnover of case generations.","preprint_author_corresponding":"Hiroshi Nishiura","preprint_author_corresponding_institution":"Hokkaido University"},{"preprint_doi":"10.1101\/2020.02.14.20023127","published_doi":"10.1126\/science.abb3221","published_journal":"Science","preprint_platform":"medRxiv","preprint_title":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19)","preprint_authors":"Li, R.; Pei, S.; Chen, B.; Song, Y.; Zhang, T.; Yang, W.; Shaman, J.","preprint_category":"infectious diseases","preprint_date":"2020-02-17","published_date":"2020-03-16","preprint_abstract":"BackgroundEstimation of the fraction and contagiousness of undocumented novel coronavirus (COVID-19) infections is critical for understanding the overall prevalence and pandemic potential of this disease. Many mild infections are typically not reported and, depending on their contagiousness, may support stealth transmission and the spread of documented infection.\n\nMethodsHere we use observations of reported infection and spread within China in conjunction with mobility data, a networked dynamic metapopulation model and Bayesian inference, to infer critical epidemiological characteristics associated with the emerging coronavirus, including the fraction of undocumented infections and their contagiousness.\n\nResultsWe estimate 86% of all infections were undocumented (95% CI: [82%-90%]) prior to the Wuhan travel shutdown (January 23, 2020). Per person, these undocumented infections were 52% as contagious as documented infections ([44%-69%]) and were the source of infection for two-thirds of documented cases. Our estimate of the reproductive number (2.23; [1.77-3.00]) aligns with earlier findings; however, after travel restrictions and control measures were imposed this number falls considerably.\n\nConclusionsA majority of COVID-19 infections were undocumented prior to implementation of control measures on January 23, and these undocumented infections substantially contributed to virus transmission. These findings explain the rapid geographic spread of COVID-19 and indicate containment of this virus will be particularly challenging. Our findings also indicate that heightened awareness of the outbreak, increased use of personal protective measures, and travel restriction have been associated with reductions of the overall force of infection; however, it is unclear whether this reduction will be sufficient to stem the virus spread.","preprint_author_corresponding":"Jeffrey Shaman","preprint_author_corresponding_institution":"Columbia University"},{"preprint_doi":"10.1101\/2020.02.13.20022822","published_doi":"10.1017\/ice.2020.81","published_journal":"Infection Control & Hospital Epidemiology","preprint_platform":"medRxiv","preprint_title":"Estimating the distribution of the incubation period of 2019 novel coronavirus (COVID-19) infection between travelers to Hubei, China and non-travelers","preprint_authors":"Leung, C.","preprint_category":"epidemiology","preprint_date":"2020-02-18","published_date":"2020-03-18","preprint_abstract":"ObjectivesAmid the continuing spread of the novel coronavirus (COVID-19), the incubation period of COVID-19 should be regularly re-assessed as more information is available upon the increase in reported cases. The present work estimated the distribution of incubation periods of patients infected in and outside Hubei province of China.\n\nMethodsClinical data were collected from the individual cases reported by the media as they were not fully available on the official pages of the Chinese health authorities. MLE was used to estimate the distributions of the incubation period.\n\nResultsIt was found that the incubation period of patients with no travel history to Hubei was longer and more volatile.\n\nConclusionIt is recommended that the duration of quarantine should be extended to at least 3 weeks.","preprint_author_corresponding":"Char Leung","preprint_author_corresponding_institution":"Deakin University"},{"preprint_doi":"10.1101\/2020.02.18.20023242","published_doi":"10.1016\/j.kint.2020.03.005","published_journal":"Kidney International","preprint_platform":"medRxiv","preprint_title":"Kidney impairment is associated with in-hospital death of COVID-19 patients","preprint_authors":"Cheng, Y.; Luo, R.; Wang, K.; Zhang, M.; Wang, Z.; Dong, L.; Li, J.; Yao, Y.; Ge, S.; Xu, G.","preprint_category":"nephrology","preprint_date":"2020-02-20","published_date":"2020-03-20","preprint_abstract":"BackgroundInformation on kidney impairment in patients with coronavirus disease 2019 (COVID-19) is limited. This study aims to assess the prevalence and impact of abnormal urine analysis and kidney dysfunction in hospitalized COVID-19 patients in Wuhan.\n\nMethodsWe conducted a consecutive cohort study of COVID-19 patients admitted in a tertiary teaching hospital with 3 branches following a major outbreak in Wuhan in 2020. Hematuria, proteinuria, serum creatinine concentration and other clinical parameters were extracted from the electronic hospitalization databases and laboratory databases. Incidence rate for acute kidney injury (AKI) was examined during the study period. Association between kidney impairment and in-hospital death was analyzed.\n\nResultsWe included 710 consecutive COVID-19 patients, 89 (12.3%) of whom died in hospital. The median age of the patients was 63 years (inter quartile range, 51-71), including 374 men and 336 women. On admission, 44% of patients have proteinuria hematuria and 26.9% have hematuria, and the prevalence of elevated serum creatinine and blood urea nitrogen were 15.5% and 14.1% respectively. During the study period, AKI occurred in 3.2% patients. Kaplan-Meier analysis demonstrated that patients with kidney impairment have higher risk for in-hospital death. Cox proportional hazard regression confirmed that elevated serum creatinine, elevated urea nitrogen, AKI, proteinuria and hematuria was an independent risk factor for in-hospital death after adjusting for age, sex, disease severity, leukocyte count and lymphocyte count.\n\nConclusionsThe prevalence of kidney impairment (hematuria, proteinuria and kidney dysfunction) in hospitalized COVID-19 patients was high. After adjustment for confounders, kidney impairment indicators were associated with higher risk of in-hospital death. Clinicians should increase their awareness of kidney impairment in hospitalized COVID-19 patients.","preprint_author_corresponding":"Shuwang Ge","preprint_author_corresponding_institution":"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"preprint_doi":"10.1101\/2020.02.22.20025320","published_doi":"10.1001\/jamaoncol.2020.0980","published_journal":"JAMA Oncology","preprint_platform":"medRxiv","preprint_title":"SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan","preprint_authors":"Yu, J.; Ouyang, W.; Chua, M. L. K.; Xie, C.","preprint_category":"oncology","preprint_date":"2020-02-25","published_date":"2020-03-25","preprint_abstract":"In December 2019, an outbreak of atypical pneumonia known as 2019 novel coronavirus disease (COVID-19) occurred in Wuhan, China. This new type of pneumonia is characterized by rapid human-to-human transmission. Among the different disease types, cancer patients are often recalled to the hospital for treatment and disease surveillance, and the majority of cancer treatments such as chemotherapy and radiotherapy are immunosuppressive. This prompts us to consider if cancer patients were at an elevated risk of SARS-CoV-2 infection.\n\nA total of 1,524 cancer patients who were managed at our tertiary cancer institution - Zhongnan hospital of Wuhan University were reviewed during the period of Dec 30, 2019 to Feb 17, 2020. It was found that cancer patients had an estimated 2-fold increased risk of COVID-19 than the general population. We identified twelve patients who were infected with SARS-CoV-2, with two recorded deaths (16.7%), albeit one patient passed away from a COVID-19 unrelated cause. Interestingly, only five of these patients were ongoing treatment at the time of contracting the virus, suggesting that hospital visitation was the likely factor contributing to the elevated incidence in cancer patients. Moreover, we also observed that the incidence of severe COVID-19 was not higher than in the general population. Consequently, for cancer patients who require treatment, proper isolation protocols must be in place to mitigate the risk of SARS-CoV-2 infection.","preprint_author_corresponding":"Conghua Xie","preprint_author_corresponding_institution":"Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University"},{"preprint_doi":"10.1101\/2020.02.19.20024851","published_doi":"10.1002\/jmv.25723","published_journal":"Journal of Medical Virology","preprint_platform":"medRxiv","preprint_title":"Early Phylogenetic Estimate Of The Effective Reproduction Number Of 2019-nCoV","preprint_authors":"Lai, A.; Bergna, A.; Acciarri, C.; Galli, M.; Zehender, G.","preprint_category":"epidemiology","preprint_date":"2020-02-23","published_date":"2020-03-03","preprint_abstract":"To reconstruct the evolutionary dynamics of the 2019 novel coronavirus, 52 2019-nCOV genomes available on 04 February 2020 at GISAID were analysed.\n\nThe two models used to estimate the reproduction number (coalescent-based exponential growth and a birth-death skyline method) indicated an estimated mean evolutionary rate of 7.8 x 10-4 subs\/site\/year (range 1.1x10-4-15x10-4).\n\nThe estimated R value was 2.6 (range 2.1-5.1), and increased from 0.8 to 2.4 in December 2019. The estimated mean doubling time of the epidemic was between 3.6 and 4.1 days.\n\nThis study proves the usefulness of phylogeny in supporting the surveillance of emerging new infections even as the epidemic is growing.","preprint_author_corresponding":"Gianguglielmo Zehender","preprint_author_corresponding_institution":"Department of Biomedical and Clinical Sciences \\\"L. Sacco\\\", University of Milan, Milano, Italy"},{"preprint_doi":"10.1101\/2020.03.09.20033050","published_doi":"10.1016\/s2468-2667(20)30073-6","published_journal":"The Lancet Public Health","preprint_platform":"medRxiv","preprint_title":"The effect of control strategies that reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China","preprint_authors":"Prem, K.; Liu, Y.; Russell, T.; Kucharski, A. J.; Eggo, R. M.; Davies, N.; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group,  ; Jit, M.; Klepac, P.","preprint_category":"public and global health","preprint_date":"2020-03-12","published_date":"2020-03-25","preprint_abstract":"BACKGROUNDIn December 2019, a novel strain of SARS-CoV-2 emerged in Wuhan, China. Since then, the city of Wuhan has taken unprecedented measures and efforts in response to the outbreak.\n\nMETHODSWe quantified the effects of control measures on population contact patterns in Wuhan, China, to assess their effects on the progression of the outbreak. We included the latest estimates of epidemic parameters from a transmission model fitted to data on local and internationally exported cases from Wuhan in the age-structured epidemic framework. Further, we looked at the age-distribution of cases. Lastly, we simulated lifting of the control measures by allowing people to return to work in a phased-in way, and looked at the effects of returning to work at different stages of the underlying outbreak.\n\nFINDINGSChanges in mixing patterns may have contributed to reducing the number of infections in mid-2020 by 92% (interquartile range: 66-97%). There are benefits to sustaining these measures until April in terms of reducing the height of the peak, overall epidemic size in mid-2020 and probability that a second peak may occur after return to work. However, the modelled effects of social distancing measures vary by the duration of infectiousness and the role school children play in the epidemic.\n\nINTERPRETATIONRestrictions on activities in Wuhan, if maintained until April, would likely contribute to the reduction and delay the epidemic size and peak, respectively. However, there are some limitations to the analysis, including large uncertainties around estimates of R0 and the duration of infectiousness.\n\nFUNDINGBill and Melinda Gates Foundation, National Institute for Health Research, Wellcome Trust, and Health Data Research UK.","preprint_author_corresponding":"Kiesha Prem","preprint_author_corresponding_institution":"London School of Hygiene & Tropical Medicine"},{"preprint_doi":"10.1101\/2020.03.15.20036392","published_doi":"10.1093\/jtm\/taaa042","published_journal":"Journal of Travel Medicine","preprint_platform":"medRxiv","preprint_title":"Routes for COVID-19 importation in Brazil","preprint_authors":"da Silva Candido, D.; Watts, A.; Abade, L.; Kraemer, M. U.; Pybus, O. G.; Croda, J.; de Oliveira, W.; Khan, K.; Sabino, E. C.; Faria, N. R.","preprint_category":"epidemiology","preprint_date":"2020-03-18","published_date":"2020-03-17","preprint_abstract":"HighlightThe global outbreak caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been declared a pandemic by the WHO. As the number of imported SARS-CoV-2 cases is on the rise in Brazil, we use incidence and historical air travel data to estimate the most important routes of importation into the country.","preprint_author_corresponding":"Nuno R. Faria","preprint_author_corresponding_institution":"University of Oxford"},{"preprint_doi":"10.1101\/2020.03.26.20044271","published_doi":"10.1093\/pubmed\/fdaa046","published_journal":"Journal of Public Health","preprint_platform":"medRxiv","preprint_title":"Negligible Risk of the COVID-19 Resurgence Caused by Work Resuming in China (outside Hubei): a Statistical Probability Study","preprint_authors":"FU, X.","preprint_category":"epidemiology","preprint_date":"2020-03-30","published_date":"2020-03-18","preprint_abstract":"The COVID-19 outbreak in China appears to reach the late stage since late February 2020, and a stepwise restoration of economic operations is implemented. Risk assessment for such economic restoration is of significance. Here we estimated the probability of COVID-19 resurgence caused by work resuming in typical provinces\/cities, and found that such probability is very limited (<5% for all the regions except Beijing). Our work may inform provincial governments to make risk level-based, differentiated control measures.","preprint_author_corresponding":"XINMIAO FU","preprint_author_corresponding_institution":"Fujian Normal University"},{"preprint_doi":"10.1101\/19005058","published_doi":"10.1016\/j.jacc.2020.01.013","published_journal":"Journal of the American College of Cardiology","preprint_platform":"medRxiv","preprint_title":"Prevalence and clinical importance of titin truncating variants in adults without known congestive heart failure","preprint_authors":"Pirruccello, J. P.; Bick, A.; Friedman, S.; Chaffin, M.; Aragam, K. G.; Choi, S. H.; Lubitz, S. A.; Ho, C.; Ng, K.; Philippakis, A.; Ellinor, P. T.; Kathiresan, S.; Khera, A. V.","preprint_category":"cardiovascular medicine","preprint_date":"2019-08-20","published_date":"2020-03-09","preprint_abstract":"BackgroundCross-sectional studies of various forms of dilated cardiomyopathy have noted a truncating mutation in the gene encoding titin ( TTNtv) in 7-30% of patients, but the clinical importance of identifying a TTNtv in an asymptomatic adult is largely unknown. In contrast to cross-sectional studies, prospective cohort studies allow for unbiased estimates of the disease risks associated with a genotype exposure.\n\nObjectivesTo determine the prevalence of cardiac imaging abnormalities and risk of incident disease among middle-aged TTNtv carriers without known congestive heart failure.\n\nMethodsWe analyze exome sequencing data of 45,747 participants of the UK Biobank without known congestive heart failure to identify TTNtv carriers. Among 10,552 with cardiac magnetic resonance imaging (MRI), we determine the relationship between TTNtv carrier status and left ventricular ejection fraction. In this prospective cohort, we quantify the absolute and relative risks of incident disease in TTNtv carriers versus noncarriers.\n\nResultsAmong 45,747 middle-aged participants without known congestive heart failure, 196 (0.43%) harbored a TTNtv. The average ejection fraction was 61% in TTNtv carriers versus 65% in noncarriers (P = 1.8 x 10-8), with a 9.3-fold increase (95% CI 3.9 - 22.2) in odds of subnormal ejection fraction (P = 5.7 x 10-5). Over a median follow-up of 6.9 years, a composite endpoint of incident dilated cardiomyopathy, congestive heart failure, or all-cause mortality was observed in 6.6% of TTNtv carriers versus 2.9% of non-carriers (adjusted hazard ratio 2.5; 95% CI 1.4 - 4.3; p = 1.1 x 10-3).\n\nConclusionsApproximately 1 in 230 middle-aged adults without known congestive heart failure harbored a TTNtv. These carriers had a substantially increased relative risk--but modest absolute risk--of having a subnormal ejection fraction or manifesting clinical disease during prospective follow-up.\n\nCondensed AbstractCross-sectional studies of dilated cardiomyopathy have noted a truncating mutation in the gene encoding titin ( TTNtv) in up to 30% of patients--but the clinical importance of TTNtv in asymptomatic adults is largely unknown. Here, we observe a TTNtv in 0.43% of 45,747 middle-aged adults. Average ejection fraction was 61% in TTNtv carriers versus 65% in non-carriers (p<0.001). Over a median follow-up of 7 years, incident congestive heart failure or mortality was observed in 6.6% of TTTtv carriers versus 2.9% of non-carriers (hazard ratio 2.5; p = 0.001).","preprint_author_corresponding":"Amit V Khera","preprint_author_corresponding_institution":"Massachusetts General Hospital"},{"preprint_doi":"10.1101\/19003012","published_doi":"10.1136\/bmjopen-2019-034299","published_journal":"BMJ Open","preprint_platform":"medRxiv","preprint_title":"Improvements in the incidence and survival of cancer and cardiovascular but not infectious disease have driven recent mortality improvements in Scotland: nationwide cohort study of linked hospital admission and death records 2001-2016","preprint_authors":"Timmers, P. R. H. J.; Kerssens, J. J.; Minton, J. W.; Grant, I.; Wilson, J. F.; Campbell, H.; Fischbacher, C. M.; Joshi, P. K.","preprint_category":"public and global health","preprint_date":"2019-08-05","published_date":"2020-03-25","preprint_abstract":"ObjectivesTo identify the causes and future trends underpinning improvements in life expectancy in Scotland and quantify the relative contributions of disease incidence and survival.\n\nDesignPopulation-based study.\n\nSettingLinked secondary care and mortality records across Scotland.\n\nParticipants1,967,130 individuals born between 1905 and 1965, and resident in Scotland throughout 2001-2016.\n\nMain outcome measuresHospital admission rates and survival in the five years following admission for 28 diseases, stratified by sex and socioeconomic status.\n\nResultsThe five hospital admission diagnoses associated with the greatest burden of death subsequent to admission were \"Influenza and pneumonia\", \"Symptoms and signs involving the circulatory and respiratory systems\", \"Malignant neoplasm of respiratory and intrathoracic organs\", \"Symptoms and signs involving the digestive system and abdomen\", and \"General symptoms and signs\". Using disease trends, we modelled a mean mortality hazard ratio of 0.737 (95% CI 0.730-0.745) across decades of birth, equivalent to a life extension of [~]3 years per decade. This improvement was 61% (30%-93%) accounted for by improvements in disease survival after hospitalisation (principally cancer) with the remainder accounted for by a fall in hospitalisation incidence (principally heart disease and cancer). In contrast, deteriorations in the incidence and survival of infectious diseases reduced mortality improvements by 9% ([~]3.3 months per decade). Overall, health-driven mortality improvements were slightly greater for men than women (due to greater falls in disease incidence), and generally similar across socioeconomic deciles. We project mortality improvements will continue over the next decade but will slow down by 21% because much of the progress in disease survival has already been achieved.\n\nConclusionMorbidity improvements broadly explain observed improvements in overall mortality, with progress on the prevention and treatment of heart disease and cancer making the most significant contributions. The gaps between men and womens morbidity and mortality are closing, but the gap between socioeconomic groups is not. A slowing trend in improvements in morbidity may explain the stalling in improvements of period life expectancies observed in recent studies in the UK. However, our modelled slowing of improvements could be offset if we achieve even faster improvements in the major diseases contributing to the burden of death, or if we improve prevention and survival of diseases which have deteriorated recently, such as infectious disease, in the future.\n\nSummary boxO_ST_ABSWhat is already known on this topicC_ST_ABSO_LILong term improvements in Scottish mortality have slowed down recently, while life expectancy inequalities between socioeconomic classes are increasing.\nC_LIO_LIDeaths attributed to ischaemic heart disease and stroke in Scotland have declined in the last two decades.\nC_LI\n\nWhat this study addsO_LIGains in life expectancy can largely be attributed to improvements in cancer survival and falls in incidence of cancer and cardiovascular disease.\nC_LIO_LIThe hospitalisation rate and survival of several infectious diseases have deteriorated, and for urinary infections, this decline has been more rapid in more socioeconomically deprived classes.\nC_LIO_LIImprovements in morbidity are projected to slow down, with much progress in survival of heart disease and cancer already achieved, and align with the recently observed slow-down in mortality improvements.\nC_LI","preprint_author_corresponding":"Paul R. H. J. Timmers","preprint_author_corresponding_institution":"Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK"},{"preprint_doi":"10.1101\/2020.02.20.20025841","published_doi":"10.1038\/s41591-020-0819-2","published_journal":"Nature Medicine","preprint_platform":"medRxiv","preprint_title":"Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19","preprint_authors":"Thevarajan, I.; Nguyen, T. H.; Koutsakos, M.; Druce, J.; Caly, L.; van de Sandt, C. E.; Jia, X.; Nicholson, S.; Catton, M.; Cowie, B.; Tong, S.; Lewin, S.; Kedzierska, K.","preprint_category":"infectious diseases","preprint_date":"2020-02-23","published_date":"2020-03-16","preprint_abstract":"We report the kinetics of the immune response in relation to clinical and virological features of a patient with mild-to-moderate coronavirus disease-19 (COVID-19) requiring hospitalisation. Increased antibody-secreting cells, follicular T-helper cells, activated CD4+ and CD8+ T-cells and IgM\/IgG SARS-CoV-2-binding antibodies were detected in blood, prior to symptomatic recovery. These immunological changes persisted for at least 7 days following full resolution of symptoms, indicating substantial anti-viral immunity in this non-severe COVID-19.","preprint_author_corresponding":"Katherine Kedzierska","preprint_author_corresponding_institution":"University of Melbourne\/Doherty Institute"},{"preprint_doi":"10.1101\/2020.02.25.20027664","published_doi":"10.1183\/13993003.00547-2020","published_journal":"European Respiratory Journal","preprint_platform":"medRxiv","preprint_title":"Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis","preprint_authors":"Guan, W.-j.; Liang, W.-h.; Zhao, Y.; Liang, H.-r.; Chen, Z.-s.; Li, Y.-m.; Liu, X.-q.; Chen, R.-c.; Tang, C.-l.; Wang, T.; Ou, C.-q.; Li, L.; Chen, P.-y.; Sang, L.; Wang, W.; Li, J.-f.; Li, C.-c.; Ou, L.-m.; Cheng, B.; Xiong, S.; Ni, Z.-y.; Hu, Y.; Xiang, J.; Liu, L.; Shan, H.; Lei, C.-l.; Peng, Y.-x.; Wei, L.; Liu, Y.; Hu, Y.-h.; Peng, P.; Wang, J.-m.; Liu, J.-y.; Chen, Z.; Li, G.; Zheng, Z.-j.; Qiu, S.-q.; Luo, J.; Ye, C.-j.; Zhu, S.-y.; Cheng, L.-l.; Ye, F.; Li, S.-y.; Zheng, J.-p.; Zhang, N.-f.; Zhong, N.-s.; He, J.-x.","preprint_category":"respiratory medicine","preprint_date":"2020-02-27","published_date":"2020-03-26","preprint_abstract":"ObjectiveTo evaluate the spectrum of comorbidities and its impact on the clinical outcome in patients with coronavirus disease 2019 (COVID-19).\n\nDesignRetrospective case studies\n\nSetting575 hospitals in 31 province\/autonomous regions\/provincial municipalities across China\n\nParticipants1,590 laboratory-confirmed hospitalized patients. Data were collected from November 21st, 2019 to January 31st, 2020.\n\nMain outcomes and measuresEpidemiological and clinical variables (in particular, comorbidities) were extracted from medical charts. The disease severity was categorized based on the American Thoracic Society guidelines for community-acquired pneumonia. The primary endpoint was the composite endpoints, which consisted of the admission to intensive care unit (ICU), or invasive ventilation, or death. The risk of reaching to the composite endpoints was compared among patients with COVID-19 according to the presence and number of comorbidities.\n\nResultsOf the 1,590 cases, the mean age was 48.9 years. 686 patients (42.7%) were females. 647 (40.7%) patients were managed inside Hubei province, and 1,334 (83.9%) patients had a contact history of Wuhan city. Severe cases accounted for 16.0% of the study population. 131 (8.2%) patients reached to the composite endpoints. 399 (25.1%) reported having at least one comorbidity. 269 (16.9%), 59 (3.7%), 30 (1.9%), 130 (8.2%), 28 (1.8%), 24 (1.5%), 21 (1.3%), 18 (1.1%) and 3 (0.2%) patients reported having hypertension, cardiovascular diseases, cerebrovascular diseases, diabetes, hepatitis B infections, chronic obstructive pulmonary disease, chronic kidney diseases, malignancy and immunodeficiency, respectively. 130 (8.2%) patients reported having two or more comorbidities. Patients with two or more comorbidities had significantly escalated risks of reaching to the composite endpoint compared with those who had a single comorbidity, and even more so as compared with those without (all P<0.05). After adjusting for age and smoking status, patients with COPD (HR 2.681, 95%CI 1.424-5.048), diabetes (HR 1.59, 95%CI 1.03-2.45), hypertension (HR 1.58, 95%CI 1.07-2.32) and malignancy (HR 3.50, 95%CI 1.60-7.64) were more likely to reach to the composite endpoints than those without. As compared with patients without comorbidity, the HR (95%CI) was 1.79 (95%CI 1.16-2.77) among patients with at least one comorbidity and 2.59 (95%CI 1.61-4.17) among patients with two or more comorbidities.\n\nConclusionComorbidities are present in around one fourth of patients with COVID-19 in China, and predispose to poorer clinical outcomes.\n\nHighlightsO_ST_ABSWhat is already known on this topicC_ST_ABS- Since November 2019, the rapid outbreak of coronavirus disease 2019 (COVID-19) has recently become a public health emergency of international concern. There have been 79,331 laboratory-confirmed cases and 2,595 deaths globally as of February 25th, 2020\n- Previous studies have demonstrated the association between comorbidities and other severe acute respiratory diseases including SARS and MERS.\n- No study with a nationwide representative cohort has demonstrated the spectrum of comorbidities and the impact of comorbidities on the clinical outcomes in patients with COVID-19.\n\n\nWhat this study adds- In this nationwide study with 1,590 patients with COVID-19, comorbidities were identified in 399 patients. Comorbidities of COVID-19 mainly included hypertension, cardiovascular diseases, cerebrovascular diseases, diabetes, hepatitis B infections, chronic obstructive pulmonary disease, chronic kidney diseases, malignancy and immunodeficiency.\n- The presence of as well as the number of comorbidities predicted the poor clinical outcomes (admission to intensive care unit, invasive ventilation, or death) of COVID-19.\n- Comorbidities should be taken into account when estimating the clinical outcomes of patients with COVID-19 on hospital admission.","preprint_author_corresponding":"Wei-jie Guan","preprint_author_corresponding_institution":"Guangzhou Institute of Respiratory Health"},{"preprint_doi":"10.1101\/2020.02.24.20027375","published_doi":"10.7326\/m20-0696","published_journal":"Annals of Internal Medicine","preprint_platform":"medRxiv","preprint_title":"Estimation of COVID-2019 burden and potential for international dissemination of infection from Iran","preprint_authors":"Tuite, A. R.; Bogoch, I.; Sherbo, R.; Watts, A.; Fisman, D. N.; Khan, K.","preprint_category":"epidemiology","preprint_date":"2020-02-25","published_date":"2020-03-16","preprint_abstract":"The Coronavirus Disease 2019 (COVID-19) epidemic began in Wuhan, China in late 2019 and continues to spread globally, with exported cases confirmed in 28 countries at the time of writing. During the interval between February 19 and 23, 2020, Iran reported its first 43 cases with eight deaths. Three exported cases originating in Iran were identified, suggesting a underlying burden of disease in that country than is indicated by reported cases. A large epidemic in Iran could further fuel global dissemination of COVID-19. We sought to estimate COVID-19 outbreak size in Iran based on known exported case counts and air travel links between Iran and other countries, and to anticipate where infections originating in Iran may spread to next. We assessed interconnectivity between Iran and other countries using using International Air Transport Association (IATA) data. We used the methods of Fraser et al. to estimate the size of the underlying epidemic that would result in cases being observed in the United Arab Emirates (UAE), Lebanon, and Canada. Time at risk estimates were based on a presumed 6 week epidemic age, and length of stay data for visitors to Iran derived from the United Nations World Tourism Organization (UNWTO). We evaluated the relationship between the strength of travel links with Iran, and destination country rankings on the Infectious Disease Vulnerability Index (IDVI), a validated metric that estimates the capacity of a country to respond to an infectious disease outbreak. Scores range between 0-1, with higher scores reflecting greater capacity to manage infectious outbreaks. UAE, Lebanon, and Canada ranked 3rd, 21st, and 31st, respectively, for outbound air travel volume from Iran in February 2019. We estimated that 18,300 (95% confidence interval: 3770 to 53,470) COVID-19 cases would have had to occur in Iran, assuming an outbreak duration of 1.5 months in the country, in order to observe these three internationally exported cases reported at the time of writing. Results were robust under varying assumptions about undiagnosed case numbers in Syria, Azerbaijan and Iraq. Even if it were assumed that all cases were identified in all countries with certainty, the \"best case\" outbreak size was substantial (1820, 95% CI: 380-5320 cases), and far higher than reported case counts. Given the low volumes of air travel to countries with identified cases of COVID-19 with origin in Iran (such as Canada), it is likely that Iran is currently experiencing a COVID-19 epidemic of significant size for such exportations to be occurring. This is concerning, both for public health in Iran itself, and because of the high likelihood for outward dissemination of the epidemic to neighbouring countries with lower capacity to respond to infectious diseases epidemics.","preprint_author_corresponding":"Isaac Bogoch","preprint_author_corresponding_institution":"Department of Medicine, University of Toronto"},{"preprint_doi":"10.1101\/2020.02.04.20020495","published_doi":"10.3201\/eid2607.200250","published_journal":"Emerging Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Using predicted imports of 2019-nCoV cases to determine locations that may not be identifying all imported cases","preprint_authors":"De Salazar, P. M.; Niehus, R.; Taylor, A.; Buckee, C. O.; Lipsitch, M.","preprint_category":"infectious diseases","preprint_date":"2020-02-05","published_date":"2020-03-24","preprint_abstract":"Cases from the ongoing outbreak of atypical pneumonia caused by the 2019 novel coronavirus (2019-nCoV) exported from mainland China can lead to self-sustained outbreaks in other populations. Internationally imported cases are currently being reported in several different locations. Early detection of imported cases is critical for containment of the virus. Based on air travel volume estimates from Wuhan to international destinations and using a generalized linear regression model we identify locations which may potentially have undetected internationally imported cases.","preprint_author_corresponding":"Pablo M De Salazar","preprint_author_corresponding_institution":"Harvard T.H. Chan School of Public Health"},{"preprint_doi":"10.1101\/2020.02.05.20020651","published_doi":"10.1136\/bmjmilitary-2020-001429","published_journal":"BMJ Military Health","preprint_platform":"medRxiv","preprint_title":"Irish Defence Forces graduates opinions and experiences of UCDs Diploma in Military Medicine.","preprint_authors":"Loughman, S.; Berry, C.; Hickey, P.; Bury, G.","preprint_category":"medical education","preprint_date":"2020-02-07","published_date":"2020-03-12","preprint_abstract":"AimsThis study explores the opinions and experiences of Irish Defences Forces graduates from UCDs Diploma in Military Medicine. It aims to identify which aspects of medical education are relevant for the development of military graduates in future.\n\nMethodsA validated Clinical Learning Environment Score (CLES) tool was adapted and incorporated into an online survey. This was sent electronically to 71 graduates. Responses were anonymous.\n\nResults38 (54%) of graduates responded. Just 16 (42%) use their new skills in their daily work. Of the 9 (24%) deployed overseas, all used their new skills. Emergency and Occupational Health skills were used more, while advanced skills were used rarely. Only 22 (40%) of DMMC graduates work in the Defence Forces Medical Unit.\n\nConclusionStudent feedback was positive regarding teaching and clinical placements at UCD. An emphasis on frequently used skills, and a change in how Defence Forces acknowledge qualifications, may support more graduates in entering the military medical workforce.\n\nKey MessagesO_LIThe Irish Defence Forces identified the need for an innovative training programme to equip its non-medical staff to address the role known as  Combat Medical Technician(CMT).\nC_LIO_LIThis led to the development of the UCD Diploma in Military Medical Care (DMMC) programme.\nC_LIO_LIThe study shows that the skills used most frequently by graduates were those of the EMT and the Occupational Health aspects of the course.\nC_LIO_LIAdvanced skillsets were used rarely even when deployed overseas.\nC_LIO_LIIn developing future CMT courses it is recommended that the EMT and Occupational health skill sets are emphasised, with streamlining of the advanced skillset elements to focus the skills are most relevant in an overseas environment.\nC_LIO_LIIt would be advantageous to the Defence Forces for systems be put in place to recognise qualifications and support graduating students in practicing and using their new skills.\nC_LI","preprint_author_corresponding":"Sheila Loughman","preprint_author_corresponding_institution":"Centre for Emergency Medical Sciences, UCD, Dublin, Ireland"},{"preprint_doi":"10.1101\/19006452","published_doi":"10.1136\/bmjdrc-2019-001023","published_journal":"BMJ Open Diabetes Research & Care","preprint_platform":"medRxiv","preprint_title":"Nothing About Us Without Us: A Scoping Review and Priority-Setting Partnership in Type 1 Diabetes and Exercise","preprint_authors":"Klaprat, N. M. D.; Askin, N.; MacIntosh, A.; Brunton, N.; Hay, J. L.; Yardley, J. E.; Marks, S. D.; Sibley, K. M.; Duhamel, T. A.; McGavock, J. M.","preprint_category":"endocrinology","preprint_date":"2019-09-20","published_date":"2020-03-04","preprint_abstract":"ObjectivesExamine the characteristics of patient engagement (PE) practices in exercise-based randomized trials in type 1 diabetes (T1D), and facilitate T1D stakeholders in determining the top ten list of priorities for exercise research.\n\nDesignTwo methodological approaches were employed: a scoping review and a modified James Lind Alliance priority-setting partnership.\n\nMethodsPublished (Medline, Embase, CINAHL, and Central databases) and grey literature (www.clinicaltrials.gov) were searched to identify randomized controlled trials of exercise interventions lasting minimum four weeks and available in English. We extracted information on PE and patient-reported outcomes (PROMs) to identify if patient perspectives had been implemented. Based on results, we set out to determine exercise research priorities as a first step towards a patient-engaged research agenda. An online survey was distributed across Canada to collect research questions from patients, caregivers and healthcare providers. We qualitatively analyzed submitted questions and compiled a long-list that a twelve-person stakeholder steering committee used to identify the top ten priority research questions.\n\nResultsOf 9,962 identified sources, 19 published trials and 4 trial registrations fulfilled inclusion criteria. No evidence of PE existed in any included study. Most commonly measured PROMs were frequency of hypoglycemia (n=7) and quality of life (n=4). The priority-setting survey yielded 194 submitted research questions. Steering committee rankings identified 10 priorities focused on lifestyle factors and exercise modifications to maintain short-term glycemic control.\n\nConclusionRecent exercise-based randomized trials in T1D have not included PE and PROMs. Patient priorities for exercise research have yet to be addressed with adequately designed clinical trials.","preprint_author_corresponding":"Nika M.D. Klaprat","preprint_author_corresponding_institution":"Faculty of Kinesiology and Recreation Management, University of Manitoba; Diabetes Research Envisioned and Accomplished in Manitoba (DREAM) Theme, Children\\'s H"},{"preprint_doi":"10.1101\/19006106","published_doi":"10.1128\/aac.02417-19","published_journal":"Antimicrobial Agents and Chemotherapy","preprint_platform":"medRxiv","preprint_title":"Using the Association Between Antibiotic Susceptibility and Genetic Relatedness to Rescue Old Drugs for Empiric Use","preprint_authors":"MacFadden, D. R.; Coburn, B.; Brinda, K.; Corbeil, A.; Daneman, N.; Fisman, D.; Lee, R.; Lipsitch, M.; McGeer, A.; Melano, R.; Mubareka, S.; Hanage, W. P.","preprint_category":"infectious diseases","preprint_date":"2019-11-29","published_date":"2020-03-06","preprint_abstract":"BackgroundRising rates of antibiotic resistance have led to the use of broader spectrum antibiotics and increasingly compromise empiric therapy. Knowing the antibiotic susceptibility of a pathogens close genetic relative(s) may improve empiric antibiotic selection.\n\nMethodsUsing genomic and phenotypic data from three separate clinically-derived databases of Escherichia coli isolates, we evaluated multiple genomic methods and statistical models for predicting antibiotic susceptibility, focusing on potentially rapidly available information such as lineage or genetic distance from archived isolates. We applied these methods to derive and validate prediction of antibiotic susceptibility to common antibiotics.\n\nResultsWe evaluated 968 separate episodes of suspected and confirmed infection with Escherichia coli from three geographically and temporally separated databases in Ontario, Canada, from 2010-2018. The most common sequence type (ST) was ST131 (30%). Antibiotic susceptibility to ciprofloxacin and trimethoprim-sulfamethoxazole were lowest (<=72%). Across all approaches, model performance (AUC) ranges for predicting antibiotic susceptibility were greatest for ciprofloxacin (0.76-0.97), and lowest for trimethoprim-sulfamethoxazole (0.51-0.80). When a model predicted a susceptible isolate, the resulting (post-test) probabilities of susceptibility were sufficient to warrant empiric therapy for most antibiotics (mean 92%). An approach combining multiple models could permit the use of narrower spectrum oral agents in 2 out of every 3 patients while maintaining high treatment adequacy ([~]90%).\n\nConclusionsMethods based on genetic relatedness to archived samples in E. coli could be used to rescue older and typically unsuitable agents for use as empiric antibiotic therapy, as well as improve decisions to select newer broader spectrum agents.\n\nSummaryRapid genomic approaches that capitalize on the association between genetic relatedness and phenotype can improve our selection of antibiotics, allowing us to rescue older drugs for empiric use and better select newer and broader spectrum agents.","preprint_author_corresponding":"Derek R MacFadden","preprint_author_corresponding_institution":"University of Toronto"},{"preprint_doi":"10.1101\/19006585","published_doi":"10.1111\/dmcn.14500","published_journal":"Developmental Medicine & Child Neurology","preprint_platform":"medRxiv","preprint_title":"Anteroposterior balance reactions of children with and without cerebral palsy: a cross-sectional, observational study of children age 5-12 years.","preprint_authors":"Crenshaw, J. R.; Petersen, D. A.; Conner, B. C.; Tracy, J. B.; Pigman, J.; Wright, H. G.; Miller, F.; Johnson, C. L.; Modlesky, C. M.","preprint_category":"rehabilitation medicine and physical therapy","preprint_date":"2019-09-25","published_date":"2020-03-02","preprint_abstract":"AimTo compare anterior and posterior standing balance reactions, as measured by single-stepping thresholds, of children with and without cerebral palsy (CP).\n\nMethodSeventeen ambulatory children with CP and 28 typically developing children, all 5-12 years of age, were recruited for this cross-sectional, observational study. Balance reaction skill was quantified as anterior and posterior single-stepping thresholds, or the treadmill-induced perturbations that consistently elicited a step in that direction. In order to understand underlying mechanisms of between-group differences in stepping thresholds, dynamic stability was quantified using the minimum margin of stability. Ankle muscle activation latency, magnitude, and co-contraction were assessed with surface electromyography.\n\nResultsWe observed large between-group differences in anterior, but not posterior, thresholds. Between-group differences were most evident in older children, with typically developing children having larger anterior thresholds than those with CP. In response to near-threshold anterior perturbations, older typically developing children recovered from more instability than their CP peers. Older children had no between-group differences in ankle muscle activity.\n\nInterpretationThe effects of CP on balance reactions are age- and direction-specific. In response to an anterior perturbation, older typically developing children recovered from more instability than their peers with CP.\n\nWhat this paper addsO_LIChildren with CP have age- and direction-specific balance-reaction impairments.\nC_LIO_LIImpairment was most evident in the anterior reactions of older children ({approx}11 years).\nC_LIO_LITypically developing children recovered from more anterior instability than those with CP.\nC_LI\n\nGraphical Abstract\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=93 SRC=\"FIGDIR\/small\/19006585v1_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (25K):\norg.highwire.dtl.DTLVardef@1d8fdf5org.highwire.dtl.DTLVardef@108fc78org.highwire.dtl.DTLVardef@f72de3org.highwire.dtl.DTLVardef@1e5c2ca_HPS_FORMAT_FIGEXP  M_FIG C_FIG","preprint_author_corresponding":"Jeremy R Crenshaw","preprint_author_corresponding_institution":"University of Delaware"},{"preprint_doi":"10.1101\/2020.01.02.20016329","published_doi":"10.1093\/cid\/ciaa269","published_journal":"Clinical Infectious Diseases","preprint_platform":"medRxiv","preprint_title":"Dissecting the mechanisms of a 5-year decline in antibiotic prescribing","preprint_authors":"Kissler, S. M.; Klevens, R. M.; Barnett, M. L.; Grad, Y. H.","preprint_category":"epidemiology","preprint_date":"2020-01-03","published_date":"2020-03-16","preprint_abstract":"ImportanceThe mechanisms driving the recent decline in outpatient antibiotic prescribing are unknown.\n\nObjectiveTo estimate the extent to which reductions in the number of antibiotic prescriptions filled per outpatient visit (stewardship) and reductions in the monthly rate of outpatient visits (observed disease) for infectious disease conditions each contributed to the decline in annual outpatient antibiotic prescribing rate in Massachusetts between 2011 and 2015.\n\nDesignOutpatient medical and pharmacy claims from the Massachusetts All-Payer Claims Database were used to estimate rates of antibiotic prescribing and outpatient visits for 20 medical conditions and their contributions to the overall decline in antibiotic prescribing. Trends were compared to those in the National Ambulatory Medical Care Survey (NAMCS).\n\nSettingOutpatient visits in Massachusetts between January 2011 and September 2015.\n\nParticipants5,075,908 individuals with commercial health insurance or Medicaid in Massachusetts under the age of 65 and 495,515 patients included in NAMCS.\n\nMain outcomes and measuresThe number of antibiotic prescriptions avoided through reductions in observed disease and reductions in per-visit prescribing rate per medical condition.\n\nResultsBetween 2011 and 2015, the January antibiotic prescribing rate per 1,000 individuals in Massachusetts declined by 18.9% and the July antibiotic prescribing rate declined by 13.6%. The mean prescribing rate for children under 5 declined by 42.8% (95% CI 21.7%, 59.4%), principally reflecting reduced wintertime prescribing. The monthly rate of outpatient visits per 1,000 individuals in Massachusetts declined (p < 0.05) for respiratory infections and urinary tract infections. Nationally, visits for medical conditions that merit an antibiotic prescription also declined between 2010 and 2015. Of the estimated 358 antibiotic prescriptions per 1,000 individuals avoided over the study period in Massachusetts, 59% (95% CI 54%, 63%) were attributable to reductions in observed disease and 41% (95% CI 37%, 46%) to reductions in prescribing per outpatient visit.\n\nConclusions and relevanceThe decline in antibiotic prescribing in Massachusetts was driven by a decline in observed disease and improved antibiotic stewardship, with a contemporaneous reduction in visits for conditions prompting antibiotics observed nationally. A focus on infectious disease prevention should be considered alongside antibiotic stewardship as a means to reduce antibiotic prescribing.\n\nKey pointsO_ST_ABSQuestionC_ST_ABSHow did the separate mechanisms of improved stewardship and reductions in observed disease contribute to a 5-year decline in outpatient antibiotic prescribing in Massachusetts from 2011-2015?\n\nFindingsIn an observational analysis of insurance claims, reduced monthly rates of outpatient visits for infectious conditions and reduced probability of prescribing an antibiotic per outpatient visit both contributed to the decline in antibiotic prescribing. An estimated 358 antibiotic prescriptions per 1,000 individuals were avoided over the study period through the two mechanisms, 211 of which were attributable to reductions in outpatient visits and 147 to reduced antibiotic prescribing per visit.\n\nMeaningPreventing the need for outpatient visits should be considered alongside antibiotic stewardship as a means of reducing antibiotic prescribing.","preprint_author_corresponding":"Yonatan H. Grad","preprint_author_corresponding_institution":"Harvard T.H. Chan School of Public Health"},{"preprint_doi":"10.1101\/19003855","published_doi":"10.1038\/s41467-020-15046-w","published_journal":"Nature Communications","preprint_platform":"medRxiv","preprint_title":"Identifying 31 novel breast cancer susceptibility loci using data from genome-wide association studies conducted in Asian and European women","preprint_authors":"Shu, X.; Long, J.; Cai, Q.; Kweon, S.-S.; Choi, J.-Y.; Kubo, M.; Park, S. K.; Bolla, M. K.; Dennis, J.; Wang, Q.; Yang, Y.; Shi, J.; Guo, X.; Li, B.; Tao, R.; Aronson, K. J.; Chan, K. Y. K.; Chan, T. L.; Gao, Y.-T.; Hartman, M.; Ho, W.-K.; Ito, H.; Iwasaki, M.; Iwata, H.; John, E. M.; Kasuga, Y.; Khoo, U. S.; Kim, M.-K.; Kurian, A. W.; Kwong, A.; Li, J.; Lophatananon, A.; Low, S.-K.; Mariapun, S.; Matsuda, K.; Matsuo, K.; Muir, K.; Noh, D.-Y.; Park, B.; Park, M.-H.; Shen, C.-Y.; Shin, M.-H.; Spinelli, J. J.; Takahashi, A.; Tseng, C.; Tsugane, S.; Wu, A. H.; Xiang, Y.-B.; Yamaji, T.; Zheng, Y.;","preprint_category":"epidemiology","preprint_date":"2019-09-04","published_date":"2020-03-05","preprint_abstract":"Common genetic variants in 183 loci have been identified in relation to breast cancer risk in genome-wide association studies (GWAS). These risk variants combined explain only a relatively small proportion of breast cancer heritability, particularly in Asian populations. To search for additional genetic susceptibility loci for breast cancer, we performed a meta-analysis of data from GWAS conducted in Asians (24,206 cases and 24,775 controls). Variants showing an association with breast cancer risk at P < 0.01 were evaluated in GWAS conducted in European women including 122,977 cases and 105,974 controls. In the combined analysis of data from both Asian and European women, the lead variant in 28 loci not previously reported showed an association with breast cancer risk at P < 5 x10-8. In the meta-analysis of all GWAS data from Asian and European descendants, we identified SNPs in three additional loci in association with breast cancer risk at P < 5 x10-8. The associations for 10 of these loci were replicated in an independent sample of 16,787 cases and 16,680 controls of Asian women (P < 0.05). Expression quantitative trait locus (eQTL) and gene-based analyses provided evidence for the possible involvement of the YBEY, MAN2C1, SNUPN, TBX1, SEMA4A, STC1, MUTYH, LOXL2, and LINC00886 genes underlying the associations observed in eight of these 28 newly identified risk loci. In addition, we replicated the association for 78 of the 166 previously reported risk variants at P < 0.05 in women of Asian descent using GWAS data. These findings improve our understanding of breast cancer genetics and etiology and extend to Asian populations previous findings from studies of European women.","preprint_author_corresponding":"Wei Zheng","preprint_author_corresponding_institution":"Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashvil"}]}